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Abstract 
The Spielman 3P and Cano-Saper models of insomnia focus on the role of 
stress in the development of insomnia. To date, the impact of both naturalistic 
stressors and experimental stressors upon sleep have been inconsistent, due to 
limitations including the varied nature of the stressor, the diverse nature of 
participants and the lack of standardised experimental protocols for measuring stress 
and sleep. In addition, previous research has tended not to include an objective 
marker of stress, and thus cannot confirm that the stressor employed reliably elicits 
physiological stress. This thesis aimed to examine the effects of stress upon sleep, 
firstly developing and testing a standard protocol to measure both subjective and 
objective stress and sleep in the same context. Cortisol, specifically the cortisol 
awakening response (CAR), was measured as a physiological marker of 
hypothalamic-pituitary-adrenal (HPA) axis activity and objective sleep was 
measured using polysomnography. The protocol was used in an experiment to 
examine the impact of anticipation on sleep and stress, and then tease apart the 
impact of anticipation and anticipation coupled with demand, on sleep and the CAR. 
The results of the thesis indicate that anticipation of stress alone is sufficient to 
disrupt subjective sleep, when teased apart from demand. The results of the thesis 
also indicate that the CAR is a marker of anticipation and with a potential secondary 
role as a marker of recovery. Theoretically, the thesis indicates that the precipitating 
dimension within the Spielman 3P model occurs irrespective of whether the stressor 
is anticipated or actual.  
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CHAPTER 1.  
Sleep, insomnia and stress 
 
1.1. Introduction 
 The aim of this chapter is to provide an overview of normal sleep, before 
outlining the relationship between stress and the development of insomnia. This 
chapter will also provide an overview of the literature regarding the effects of stress 
upon sleep, including the effects upon both subjective and objective sleep. This 
chapter will also explore whether there are differences in the relationship between 
stress responsivity and sleep based upon the nature of the stressor, specifically real-
world naturalistic stressors and experimentally-induced stressors. 
 
1.2. Overview of normal sleep and methods of measurement 
1.2.1. Normal sleep and polysomnography 
 ‘Normal’ human adult sleep can be divided into two states, comprising non-
rapid eye movement (NREM) sleep and rapid eye movement (REM) sleep. These 
alternate across the night and are defined by different characteristics derived from 
the electroencephalogram (EEG), electromyogram (EMG) and electrooculogram 
(EOG: eye movements). When sleep is examined objectively using these 
simultaneous measures this is known as polysomnography (PSG), which also 
includes the measurement of heart rate using electrocardiogram (ECG).  Objective 
sleep can be examined in terms of sleep continuity and sleep architecture. Sleep 
continuity refers to variables including total sleep time (TST), which refers to the 
number of minutes scored as Stage 1, Stage 2, Stage 3 or rapid eye movement 
27 
 
(REM) sleep, sleep efficiency (SE%), which refers to the total sleep time as a 
percentage of the total recording time (TRT), (TST / TRT × 100 = SE%). The TRT 
refers to the time taken from lights off to lights on. Lights off refers to the time at 
which the participant is allowed to fall asleep and lights on refers to the end of the 
recording period (Berry, 2012). A sleep efficiency of 85% or above is considered 
good (Berry, 2012). Other sleep continuity variables include sleep onset latency 
(SOL), which refers to the time taken to get to sleep from lights out, the number of 
awakenings (NWAK) and the duration of wake after sleep onset (WASO) (Keenan 
& Hirshkowitz, 2011). Sleep architecture refers to the structure of sleep (Berry, 
2012) and includes measures such as the percentage of time spent in each sleep stage 
and the time taken to reach the first expression of each specific stage of sleep (Lauer, 
Riemann, Wiegand, & Berger, 1991; Spiegelhalder et al., 2012).  
 
1.2.2. Functions of sleep 
The precise function of sleep is not currently known (Allada & Siegel, 2008) 
although the importance of sleep is highlighted as sleep, or sleep-like states, are 
present in all animals (Campbell & Tobler, 1984).The importance of sleep is also 
highlighted by the fact that studies in rats have indicated that the consequences of 
total sleep deprivation is death  (Rechtschaffen, Bergmann, Everson, Kushida, & 
Gilliland, 1989). Death occurred after a period of approximately two to three weeks 
and was accompanied by physical signs including weight loss, a drop in body 
temperature and the development of ulcers on the tail and paw (Rechtschaffen et al., 
1989). Given the importance of sleep, one theory is that sleep has a restorative 
function, specifically where NREM sleep restores glycogen stores in the brain, 
which are depleted during wake (Benington & Heller, 1995). A further suggestion is 
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that sleep has a necessary function related to neural plasticity (Tononi & Cirelli, 
2006) or that sleep has a function related to  memory, in particular, where slow-wave 
sleep and REM sleep both optimise memory consolidation (Diekelmann & Born, 
2010). Whilst not fully understood, a further possibility is that sleep may have 
multiple roles, including within energy conservation, learning and memory 
consolidation, or  in the recovery and restoration of cellular processes, which occur 
during wakefulness (Mignot, 2008). 
Sleep is regulated by three processes, including a homeostatic process, a 
circadian process which is independent of sleep and waking, and an ultradian process 
occurring within sleep, where sleep alternates between REM and NREM (Borbely, 
1982; Borbely & Achermann, 2000; Luyster et al., 2012). Homeostasis refers to the 
co-ordinated physiological processes which, within an organism, maintain steady 
states, and sleep homeostasis refers to the aspect of sleep regulation which is 
dependent upon sleep and wake (Borbely & Achermann, 2000). This is where 
homeostatic mechanisms act upon any changes from a sleep ‘reference level’, where 
sleep deprivation adds to the propensity to sleep and where excess sleep reduces the 
propensity to sleep (Borbely & Achermann, 2000). The two-process model of sleep 
regulation is based on the interaction between the homeostatic process (process S) 
and the circadian process (process C) (Borbely, 1982). Within the model, process S 
increases during sleep and reduces during wake. The homeostatic sleep pressure 
increases depending on the amount of time since the last sleep period, where the 
longer an individual stays awake, the greater the homeostatic pressure to sleep. Short 
sleep durations also lead to an increase in pressure in order to recover the lost sleep 
(Borbely & Achermann, 2000; Luyster et al., 2012). It is believed that process C is 
under the control of a circadian oscillator which is unaffected by the occurrence of 
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sleep and wake (Borbely, 1982).  The process of switching between sleep and wake 
is under neural control. Saper and colleagues outlined the ‘flip-flop’ model of sleep, 
describing the sleep/wake switch , where stable wakefulness and sleep results from 
the inhibition of both wake-promoting and sleep-promoting neurons  (Saper, Chou, 
& Scammell, 2001). Within the flip-flop model, the ventrolateral preoptic nucleus 
(VLPO) and major arousal systems, and in particular the monoamine systems, inhibit 
each other and generally avoid an intermediate state between sleep and wake. The 
antagonism between the VLPO neurons and the monoaminergic cells occurs between 
large numbers of neurons, meaning that the subsequent sleep/wake transition occurs 
over a period of minutes in humans, resulting in distinct behavioural and EEG 
changes (Saper, Fuller, Pedersen, Lu, & Scammell, 2010).  
 
1.2.2.1. Consequences of sleep deprivation and sleep disruption 
Sleep disruption and sleep deprivation has a variety of consequences. 
Ultimately, the main consequence of prolonged sleep deprivation, as shown from 
animal studies involving rats and dogs, are death (Rechtschaffen et al., 1989). 
Insufficient sleep has a range of physiological effects which might contribute to 
health problems including cardiovascular disease and diabetes, which show an 
association with increased mortality rates (Luyster et al., 2012).  
Most knowledge of the effects of sleep deprivation come from studies 
examining total sleep deprivation, acute sleep deprivation  (25-50% of a normal 
eight hour sleep over a single night) or chronic sleep restriction (50%-75% of a 
normal eight hour sleep) over several consecutive nights (Faraut, Boudjeltia, 
Vanhamme, & Kerkhofs, 2012). The results of well-controlled sleep deprivation 
studies indicate that sleep loss results in a non-specific activation of blood immune 
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markers and also appears to cause low-level systematic inflammation, as indicated 
by cytokine and C-reactive protein levels after sleep loss. Importantly, it appears that 
one night of recovery sleep may not allow the recovery of these markers and that 
long-term exposure to sleep restriction may result in cumulative negative health 
results, particularly within night and shift workers (Faraut et al., 2012). 
In addition to the physiological effects, sleep deprivation can result in 
negative effects upon a range of cognitive function, including psychomotor function, 
executive attention and working memory, although these effects may be moderated 
by intra-individual differences (Goel, Rao, Durmer, & Dinges, 2009; Van Dongen, 
Baynard, Maislin, & Dinges, 2004). Sleep deprivation has been shown to result in 
cognitive impairments comparable to those observed in individuals who had 
consumed alcohol and were above the legal drink-driving limit (Williamson & 
Feyer, 2000). Shift work can also result in disruptions to sleep, where shift workers 
obtain less sleep and also have higher levels of sleepiness than daytime workers, 
where the two most dominant problems are disturbed sleep and increased levels of 
fatigue (Åkerstedt, 2003; Wright Jr, Bogan, & Wyatt, 2013). Shift work has been 
shown to be associated with a range of negative health outcomes, including heart 
disease, stroke, depression, cancer, obesity, gastrointestinal problems (Wright Jr et 
al., 2013). 
 
1.2.3. NREM sleep 
Historically, NREM sleep was divided into four separate stages, ranging 
from Stage 1 through to Stage 4 (Rechtschaffen & Kales, 1968) with each stage 
reflecting distinct properties of the polysomnogram. More recently, updated 
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American Academy of Sleep Medicine (AASM) guidelines now refer to NREM 
sleep as N1 (NREM Stage 1) through to N3 (NREM Stage 3) where N3 represents a 
combination of the Rechtschaffen & Kales (1968) Stages 3 and 4 (Iber, Ancoli-
Israel, & Quan, 2007). These stages roughly reflect the depth of sleep. Arousal 
thresholds, the point at which sleep can be discontinued, are usually at their lowest 
during Stage 1 sleep and are at their highest during Stage 4 sleep (Carskadon & 
Dement, 2011). 
 
1.2.4. REM sleep 
 REM sleep is characterised by a low-voltage, mixed-frequency EEG, muscle 
atonia and episodic bursts of rapid eye movements. In this stage muscle tone is not 
visible in the EMG channel and saccadic eye movements occur. Participants 
awakened from REM sleep typically report detailed, visual dreams and the EEG 
activity observed in REM sleep is similar to that of wake (Aserinsky & Kleitman, 
1953; Carskadon & Dement, 2011; Siegel, 2011). 
 
1.2.5. The structure of sleep during a typical night 
 A typical sleep episode in the human adult comprises 75% to 80% NREM 
sleep and 20% to 25% REM sleep, over six to seven cycles. Typical sleep is made up 
of approximately 2% to 5% of Stage 1 sleep, approximately 45% to 55% of Stage 2 
sleep, approximately 3% to 8% of Stage 3 sleep and approximately 10% to 15% of 
Stage 4 sleep. Less than 5% of the night is comprised of wakefulness (Carskadon & 
Dement, 2011). Sleep is typically examined in separate sections known as ‘epochs’, 
which are 30-seconds in duration (Iber et al., 2007; Keenan & Hirshkowitz, 2011). 
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EEG activity can be separated into frequency bandwidths, where delta activity refers 
to low frequency waves (< 4 Hertz (Hz)). Theta waves range between 4-7Hz and 
alpha activity refers to waves in the range of 8Hz to 13Hz and beta waves are low 
amplitude waves at higher frequencies (Keenan & Hirshkowitz, 2011).A normally-
sleeping adult enters sleep through NREM sleep then into REM sleep and then 
alternates between them, throughout the night, in 90-minute cycles. As such, the first 
cycle of REM sleep generally occurs 80-90 minutes following the onset of sleep 
(Carskadon & Dement, 2011).  
During the first cycle of sleep in a healthy normal adult, Stage 1 sleep is 
predominant. This episode lasts between one and seven minutes at the onset of sleep 
and occurs periodically throughout the night, usually signalling transitions between 
sleep stages. Stage 1 sleep is characterised by low-voltage, mixed frequency EEG 
activity, predominantly theta activity in the range of 4 to 7 Hz (Keenan & 
Hirshkowitz, 2011). Stage 1 sleep contains minimal amounts of slow-wave activity.  
Slow-wave activity refers to sleep-related waves of delta activity which occur at low 
frequencies (≤4 Hz) and have an amplitude of  ≥75 millivolts (mV) (Keenan & 
Hirshkowitz, 2011).  
The first episode of Stage 2 sleep, signalling the transition from wake to 
sleep, generally follows from Stage 1 and lasts for approximately 10 to 25 minutes. 
This stage is characterised by distinctive EEG patterns including sleep spindles and 
K-complexes, with low-voltage mixed-frequency background EEG and low amounts 
of slow-wave activity. Sleep spindles and K-complexes are transient waveform 
events. A sleep spindle is a short (minimum of .5 seconds) burst of activity, shaped 
like a spindle, which occur in the 12-14Hz range. K-complexes are sharply 
contoured, negative waveforms, lasting a minimum of .5 seconds, immediately 
33 
 
followed by a large and typically slower positive waveform (Keenan & Hirshkowitz, 
2011).  An example of a sleep spindle and K-complex are shown in Figure 1.1. 
Stimuli which may awaken someone from Stage 2 sleep, such as calling the name of 
a person, touching a person or closing a door, will result in an evoked K-complex, 
but will not result in an awakening if the individual is in a deeper sleep stage 
(Carskadon & Dement, 2011; Keenan & Hirshkowitz, 2011). It is generally thought 
that the function of an evoked K-complex is to protect against internal and external 
sensations creating sleep disturbances (Bastien, Ladouceur, & Campbell, 2000). 
Stage 3 sleep occurs when high-voltage slow-wave activity reaches more than 20% 
but less than 50% of EEG activity per epoch and Stage 4 occurs when this high-
voltage activity comprises more than 50% 
 
Figure 1.1: Example of an EEG waveform showing (A) a sleep spindle and (B) a K-
complex during sleep (Adapted from Berry, 2012, p. 6) 
 
of EEG activity per epoch. This usually lasts 20 to 40 minutes in the first cycle 
(Carskadon & Dement, 2011; Keenan & Hirshkowitz, 2011). Slow-wave sleep is 
typically dominant in the first third of the night. After the first third of the night, a 
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series of body movements usually occur and a brief episode of Stage 3 sleep may 
occur. This is followed by a brief episode of Stage 2 sleep, lasting five to 10 minutes, 
which is interrupted by body movements and precedes the first episode of REM 
sleep (Carskadon & Dement, 2011). 
The first cycle of REM sleep typically lasts between one to five minutes. 
NREM and REM sleep then alternate and periods of REM sleep usually lengthen 
during the night, dominating in the last third of the night, whilst Stage 3 reduces. The 
first NREM/REM sleep cycle lasts approximately between 70 to 100 minutes, and 
the second NREM/REM sleep cycle lasts between approximately 90 to 120 minutes. 
The total amount of REM sleep obtained over the night is typically between five and 
30 minutes (Carskadon & Dement, 2011; Keenan & Hirshkowitz, 2011; Siegel, 
2011). Figure 1.2 displays a hypnogram showing the progression of sleep over a 
typical night in a normally-sleeping, healthy adult. 
 
Figure 1.2: A hypnogram displaying normal sleep in a healthy, normally sleeping 
individual (Adapted from Berry, 2012, p. 80). 
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1.2.6. Alterations to normal sleep 
Stage 1 sleep is associated with a low arousal threshold and an increase in the 
amount and percentage of Stage 1 sleep is a common indicator of severe sleep 
disruption (Carskadon & Dement, 2011; Keenan & Hirshkowitz, 2011). A meta-
analysis of objective sleep across the lifespan (Ohayon, Carskadon, Guilleminault, & 
Vitiello, 2004), incorporating a total of 65 studies with normal, healthy participants 
(n = 3,577) ranging in age from 5 to 102 years old, showed that the percentage of 
REM sleep slightly increased from childhood until the end of adolescence, remaining 
stable throughout adulthood before declining at the age of 60. Sleep latency 
increased slightly in accordance with age and the percentage of Stage 1 sleep 
increased during adulthood. The percentage of Stage 2 sleep increased from 
childhood onwards until old age. Interestingly, sleep efficiency was the only sleep 
measure to show a change after 60 years of age, significantly decreasing after this 
point. However, Vitiello (2006) states that when factors including health burdens, 
sleep disorders and poor sleep hygiene are accounted for, successfully-aging adults 
can expect relatively little change in their sleep, with the exception of earlier bed and 
rise times and a reduced tolerance to circadian phase shifts. Ethnic differences in 
terms of objective sleep are, however, still poorly understood (Ohayon et al., 2004). 
Alterations to sleep are observed when sleep is measured in a sleep laboratory for the 
first time, commonly known as the ‘first-night effect’, where the adaptation to the 
laboratory results in a reduction in total sleep time, a reduced sleep efficiency, 
increased REM sleep latency and a reduction in REM sleep alongside increases in 
both sleep latency and wake after sleep onset (Agnew, Webb, & Williams, 1966; 
Kim & Dimsdale, 2007; Toussaint et al., 1995).  
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1.2.7. Limitations of polysomnography 
Limitations of PSG can include the cost and the invasiveness of the 
procedure (Blackwell et al., 2008) and despite its accuracy , PSG is unsuitable for 
the measurement of sleep within insomnia (Littner et al., 2003; Reite, Buysse, 
Reynolds, & Mendelson, 1995). In addition, PSG is not routinely used in the 
diagnosis of circadian rhythm sleep disorders resulting from a mismatch between the 
timing of sleep and the desired timing of sleep (Kushida et al., 2005). Despite these 
limitations PSG is the current ‘gold standard’ for measuring sleep (Kushida et al., 
2001). 
 
1.2.8. Additional methods of sleep assessment 
In addition to PSG, other methods of sleep assessment are commonly used, 
including actigraphy and sleep diaries. 
 
1.2.8.1. Actigraphy 
Actigraphy is a technique where sleep is measured objectively though the use 
of actiwatches. Actiwatches measure activity using a piezo-electric accelerometer 
and are typically worn on a non-dominant wrist, although in some occasions leg 
activity can be monitored (Ancoli-Israel et al., 2003). This records the intensity, 
amount and duration of movement. The recorded activity is used as a gross indicator 
of wakefulness or sleep (specifically sleep continuity) and actigraphy is considered 
to be a reliable measure of sleep and wake activity in healthy adult populations 
(Ancoli-Israel et al., 2003; Lichstein et al., 2006; Sadeh, 2011). One advantage of 
actigraphy is that it is a relatively inexpensive method of measuring sleep. An 
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additional advantage of actigraphy is that it can be used to measure the sleep of 
individuals who would find it difficult to sleep in a laboratory situation and 
actigraphy can be used for extended periods of time (Stone & Ancoli-Israel, 2011),.  
However, actigraphy does suffer from some limitations. The accuracy of detecting 
wakefulness is lower than 60% and can impact upon sleep indices such as total sleep 
time, sleep efficiency and wake after sleep onset, although extended periods of 
actigraphy may compensate for this to some extent (Sadeh, 2011). 
 
1.2.8.2. Sleep diaries 
Sleep diaries are a subjective method of sleep monitoring. These typically 
require individuals to keep a log of aspects of their sleep that include sleep duration, 
bed time, wake time, the amount of awakenings and duration of awakenings (Carney 
et al., 2012). Measures of sleep continuity can be derived from sleep diaries, 
including TST, SE% (calculated from TST / time in bed (TIB) × 100), SOL, NWAK 
and WASO (Berry, 2012).  Sleep diaries are a reliable and inexpensive method of 
obtaining subjective sleep information and are useful in providing general 
sleep/wake activity information (Berry, 2012; Rogers, Caruso, & Aldrich, 1993).  A 
diary monitoring period of one week is adequate, although up to two weeks may be 
necessary in the case of treatment studies (Sateia, Doghramji, Hauri, & Morin, 
2000).  
 
1.3. Characteristics and diagnosis of insomnia  
Individuals with insomnia report impaired daytime functioning and exhibit 
difficulties in falling asleep, dissatisfaction with the sleep quality or duration and 
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complain of waking up during the night or too early in the morning (Morin & Benca, 
2012; Riemann et al., 2010). The objective assessment of sleep within insomnia, 
using PSG, can show objective impairments, however these impairments typically 
display discrepancies with the subjective complaint of poor sleep (Morin & Benca, 
2012). The daytime consequences of insomnia also tend to be over-stated, with 
objective neuropsychological functioning not matching the self-reported daytime 
deficits (Orff, Drummond, Nowakowski, & Perils, 2007). Two main nosologies are 
used for diagnosis: the recently-updated Diagnostic and Statistical Manual of Mental 
Disorders, fifth edition (DSM-V) (American Psychiatric Association, 2013) and the 
American Academy of Sleep Medicine (AASM) International Classification of Sleep 
Disorders Manual, revised edition (ICSD-2) (American Academy of Sleep Medicine, 
2005).  The diagnostic criteria for both nosologies (DSM-V and ICSD-2) are listed 
in Table 1.1 and Table 1.2. 
 
1.3.1. Prevalence of insomnia 
Insomnia is a common sleep disorder (Leger & Bayon, 2010) and data assessing 
prevalence largely comes from point prevalence studies. Morphy and colleagues 
(Morphy, Dunn, Lewis, Boardman, & Croft, 2007) estimated the prevalence of 
insomnia in the UK to be 37%, based on the response to four questions assessing 
trouble falling asleep, waking during the night, trouble staying asleep and waking 
after the usual amount of sleep feeling unrefreshed. Depending on the criteria 
applied, the prevalence rate of insomnia can be as high as 50% (Riemann et al., 
2010).The use of a more stringent definition of insomnia gives a prevalence rate of 
approximately 6% (Ohayon, 2002). There are gender differences in the prevalence of 
insomnia, as the female/male ratio for insomnia symptoms is 1.4 and this ratio  
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Table 1.1:  
DSM-V criteria for Insomnia Disorder (American Psychiatric Association, 2013) 
Criterion Description 
A A predominant complaint of dissatisfaction with sleep quantity or 
quality, associated with one (or more) of the following symptoms: 
1. Difficulty initiating sleep (in children, this may manifest as 
difficulty initiating sleep without caregiver intervention). 
2. Difficulty maintaining sleep, characterised by frequent 
awakenings or problems returning to sleep after awakenings (in 
children, this may manifest as difficulty returning to sleep 
without caregiver intervention). 
3. Early-morning awakening with inability to return to sleep. 
B The sleep disturbance causes clinically significant distress or 
impairment in social, occupational, education, academic, behavioural, 
or other important areas of functioning. 
C The sleep difficulty occurs at least 3 nights per week. 
D The sleep difficulty is present for at least 3 months. 
E The sleep difficulty occurs despite adequate opportunity for sleep. 
F The insomnia is not better explained by and does not occur exclusively 
during the course of another sleep-wake disorder (e.g. narcolepsy, a 
breathing-related sleep disorder, a circadian rhythm sleep-wake 
disorder, a parasomnia). 
G The insomnia is not attributable to the physiological effects of a 
substance (e.g. a drug of abuse, a medication). 
H Coexisting mental disorders and medical conditions do not adequately 
explain the pre-dominant complaint of insomnia. 
Specify if : - With non-sleep disorder mental comorbidity, including 
substance use disorders 
- With other medical comorbidity 
- With other sleep disorder  
Specify if : - Episodic: symptoms last at least 1 month but less than 3 months 
- Persistent: symptoms last 3 months or longer. 
- Recurrent: Two (or more) episodes within the space of 1 year 
 
Note: acute and short-term insomnia (i.e. symptoms lasting less than 3 
months but otherwise meeting all criteria with regard to frequency, 
intensity, distress, and/or impairment) should be coded as another 
specified insomnia disorder. 
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Table 1.2:  
ICSD-2 criteria for diagnosis of insomnia (American Academy of Sleep Medicine, 
2005) 
A. One or more of the following symptoms: 
- Difficulty initiating sleep 
- Difficulty maintaining sleep 
- Waking up too early 
- Non-restorative sleep 
B. Sleep difficulty occurs despite adequate opportunity for sleep 
C. At least one of the following daytime symptoms related to the night-time 
sleep difficulty reported: 
- Fatigue or malaise 
- Attention, concentration or memory impairment 
- Social or vocational dysfunction or poor school performance 
- Mood disturbance or irritability 
- Daytime sleepiness 
- Motivation or energy or initiative reduction 
- Proneness for errors or accidents 
- Tension headaches or gastrointestinal symptoms, or both 
- Concerns or worries about sleep 
 
increases to 1.7 when over 45 years of age. Women are also twice more likely than 
men to be diagnosed with insomnia (Ohayon, 2002). The prevalence of insomnia 
increases with age, with the prevalence of insomnia reported to be close to 50% in 
elderly individuals over 65 years of age (Ohayon, 2002). 
 
1.3.2. Comorbidity of insomnia with health problems and disorders 
Insomnia is often co-morbid with other illnesses and disorders (Taylor, 
Lichstein, & Durrence, 2003) including heart disease, high blood pressure, chronic 
pain (Taylor et al., 2007), cancer (J. R. Davidson, MacLean, Brundage, & Schulze, 
2002), anxiety, substance misuse (Roth et al., 2006) and depression (Luc, 2010). 
Taylor and colleagues (Taylor, Lichstein, Durrence, Reidel, & Bush, 2005) showed 
that individuals with insomnia were 9.82 times and 17.35 times more likely than 
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people without insomnia to have clinically significant depression and anxiety, 
respectively.  
Insomnia is in itself a risk factor for depression, as having symptoms of 
insomnia for more than two weeks resulted in an increased risk of depression during 
the following one to three years (Riemann & Voderholzer, 2003). Whilst Riemann & 
Voderholzer (2003) did not specify the extent to which symptoms relate to 
depression, a meta-analysis by Baglioni and colleagues (Baglioni et al., 2011) 
showed that insomnia predicted depression with an overall odds ratio (OR) of 2.1 
(95% confidence interval (CI): 1.86 – 2.38). Further studies have also observed this 
comorbidity between insomnia and depression (Buysse et al., 2008) although the 
relationship can be bi-directional (Jansson-Fröjmark & Lindblom, 2008).  
A large-scale Norwegian study (n = 47,700) showed a co-morbidity between 
insomnia symptoms and conditions such as anxiety, depression, conditions with pain 
such as fibromyalgia, headaches, osteoporosis and musculoskeletal disorders. The 
strongest associations were shown between insomnia symptoms and mental 
conditions (OR = 2.66) and pain conditions (OR =  2.75) (Sivertsen, Krokstad, 
Øverland, & Mykletun, 2009a).   
 
1.3.3.  Costs of insomnia 
 Insomnia also has an associated economic and occupational cost. Individuals 
with insomnia display higher rates of absenteeism from work than good sleepers, 
being absent from work twice as often as good sleepers (OR = 1.96) (Leger, 
Massuel, Metlaine, & Group, 2006). Insomnia is also a significant predictor of long-
term sick leave from work (Sivertsen, Øverland, Bjorvatn, Mæland, & Mykletun, 
2009b). A French study concluded that the annual cost of absenteeism in those with 
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insomnia is approximately €2,500 per employee, and that this cost is largely 
burdened by employers (Godet-Cayre et al., 2006).  
 Whilst the overall cost of insomnia upon society is not known (Leger & 
Bayon, 2010), studies in various have attempted to estimate the costs of insomnia in 
relation to the Gross Domestic Profit of various countries. The direct cost of 
insomnia in France in 1995 was estimated to be 10.2 billion Francs (approximately 
$2 billion) (Leger, Levy, & Paillard, 1999) and the total direct costs of insomnia in 
the United States in 1995 were estimated to be $13.9 billion (Walsh & Engelhardt, 
1999). An additional study estimated the costs of insomnia in the area of Quebec in 
Canada (Daley, Morin, LeBlanc, Gregoire, & Savard, 2009) at approximately C$6.6 
billion per year. This figure included C$191 million in medical consultations, 
C$16.5 million in prescription medication, C$1 billion in work absenteeism, and 
C$5 billion in the loss of work productivity. This also included alcohol, used as a 
sleep aid, which cost C$339.8 million and over-the-counter medication, which cost 
C$1.8million. A further study examined the economic burden of insomnia on an 
individual level and found that in younger adults, the direct and indirect costs were 
about $1,250 higher than those without insomnia, and in older adults, direct costs 
were about $1,150 higher for those with insomnia (Ozminkowski, Wang, & Walsh, 
2007).  
 Whilst the cost of insomnia to the United Kingdom is unknown, data from 
the National Institute for Health and Care Excellence (NICE) does highlight the cost 
of medication prescribed for insomnia in England. A variety of hypnotics referred to 
as ‘z-hypnotics’, including zaleplon, zolpidem and zopiclone, are often prescribed 
for insomnia. In the 12-month period from March 2007 to March 2008, a total of 5.2 
million prescriptions were dispensed at a cost of £12.3 million. Benzodiazepine 
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hypnotics are also used to treat insomnia and in the same period 4.7 million of these 
prescriptions were dispensed, at a cost of £17.9 million (National Institute for 
Clinical Excellence, 2008). NICE guidelines currently state that these z-hypnotics 
are appropriate for the management of severe insomnia after considering non-
pharmacological measures, but that hypnotics should only be prescribed for a short 
period of time (National Institute for Clinical Excellence, 2004).  
 
1.4. The role of stress within the development of insomnia 
Whilst insomnia is a common sleep disorder, is typically co-morbid with 
conditions such as depression and has an associated economic cost (Godet-Cayre et 
al., 2006; Leger & Bayon, 2010; Taylor et al., 2003), the transition from normal 
sleep to acute insomnia is currently poorly understood (Ellis, Gehrman, Espie, 
Riemann, & Perlis, 2012). Only one diagnostic system, the ICSD-2 (American 
Academy of Sleep Medicine, 2005) acknowledges that insomnia may be a direct 
result of stress. The ICSD-2 states that adjustment insomnia or acute insomnia, 
which refers to short-term insomnia, occurs in association with an identifiable 
stressor and is typically short in duration, lasting between a few days and a few 
weeks. The stressor may include psychological, psychosocial, physical, medical or 
environmental circumstances and can include events such as interpersonal 
relationship issues, occupational stress, personal losses, bereavement, a medical 
diagnosis, visiting or moving to a new location, or changes to the sleeping 
environment. Events with a positive or a negative valence can act as a stressor in the 
context of adjustment insomnia (American Academy of Sleep Medicine, 2005). The 
ICSD-2 states that adjustment insomnia lasts for a maximum of three months and 
that sleep disturbances are the primary feature. Waking symptoms such as anxiety, 
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worry, sadness or depression in relation to the stressor may also be apparent, 
alongside other physical and daytime symptoms.  
Previous research has examined the role of stress, in terms of life events, 
within insomnia. Bastien and colleagues interviewed 345 patients at a sleep disorders 
clinic and identified precipitating events which were associated with the onset of 
insomnia. It was shown that 78.3% of participants were able to identify a specific 
precipitating event. The most common events identified included those related to 
family, health and work or education events and the majority of these events were 
negatively valenced (Bastien, Vallieres, & Morin, 2004). Healey and colleagues 
reported that 23 out of 31 (76.2%) individuals with insomnia reported that their 
insomnia was subjectively connected to a major event (Healey et al., 1981). 
Interestingly, each of the remaining eight participants with insomnia (25.8%) 
reported the occurrence of at least one major life event in their lives at that 
approximate time point.  In addition, those with insomnia experienced a greater 
amount of stressful life events during the year of insomnia onset when compared to 
good sleepers (Healey et al., 1981). This finding in terms of the amount of stressful 
life events was not shown elsewhere, as Morin and colleagues reported that whilst 
good sleepers and individuals with insomnia reported similar amounts of stressful 
life events, those with insomnia reported that major negative life events were more 
intense and that daily stressors had a higher impact (Morin, Rodrigue, & Ivers, 
2003). Levels of bedtime arousal and coping style both acted as mediators between 
daytime stress and night-time sleep. Those with insomnia more frequently relied 
upon emotion-oriented coping strategies than good sleepers, which focus on 
reducing the emotional distress resulting from a stressful situation rather than 
resolving the problem itself. Overall, this suggests that it is the perceived lack of 
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control over the stressful events, rather than the number of stressful events, which 
enhance the vulnerability to insomnia (Morin et al., 2003).  Taken together, this 
confirms the role of stressors in insomnia.  
Other studies have incorporated objective measures of sleep in order to 
examine the relationship between sleep and stress within insomnia. Hall and 
colleagues examined this relationship within healthy adults who met DSM-IV 
criteria for primary insomnia (Hall et al., 2000). Those who showed an increase in 
subjective stress burden also showed an associated reduction in delta power and 
showed a trend towards a higher level of intrusion tendencies. The measure of 
intrusion tendencies referred to the tendency to experience stress-related intrusive 
thoughts, measured using a scale in which participants were required to indicate how 
frequently they experienced symptoms of intrusive thoughts after a stressful event. In 
a later study Hall and colleagues assessed the relationship between psychological 
stress and measures of physiological arousal during NREM sleep in those with 
insomnia. Quantitative EEG showed that an increase in perceived levels of stress 
was associated with a decrease in delta power and an increase in beta power during 
NREM sleep (Hall et al., 2007). That said, Riemann (2010) reports that large and 
well-controlled studies are needed in order to clarify contradictory findings from 
quantitative EEG studies in insomnia. Overall, stress does show a relationship with 
insomnia, but it is possible that stress can cause the acute sleep disturbance, 
presaging the development of insomnia. The following section will briefly outline 
models of insomnia which specifically describe the circumstances under which acute 
sleep disturbances occur in response to a stressor (Ellis et al., 2012).  
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1.5. Models of insomnia with a focus on stress-diathesis  
Two theoretical models of insomnia, the Spielman 3P model (Spielman, Caruso, 
& Glovinsky, 1987; Spielman & Glovinsky, 1991; Spielman, Nunes, & Glovinsky, 
1996) and the Cano-Saper rodent model of insomnia (Cano, Mochizuki, & Saper, 
2008) have a role of stress as the cause of insomnia. Within both of these models, 
stress can disrupt sleep by causing an individual to go beyond an insomnia/sleep 
disturbance threshold or a ‘switch point’. This switch point is most clearly identified 
and incorporated within the Spielman 3P model, although, it is possible that each 
individual animal within the Cano-Saper model has such an individual switch point. 
However, this is not identified or described within the Cano-Saper model. This 
section will provide an overview of each model and will explain the role of the 
stressor. 
 
1.5.1. Spielman 3P model of insomnia 
The Spielman 3P model  focuses on three factors; predisposing, precipitating 
and perpetuating factors, describing how normal sleep can lead to acute insomnia 
and how this can lead to chronic insomnia,  by taking an individual over an insomnia 
threshold or ‘switch point’ (Spielman et al., 1987; Spielman & Glovinsky, 1991; 
Spielman et al., 1996). Predisposing factors are biological vulnerabilities which 
determine the threshold for insomnia. These may factors such as basal metabolic 
rate, hyper-reactivity to stress, sleep and wakefulness, neurotransmitter alterations, 
potentially governed by underlying genetic differences between individuals, 
psychological factors such as vulnerability to depression and anxiety or a tendency to 
excessively worry or ruminate (Perlis, Shaw, Cano, & Espie, 2011; Spielman & 
Glovinsky, 1991; Spielman et al., 1996). Social factors may also be an influence, by 
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having a bed-partner with opposing sleep habits or having undesirable sleeping 
schedule (Perlis et al., 2011; Spielman & Glovinsky, 1991). Precipitating factors are 
acute stressors, which can include medical illness and psychiatric illnesses. These 
factors then interact with the predisposing vulnerability factors resulting in an initial 
period of sleep disruption (Ellis et al., 2012; Perlis et al., 2011). The final aspect of 
the model examines perpetuating factors, which are the behaviours which the 
individual suffering from insomnia adopts in order to either cope with or compensate 
for the associated sleeplessness/sleepiness. This consists of behavioural and 
cognitive factors, including excessive time in bed, keeping irregular sleep/wake 
patterns, the anxiety over the subsequent daytime deficit, the expectation of a bad 
night and fragmentation of sleep and maladaptive conditioning. In addition, this 
includes caffeine, hypnotic and alcohol consumption as coping mechanisms. The 
complaint of insomnia persists even after the stress has ended (Perlis et al., 2011; 
Spielman & Glovinsky, 1991). Figure 1.3 displays the various stages of the 3P 
model and the threshold for insomnia.  
Spielman & Glovinsky (1991) provide a hypothetical example of the working 
model in a young man who has a tendency towards eveningness (i.e. exhibiting a 
preference for evening activities as opposed to morning activities).  In the example 
the stressor is that the young man receives a job promotion that results in a higher 
level of scrutiny and provokes the development of an anxiety state, which pushes 
him over the threshold for insomnia. He tries to cope by recouping sleep at the 
weekend but worries about the impact of his working schedule on sleep loss. By the 
time the individual seeks treatment for the sleep problems, he has adapted to the 
increased work demands but still has problems sleeping, reflecting the chronic 
insomnia stage. The model has been tested to an extent, for example, in the case of 
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stress-induction studies within good sleepers, however a limitation is that it is 
difficult to test the model as no specific circumstances or characteristics are provided 
at each stage of the model (Ellis et al., 2012; Perlis et al., 2011). 
 
 
Figure 1.3: Spielman 3P Model (Adapted from Spielman & Glovinsky, 1991, p. 12) 
   
1.5.2. Cano-Saper rodent model of insomnia 
The Cano-Saper rodent model of insomnia has offered an insight into the 
neurobiology of stress-induced insomnia  (Cano et al., 2008). Within the Cano-Saper 
model of insomnia (Figure 1.4) stress was induced by taking a male rat at the peak 
level of their sleep, and placing it into a dirty cage which had been occupied by 
another male rat for a period of one week. As rats are extremely territorial and the 
cage exchange acted as a stressor. 
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Exposure to surroundings that have been occupied by another rat, even 
though the rat is not present, provokes and induces a stress fight-or-flight response 
through olfactory and visual cues. This includes activation of the autonomic nervous 
system and of the hypothalamic-pituitary-adrenal (HPA) axis and results in sustained 
wakefulness (Cano et al., 2008; Perlis et al., 2011). Rats subjected to the cage 
exchange displayed less sleep than control rats, as expressed through a higher 
percentage of wake and through a decreased percentage of NREM sleep. This was 
the case in the first and second hours after the cage exchange, indicating a stress 
response and five and six hours afterwards, analogous to a period of acute insomnia. 
The cage exchange rats also displayed almost double the sleep latency than control 
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Figure 1.4: Assumed mechanisms involved in Cano-Saper stress-induced 
insomnia (adapted from Perlis et al., 2011, p. 860. Within the model, + represents 
activation and - represents inactivation 
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rats, showing a mean sleep latency of 58.7 minutes compared to a control group 
duration of 31.8 minutes. There were no differences in NREM bouts, but cage 
exchange rats also showed a reduced percentage of REM sleep. Cage exchange rats 
also showed higher levels of sleep fragmentation, observed through fewer transitions 
from NREM to REM sleep and a greater amount of transitions to wakefulness. 
 Neuronal activity in the rats was also examined through measuring the 
expression of Fos proteins. Increases in Fos levels were observed in the caudal 
section of the medial paraventricular hypothalamic nucleus (mp-PVH) in the cage 
exchange rats. The mp-PVH contains corticotropin-releasing hormone (CRH) as well 
as neurons involved in the control of autonomic function. Overall, Fos activation 
patterns showed that the cage exchange rats were aroused several hours after the 
exchange procedure. The cage exchange initially produced acute stress and indicated 
an increase in both autonomic arousal and in HPA axis function. One interesting 
finding from this study was that even though cage exchange resulted in sleep 
disturbances, with these animals sleeping less (25% - 30% in the later phase), 
increases in Fos levels were observed in neural regions believed to be sleep-
promoting. These regions included the ventrolateral preoptic nucleus core (VLPOc), 
the extended ventrolateral preoptic nucleus (VLPOex) and the median preoptic 
nucleus (MnPO). Overall this suggested that the stressor evoked the simultaneous 
activation of sleep systems and arousal systems. Fos activation patterns were also 
found to be very similar to results from a positron emission tomographic (PET) 
neuroimaging study conducted in humans with insomnia (Nofzinger et al., 2004), 
where individuals with insomnia displayed a slightly smaller decrease in relative 
glucose metabolism than good sleeper controls during the transition from wake to 
sleep. This was the case in wake-promoting regions of the brain including the 
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ascending reticular system, hypothalamus, insular cortex, amygdala and 
hippocampus, as well as in the anterior cingulate and the medial prefrontal cortex. 
This suggested that the inability to fall asleep as seen in insomnia may be related to 
the failure of the arousal systems to decline in activity when transitioning from wake 
to sleep, with the decline in prefrontal cortex activity possibly being a consequence 
of daytime fatigue.  
Therefore, the Cano-Saper animal model of stress-induced acute insomnia fits 
well with the psychobiological inhibition model of insomnia (Espie, 2002) in that the 
results suggest that there was an inability to inhibit wakefulness rather than sleep. 
The cage exchange rats show a unique pattern of activity, as whilst neural activity is 
the same as that of a sleeping rat, the arousal system and cortex show activity similar 
to wake (Perlis et al., 2011).  Cano and Saper conclude that during insomnia, the 
VLPO (both the VLPOc and VPLOex) is fully activated due to a combination of 
homeostatic and circadian pressure, and that the arousal system cannot be turned off 
due to excitation of the limbic system.  Simultaneously, the arousal system is unable 
to turn off the VLPO due to the input of the homeostatic and circadian systems, with 
the stronger homeostatic pressure coming from the fact that the stressed rats suffer 
from partial sleep deprivation (Cano et al., 2008; Perlis et al., 2011). The model 
involves olfactory signals from the cage exchange being sent to the limbic system, 
and this activates both the arousal and autonomic systems in addition to non-orexin 
neurons in the lateral hypothalamus. As a result, the cerebral cortex becomes 
activated by the input from the arousal system and lateral hypothalamus, generating 
high-frequency activity during NREM sleep. Co-activation of both sleep and arousal 
systems would usually be prevented, however the combination of homeostatic and 
circadian pressure activates the sleep system. The stress results in an activation of the 
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arousal system and this results in the observed simultaneous neural activation (Cano 
et al., 2008; Perlis et al., 2011). 
A major strength of the Cano-Saper model is that it directly shows the negative 
effects of a psychosocial stressor, rather than a physical stressor upon sleep variables 
and upon the neurological markers and thus shows the link between acute stress and 
sleep (Ellis et al., 2012). As the stressor produced an increase of Fos expression in 
the mp-PVH, an initiator of the adrenocortical stress response (Cano et al., 2008) a 
human analogue of the model could be potentially examined wherein the 
glucocorticoid cortisol, one of the secretory adrenocortical end products of the HPA 
axis, is measured through blood or saliva sampling (Hucklebridge, Hussain, Evans, 
& Clow, 2005). However, as this is an animal model it may be difficult to translate 
and develop this to a human model of provoking and examining acute insomnia in 
humans (Ellis et al., 2012). One positive aspect of the Cano-Saper model is that it 
suggests insomnia can be transitional where acute insomnia is either part of the fight-
or-flight response to stress or as a consequence, showing that the insomnia is an 
adaptive response to a perceived or actual threat (Ellis et al., 2012; Perlis et al., 
2011).. Whilst the Cano-Saper rodent model identifies useful aspects of the potential 
neurobiology of acute insomnia, it cannot assess the subjective complaint nor is it 
relevant to chronic insomnia. Furthermore, not all groups of neurons express Fos in 
association with action potential activity, which may limit the model when used to 
examine human neural substrates of acute insomnia (Perlis et al., 2011).   
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1.6. Models of insomnia with a involvement of stress in sleep maintenance  
Whilst, as discussed, the Spielman 3P and Cano-Saper models of insomnia 
outline the role of stress in causing the insomnia, there are other models of insomnia 
which have an involvement of stress within sleep maintenance. These models are 
discussed in the following sections. 
 
1.6.1. Lundh & Broman model of insomnia 
 Lundh & Broman’s (2000) model explains  how ‘sleep-interfering’ and ‘sleep-
interpreting’ processes combine to produce insomnia (Figure 1.5). Sleep-interfering 
processes refer to those that create physiological, emotional or cognitive arousal. 
Within the model, physiological and psychological arousal are both potential causes 
of insomnia and Lundh & Broman suggest that in order to understand the cause of 
insomnia, the causes of arousal must also be understood. Within the framework of 
the model, the causes of arousal may result from interactions between a particular 
event and individual factors. These may include basic arousal levels, ‘arousibility’, 
shown in response to the arousing event and slow levels of habituation, referring to 
the return to the basic arousal level following the event. The second part of the 
model focuses on intra-individual differences in sleep-interpreting processes, 
referring to the psychological processes involved in each individual’s personal 
definition of insomnia in relation to their current state. This integrative model also 
takes into account psychological factors where individuals may have a predisposition 
to both the sleep-interfering processes and the sleep-interpreting processes. These 
would include having higher basal levels of arousal and arousability, which can 
include personality traits such as having a high level of emotional sensitivity, being  
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easily hurt and having a slow recovery from stress. Other psychological variables 
could include having a personal disposition to worry, experiencing emotional 
conflicts in personal relationships and emotional involvement in the problems of 
others. Lundh & Broman (2000) also speculate that the personality trait of 
perfectionism may also act as a pre-dispositional factor for insomnia, as poor sleep 
and what counts as impaired daytime functioning are largely subjective experiences. 
Therefore, the higher the level of perfectionism which an individual has, the lower 
their threshold level is for perceiving insufficient sleep. Within the framework of the 
model, perfectionism may also feed into the sleep-interfering processes, such as 
through worrying about sleeplessness and through predisposing an individual to 
having a stronger emotional response to a negative life event which may in turn 
disrupt sleep.  
Figure 1.5: Lundh & Broman’s Integrative model of insomnia (Adapted from Lundh 
& Broman, 2000, p. 308) 
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 Lundh & Broman’s model involves four categories of vulnerability factors for 
sleep-interfering arousal processes (arousability, stimulus-arousal associations, 
behavioural and cognitive strategies with regard to the sleep situation and emotional 
aspects of interpersonal relations) and three categories of vulnerability for sleep-
interfering processes (high personal standards, dysfunctional beliefs, and 
attributions). The fact that this model does take into account intra-individual 
differences in baseline arousal levels, intra-individual differences in stress responses 
and intra-individual levels in habituation is a particular strength of the model (Ellis et 
al., 2012).  
 Support for the model comes from a study that showed that within normal 
sleepers, perfectionism was related to the severity of sleeping problems and with an 
increased level of concern over the negative consequences. In addition, within the 
same study, a group of insomnia patients showed higher levels of perfectionism than 
normal sleepers (Lundh, Broman, Hetta, & Saboonchi, 1994). A further study 
assessed whether perfectionism was related to pre-existing insomnia and future 
insomnia, at a baseline and at a one-year follow-up time point (Jansson-Fröjmark & 
Linton, 2007) and an association was shown between perfectionism and insomnia, 
although this association was weak. Those with insomnia show high levels of 
neuroticism and display traits related to perfectionism. These include where 
individuals are over-concerned (lacking in self-confidence and where they have 
greater doubts about action), however, the role of personality within insomnia is 
complex and longitudinal studies are needed (van de Laar, Verbeek, Pevernagie, 
Aldenkamp, & Overeem, 2010). The main drawback of this model is that it does not 
specifically explain how the sleep-interfering processes and sleep-interpreting 
processes interact with each other. A further drawback is that the model cannot be 
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used to determine a causal relationship between these two processes and requires 
further detail and development (Ellis et al., 2012; Lundh & Broman, 2000). 
 
1.6.2. Espie’s psychobiological inhibition model of insomnia 
 The psychobiological inhibition model of insomnia focuses on the idea that  
 insomnia is a failure of automatic sleep activation and of sleep maintenance (Espie, 
2002). In the psychobiological inhibition model, good sleep is the default state. 
Under normal circumstances both homeostatic and circadian processes are set to 
have sleep as the default setting rather than insomnia. The psychobiological 
inhibition model focuses on normalcy rather than on the pathology of insomnia 
(Espie, Broomfield, MacMahon, Macphee, & Taylor, 2006). The model (Figure 1.6) 
is framed as being a neurobehavioural, biological model, where good sleep has 
functional properties of both ‘plasticity ‘ and ‘automaticity’.  Plasticity refers to the 
capability of the system to react to stressors (situational and personal factors) where  
 
 Figure 1.6: Espie psychobiological inhibition model (Adapted from Espie, 2002, p. 227) 
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the sleep-wake system can tolerate and minimise the effects of night-to-night 
variability in sleep patterns (Espie, 2002). Automaticity refers to the involuntary 
nature of a well-adjusted sleep schedule, to habitual associations forming part of a 
stimulus control paradigm and to the implicit expectations a good sleeper has 
regarding sleep continuity and quality (Espie, 2002), where this refers to the 
involuntary regulation of sleep under normal circumstances (Ellis et al., 2012). 
Automaticity can be disrupted through selective attention to sleep, the explicit 
intention to sleep and also through the introduction of effort in the sleep process, 
which Espie terms the ‘attention-intention-effort’ (A-I-E) pathway (Espie et al., 
2006).  
 At the core of the model is an involuntary process of interaction between the 
sleep homeostat and the circadian timer, associated with the self-perception of good 
sleep quality. The role of plasticity and automaticity is to defend this core. Espie 
(2002) notes that both endogenous sleep-related cues such as physical and mental 
fatigue interact with exogenous, external cues in the environment. Essentially, good 
sleepers are passive as both these internal and external cues allow conditions for 
sleep to be set automatically and without effort.  
 In the model, the defensive properties of the plasticity and automaticity are 
maintained by four sub-systems that interact with each other, which are a mixture of 
behavioural, cognitive and biological processes. The subsystems are sleep-stimulus 
control, physiological de-arousal, cognitive de-arousal, and daytime facilitation. 
These interactions maintain sleep homeostasis, circadian timing and sleep quality, 
through action and interaction between these subsystems. A good sleeper is able to 
accurately interpret both physiological and mental signs of readiness for sleep and 
the stimulus environment of the bedroom reinforces de-arousal, thus affording the 
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optimal circumstances for sleep to be initiated. Both the process of physiological and 
cognitive de-arousal is assumed to occur simultaneously in the model in a parallel 
manner. The model states that dysregulation would occur as a result of strong 
negative or positive emotions, which cause arousal.  
 Whilst the focus of this model is on the inhibition of normal sleep, it does 
acknowledge insomnia as mediating from the activation of the nervous system, 
psychological or environmental arousal (Espie, 2002). However, the model does not 
provide information with regards to the timing and does not discuss circumstances in 
which an individual would recover from the stress or would continue towards the A-
I-E aspect of the model (Ellis et al., 2012). Support for the model comes from the 
fact that evidence for selective attention to salient cues (i.e. the ‘attentional bias’) is 
strong enough to suggest it has a casual role in the majority of anxiety disorders and 
that the experimental evidence is strong when applied to sleep (MacMahon, 
Broomfield, & Espie, 2006; Marchetti, Biello, Broomfield, Macmahon, & Espie, 
2006; Spiegelhalder, Espie, Nissen, & Riemann, 2008; Woods, Marchetti, Biello, & 
Espie, 2009). However, inconsistencies have been shown in attentional bias studies 
even when using the same Emotional Stroop Task, although this may be potentially 
explained by poor sleepers showing an attentional bias towards sleep-related cues 
and also showing an increased monitoring or avoidance for anxiety-provoking cues 
(Barclay & Ellis, 2013). Limitations include the fact that most of the model and of 
the A-I-E pathway component remains to be validated (Perlis et al., 2011).  
 
1.6.3. High risk model of threat perception 
 A further model of insomnia which acknowledges the role of a stressor is the 
high risk model of threat perception (HRMTP) which suggests insomnia as a largely 
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somatic disorder (Perlstrom & Wickramasekera, 1998). In the HRMTP, a perceived 
threat results in an increase in physiological arousal which inhibits the sleep process 
(Ellis et al., 2012). In the HRMTP, there are specific psychosocial and 
psychophysiological risk factors, including a high susceptibility to hypnosis, high 
levels of neuroticism, repression and the tendency to catastrophise. In the HRMTP, 
neuroticism interacts with hypnotic susceptibility and levels of catastrophising, in 
order to predispose a person to have enhanced levels of threat perception for an acute 
stressor. The predisposing factors also interact with other factors such as major life 
events, accumulation of daily hassles, and low social support systems and coping 
skills. This interaction drives, either consciously or unconsciously, psychological 
and somatic symptoms of insomnia that manifest in sympathetic reactivity.  
 The interaction between hypnotic ability and the perception of threat results in 
an increased sympathetic response, and/or increases the sensitivity towards a threat.  
The main advantage, and also the main limitation of the model, is that the 
circumstances of the sleep disturbance are extremely specific meaning that other 
relevant factors may be ignored (Ellis et al., 2012). Some support for the model does 
come from the finding that those with insomnia display high levels of neuroticism 
(van de Laar et al., 2010) and a tendency to catastrophise (Harvey & Greenall, 
2003), both of which are specific examples within the HRMTP model. That said, it is 
unclear whether these aspects are the cause or the consequence of the insomnia (van 
de Laar et al., 2010). 
 
1.6.4. Morin’s microanalytic model of insomnia 
Morin’s microanalytic model of insomnia (Morin, 1993) proposes that 
maladaptive sleep habits and dysfunctional beliefs perpetuate insomnia (Bélanger, 
60 
 
LeBlanc, & Morin, 2012). Four components of the model (Figure 1.7) feed into the 
insomnia and relate to each other, including arousal, beliefs and attitudes, 
maladaptive habits and consequences. The arousal component refers to aspects such 
as emotional arousal (i.e. fear or sadness), cognitive arousal (i.e. thoughts and 
images) and physiologic arousal (e.g. pain or muscular tension). 
 
The beliefs and attitudes component refers to aspects such as the worry over 
the sleep loss caused by the insomnia and the associated rumination over the 
consequences of insomnia, unrealistic expectations, and misattributions and 
amplifications. The maladaptive habits component refers to behaviours such as 
spending too much time in bed, keeping an irregular sleep schedule, daytime napping 
and the inappropriate use of hypnotic drugs. The consequences component refers to 
the consequences of the insomnia, such as fatigue, impaired performance, mood 
disturbances and social discomfort. One way in which the model has an opportunity 
Figure 1.7: Morin’s microanalytic model of insomnia. 
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for a stressor to become involved is within the arousal component of the model, as a 
stressor may cause emotional arousal through fear or sadness; however, the main 
limitation of the model is that it does not specify the circumstances under which this 
arousal occurs. 
  
1.6.5. Buysse’s neurobiological model of insomnia  
Buysse’s neurobiological model of insomnia (Buysse, Germain, Hall, Monk, 
& Nofzinger, 2011) proposes that insomnia is primarily a disorder of sleep-wake 
regulation, characterised by wake-like activity in neural structures during NREM 
sleep. This results in simultaneous sleep/wake brain activity patterns that are specific 
to regions of the brain. The model (Figure 1.8) suggests that during centrally and 
frontally-defined NREM sleep, those with insomnia show greater levels of brain 
activity and metabolism in limbic and parietal cortices, the thalamus and 
hypothalamic-brainstem arousal centres. According to the model, the simultaneous 
sleep/wake activity may help explain the characteristics of and the effects of 
treatment within insomnia. Buysse and colleagues give the example that those with 
insomnia perceive wake or an awareness of the environment despite EEG showing 
that the individual is obtaining sleep. The model states that even a small increase in 
the duration of sleep or a decrease in wakefulness with treatment could show an 
association with a subjective improvement if the treatment caused reductions in 
waking brain activity. Overall, the model suggests that the psychological and 
behavioural aspects of insomnia have a neurobiological cause. Support for the model 
comes from animal studies of insomnia, based on the Cano-Saper model of insomnia 
which suggests that an acute stressor may lead to biological sleep disturbances.  
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  Figure 1.8: Buysse’s neurobiological model of insomnia 
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However, the main limitation of the model is that there is no opportunity in the 
model for specific stressful event acting as a trigger. 
 
1.6.6. Harvey’s cognitive model of insomnia 
The starting point of Harvey’s cognitive model of insomnia (Harvey, 2002) is 
an excessive amount of negatively-valenced cognitive activity regarding the amount 
of sleep obtained and also about the subsequent impact of  the sleep disturbances 
upon health and/or daytime function. This worry and rumination then triggers both 
autonomic arousal and emotional distress, where the arousal occurs due to 
sympathetic nervous system activation, resulting in the individual being in an 
‘anxious’ state. The model (Figure 1.9) proposes that as a result of this anxious state, 
the individual would then preferentially allocate attentional resources in order to 
monitor for sleep-related threat cues. 
 Figure 1.9: Harvey's cognitive model of insomnia 
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This would occur in terms of monitoring both internal body sensations and external 
environmental cues for sleep-related threats, for example indicators of sleep loss and 
a reduced daytime ability to cope or reduced daytime function. The monitoring 
happens automatically and detection of a sleep-related cue leads to further worry. 
Due to the selective attention causing the detection of usually unnoticeable cues and 
the state of increased arousal causing increased body sensations, the chance of 
detecting a threat is increased. Together these processes lead to the individual 
overestimating the severity of the deficit in their sleep and in the subsequent daytime 
functioning. This then fuels further worry and in the context of the model, cognitive 
activity can be maintained by erroneous beliefs about sleep and worry. These 
processes continue to exacerbate the negative cognitive activity and the arousal and 
distress. The excessive and escalating levels of anxiety and worry may actually lead 
to an actual sleep impairment due to the cognitive activity rather than a deficit in the 
sleep/wake cycle. Whilst the model does not explicitly acknowledge the role of a 
stressor, the model does place as much importance upon daytime symptoms as it 
does night-time symptoms. However, Harvey does acknowledge that precipitants to 
insomnia may include stressors such as life stress, or an accident, or illness. 
 
1.6.7. Fitchen and Libman cognitive model of insomnia 
The Fitchen and Libman model of insomnia (Fichten & Libman, 1991; 
Libman, Creti, Amsel, Brender, & Fichten, 1997) focuses primarily on insomnia 
within older adults, although the model does have a role for stressors. The model 
(Figure 1.10) proposes that predominantly negative cognitive activity, comprising 
negative, worrying and anxious thoughts alongside self- statements, during periods 
of nocturnal wake, may act as a mediator of insomnia complaints. The starting point 
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of the model is the recognition that older people suffer from nocturnal awakenings 
and the model then proposes that it is the nature of thoughts experienced during 
nocturnal awakenings which determine whether or not a complaint of insomnia is 
made. The model suggests that the complaint of insomnia is compounded by 
negative cognitive activity, including daily event-related concerns and worry, which 
may include consequences of not obtaining enough sleep (Fichten & Libman, 1991; 
Libman et al., 1997). Although there is a potential role for negative cognitive activity 
resulting from a specific stressor, the main limitation is that the model only focuses 
on insomnia within older adults. 
 
 
Figure 1.10: Fitchen and Libman's cognitive model of insomnia 
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1.7. The effects of stress upon sleep 
The relationship between stress and sleep has been examined using a variety of 
methods. This has included assessing the effects by using naturalistic stressors and 
by using experimental stressors. These studies are described in the following 
sections of the thesis.  
 
1.7.1. Naturalistic stressors 
 Studies which have examined the effects of naturalistic stressors upon sleep 
have included events such as natural disasters, war, bereavement and financial strain. 
Davidson and colleagues (L. M. Davidson, Fleming, & Baum, 1987) assessed 
subjective sleep in a population of residents from the Three Mile Island (TMI) area, 
approximately three years after a nuclear incident where subjective sleep was 
assessed and compared to controls. TMI residents reported more awakenings during 
the night and reported greater sleep-onset latencies compared to control participants 
and took longer to return to sleep when awakened compared to controls. 
Additionally, a greater number of sleep disturbances were related to higher levels of 
stress. One study followed up on survivors of a ferry disaster, in which survivors and 
their relatives were referred for assessment of psychological injury, showing that 
subjective sleep disturbances were one of the most common symptoms (Dooley & 
Gunn, 1995).  
Elsewhere, in a study of state personnel who responded to the September 11 
World Trade Center terrorist attacks in 2001 and who were evaluated between 2002 
and 2003, subjective sleep problems were one of the most common psychological 
symptoms, present in 16.4% of individuals (Mauer, Cummings, & Carlson, 2007). 
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Also following the September 11 attacks, Schuster and colleagues (Schuster et al., 
2001) surveyed a nationally representative sample of 560 adults in order to 
determine their reactions to the incident. In addition, respondents were also asked 
about their perceptions of how their children reacted to the attacks, providing 
information on 167 children. The results showed that 11% of adults and 10% of 
children exhibited sleeping difficulties since the event (as indicated by ‘trouble 
falling or staying asleep’).  
Following the Oklahoma bombings, North and colleagues (North et al., 
1999) contacted and assessed a sample of 182 survivors approximately six months 
after the event, using systematic interviews. Approximately 70% of the survivors 
assessed reported insomnia and approximately 50% reported suffering nightmares. 
Natural disasters have also been examined. Following a 1995 earthquake in Japan, a 
survey of 143 individuals showed that sleep disturbances were the most common 
symptom, with 63% of respondents reporting a sleep disturbance three weeks after 
the earthquake (Kato, Asukai, Miyake, Minakawa, & Nishiyama, 1996). One study 
examined sleep in a sample of 54 adults directly affected by Hurricane Andrew, 
between six to twelve months following the event (Mellman, David, Kulick-Bell, 
Hebding, & Nolan, 1995). Participants were asked to detail their sleep before the 
hurricane and after the hurricane, using the Pittsburgh Sleep Quality Index (PSQI; 
Buysse, Reynolds III, Monk, Berman, & Kupfer, 1989). Sleep quality was rated to 
be worse following the hurricane and this was more pronounced in participants with 
a psychiatric morbidity. 
Other studies have examined the impact of war. A study which examined a 
large sample (n = 1,045) of respondents both during the 1991 Gulf War and 30 days 
following the war (Askenasy & Lewin, 1996) showed that 51% reported suffering 
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disturbed sleep. It was shown that the war provoked stress in 67.5% of respondents 
and that 19% of the individuals who reported normal sleep previous to the war were 
now suffering from insomnia. Seelig and colleagues (Seelig et al., 2010) conducted a 
longitudinal cohort study in a large sample (n = 41,225) of soldiers who were 
assessed at a baseline period (2001 – 2003) and a follow-up period (2004 - 2006). It 
was shown that those who were deployed to Iraq or Afghanistan and who were 
surveyed either during or after the deployment period, showed a shorter subjective 
sleep duration compared to those who were not deployed, where duration was 
assessed on the basis of how many hours of sleep participants reported obtaining 
each night. Those who had experienced deployment, who were either currently 
deployed or had been deployed in the past, showed increased odds of reporting sleep 
problems (defined as having trouble falling asleep or staying asleep) than those who 
were not deployed. It was also shown that combat exposure during the deployment 
period was an independent predictor of the sleep difficulties.  
The effects of more commonplace naturalistic stressors have also been 
investigated, such as financial strain, health events, bereavement and examinations. 
Financial strain has been shown to relate to subjective and objective sleep. Hall and 
colleagues (Hall et al., 2009) reported a relationship between financial strain and 
subjective sleep quality in a sample of middle-aged women, where greater financial 
complaints were associated with poorer sleep quality. Financial strain was also 
related to objective sleep, where greater financial strain was associated with poorer 
levels of sleep efficiency (Hall et al., 2009).  Effects of financial strain have been 
shown elsewhere in a sample of older adults with a mean age of 74 years (Hall et al., 
2008). Sleep was measured using PSG and this study showed that the older adults 
who reported on-going financial strain to be either “somewhat upsetting” or “very 
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upsetting” showed a longer sleep latency, greater WASO and lower sleep efficiency 
compared to those who reported that financial strain to be either absent or “not 
upsetting”.  Lallukka and colleagues (Lallukka, Arber, Rahkonen, & Lahelma, 2010) 
reported that in a cross-sectional study involving a large sample (n = 8,960) of 
middle-aged participants (aged 40-60 years), childhood economic difficulties were 
associated with complaints of insomnia amongst both women and men, although a 
relationship between current economic problems and complaints of insomnia were 
only observed in women. A separate cohort study assessed Finnish and British public 
sector workers at baseline and at a follow-up period approximately 5-7 years later 
(Lallukka et al., 2012). Sleep problems were assessed in the previous four weeks on 
the basis of difficulties with sleep onset, sleep maintenance, non-restorative sleep at 
baseline and non-restorative sleep at follow up periods. The results showed that the 
odds of having a sleep problem were higher in those with persistent economic 
difficulties, termed as frequent economic difficulties at both the baseline and the 
follow-up period. Taken together, this suggests that economic difficulties and 
financial strain, as stressors, have a negative and disruptive influence upon sleep.  
The impact of health-related stressors has also been assessed. One study 
examined women with metastatic breast cancer taking part in a group therapy 
intervention programme, and found higher baseline levels of life stress to be related 
to increases in problems both with sleep onset and with daytime sleepiness (Palesh et 
al., 2007). However, this study has potential problems with temporality as 
participants took part in the study just over two years (27 months) after receiving a 
diagnosis and there was no control group. Further, a study used a retrospective 
sample of 350 patients participating in a cardiovascular disease prevention 
programme, in which perceived stress over the past month was assessed (Kashani, 
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Eliasson, & Vernalis, 2012). Overall, increased levels of stress correlated with a 
poorer sleep quality over the past month, shorter durations of sleep, and higher 
reported sleepiness and fatigue.  
The effects of bereavement on sleep have also been investigated. Objective 
sleep in a sample of bereaved individuals with major depression was compared to 
bereaved individuals without depression and healthy control participants, showing 
reductions in sleep efficiency and in the latency to REM. Bereaved individuals  also 
showed more early morning awakenings, spent a greater percentage of sleep in REM 
and showed less delta wave generation in the first NREM period compared to 
controls (Reynolds 3rd et al., 1992).  
One study with elderly participants who had experienced spousal 
bereavement within the last 12 months were followed-up at time intervals of 3, 6, 11, 
18 and 23 months. REM density, which refers to the ratio of the number of rapid eye 
movements per minute of REM sleep, was increased in the bereaved participants as 
compared to age-matched controls and REM density increased over time,  suggesting 
that REM density may be a correlate of late-life bereavement and a marker of this 
particular stressor (Reynolds 3rd et al., 1993), However, sleep efficiency, the latency 
to REM and the ratio of delta sleep were stable, with the exception of slow-wave 
sleep, over the two-year period. In addition, these were not significantly different 
between bereaved individuals and control individuals. In addition, since sleep was 
measured three months after bereavement, it does not exclude the possibility that 
sleep disturbances may have occurred before the measurement of sleep three months 
post-bereavement (Reynolds 3rd et al., 1993).  
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Hall and colleagues (Hall et al., 1997) showed that in a sample of elderly 
(with a mean age of 65 years) participants with bereavement-related depression, 
bereavement-related intrusive thoughts and avoidance behaviours were related to 
measures of objective sleep, where avoidance behaviours referred to attempts made 
to stop thinking about a stressful event or circumstance (i.e. the bereavement). 
Subjective (PSQI) and objective measures, in terms of sleep latency, REM latency 
and sleep maintenance suggested sleep was disrupted in this group. Sleep latency 
was defined as the time taken to the first 10 minutes of Stage 1 or deeper sleep, 
interrupted by no more than two minutes of either Stage 1 or wake and sleep 
maintenance was defined as the percentage of the overnight PSG recording period 
spent asleep after the onset of sleep. After relevant variables (age, the time since 
bereavement and the severity of depression) were controlled for, the frequency of 
intrusive thoughts and avoidance behaviours were associated with a longer sleep 
latency and a lower delta sleep ratio. Disrupted sleep following bereavement has also 
been observed in a non-elderly sample of participants, where a greater prevalence of  
DSM-defined insomnia, on the basis of the DSM-IV text revision (DSM-IV-TR), 
was  observed in students bereaved over the previous two years as compared to those 
who were not bereaved (Hardison, Neimeyer, & Lichstein, 2005). 
Other naturalistic stressors have also been assessed, including educational 
examinations and work-related psychosocial stress. Vahtera and colleagues (2007) 
followed a large sample (n = 19,199) at baseline and five years later, where sleep 
disturbances were assessed using a five-point response scale to the single question 
“how well do you sleep in general?”.  The occurrence of stressful life events such as 
divorce, marital difficulties or the death of a family member was also assessed.  
Stressful events were predictive of sleep disturbances amongst individuals with no 
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pre-existing sleep disturbances. Moreover, individuals who had experienced severe 
events, on the basis of extremely burdensome and stressful events either between 
zero and six months , or between six months and five years before the measurement 
of sleep, showed double the odds of disturbed sleep than those who did not 
experience severe events, even after adjustment for relevant factors. This study also 
suggested individual factors were involved.  The individual liability to anxiety was 
assessed using a questionnaire assessing general perceptions of stress in daily life 
and a questionnaire assessing sympathetic nervous system hyperactivity, through 
indicating the extent to which several statements applied to them. Those who were 
liable to anxiety were at a higher risk of developing sleep disturbances after the 
stressful event, but only in the six-month period following the event.  
The effects of examinations upon sleep have also been assessed. Holdstock & 
Verschoor (1974) showed that students showed a reduced total sleep time over a ten-
day examination period, measured objectively within a sleep laboratory and 
compared to an earlier period (two to three months before the exam) or a later period 
(three months afterwards). No sleep architectural differences were evident with the 
exception of a greater amount of time spent in Stage 3 sleep during the post-
examination period. In a separate study, students were monitored over the course of 
an exam period using sleep diaries, both one week before the exam and on the 
morning of an exam (Ellis & Fox, 2004). Whilst levels of perceived stress and sleep 
catastrophising increased between the time points, there were no differences in sleep 
efficiency, timing or in the estimated sleep quality. Interestingly, two sleep variables, 
sleep catastrophising and a later bedtime, were both predictive of perceived stress on 
the morning of the exam.  
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The effects of work-related stress have also been shown to affect sleep. 
Sekine and colleagues (Sekine, Chandola, Martikainen, Marmot, & Kagamimori, 
2006) showed that psychosocial stress at work, in addition to aspects such as shift 
work, working hours, marital status and conflicts between work and family were 
associated with poor sleep quality in the previous month, assessed using the PSQI, in 
a large sample (n = 3,556) of Japanese civil servants. One self-report study required 
participants to keep a sleep diary across 42 consecutive days (Åkerstedt et al., 2012).  
The main predictor of sleep quality was the level of stress and worries at bedtime, 
with increases in stress and worry corresponding with reduced sleep quality. The 
study also showed that poor sleep quality was a predictor of stress and worry at 
bedtime, although the decrease in sleep quality appeared to have a more pronounced 
effect on stress than on worry. Additionally, the link between daytime stress and 
poor sleep quality was not significant, which may suggest that the subsequent effects 
of stress upon sleep are largely due to anticipation of the forthcoming day (Åkerstedt 
et al., 2012).   
Other approaches have assessed the effects of stress upon sleep, where 
participants have been required to predict low-stress or high-stress weeks in advance 
of the measurement of sleep.  One prospective study (Dahlgren, Kecklund, & 
Akerstedt, 2005) followed office workers during a week with high levels of stress 
and during a week with low levels of stress, where stress levels were predicted by the 
participants. Sleep quality was measured subjectively by asking participants to rate 
their sleepiness several times a day and to rate their sleep quality once a day. Sleep 
was also objectively measured using actigraphy.  
There were no differences between high and low stress weeks in terms of the 
sleep quality reported, the ease of falling asleep or in the level of sleepiness 
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experienced at awakening. Greater levels of stress or restlessness were shown during 
a high-stress week than during a low stress week. Greater levels of sleepiness were 
shown during a high-stress workday than during a high-stress weekend, low stress 
workday or weekend.  
Participants were also required to predict sleep quality for the coming night. 
Sleep quality was expected to be poorer following a high-stress workday compared 
to a workday with low levels of stress or a non-workday, irrespective of stress levels. 
Overall, this indicated that whilst subjective sleep seemed to be relatively unaffected 
by the change in stress levels during the week, the predicted subjective sleep quality 
was affected in that individuals expected to have poorer sleep during a week of high-
stress. Interestingly, objective sleep was affected, as actigraphy indicated that total 
sleep time varied between the low-stress and the high-stress weeks, with less total 
sleep obtained during the high-stress week.  
In a separate study, Petersen and colleagues (Petersen, Kecklund, D'Onofrio, 
Nilsson, & Åkerstedt, 2013) measured objective sleep during a low-stress and high-
stress period. In this study a sample of teachers were divided into groups of those 
who showed either a high sensitivity or a low sensitivity to stress-related sleep 
disturbances, on the basis of scores obtained on a modified response to stress scale.  
Participants were asked to identify low-stress and high-stress periods in advance and 
PSG was used to record sleep in the homes of participants. Irrespective of group 
differences, a decrease in sleep efficiency was shown during the high-stress period, 
suggesting an overall effect of stress on sleep. The two groups did differ in their 
sleep, as the percentage of REM sleep increased in the low-sensitivity group during 
the high-stress period and the percentage of REM decreased in the high-sensitivity 
group. Additionally, the high sensitivity group showed an increase in arousals and 
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transitions between sleep stages during the high-stress condition, with the low 
sensitivity group showing the opposite pattern in arousals and stage transitions.  
Overall, these studies have demonstrated that naturalistic stress does have a 
disruptive effect upon both subjective and objective sleep; however, the findings are 
inconsistent. Whilst it is a strength that the effects of serious naturalistic stressors 
such as war, financial strain and bereavement have been examined, where these 
represent salient, important and meaningful stressors, there are limitations to this 
approach. The limitations include the diverse nature of participants, typically with 
co-morbid conditions and the lack of a suitable control group, the wide variation in 
the nature of stress, the varied manner in which subjective and objective sleep has 
been measured and the time lag between the stressful event and the measurement of 
sleep. The following section describes the effects of experimental studies upon sleep. 
 
1.7.2.  Experimental stressors 
The effects of stress upon sleep have also been examined experimentally, 
where a wide range of stressors have been employed, including intelligence tests, 
cognitive tasks, the stress of sleeping with medical equipment attached to the body 
and emotional stressors. Koulack and colleagues (1985) examined the effects of 
stress upon sleep by using intelligence tests. In this study, objective sleep was 
measured during an adaptation night, a baseline night and during the experimental 
night where the intelligence tests were completed. Half of the participants 
experienced an easier version of the tests which could be completed within the time 
allowed, whilst the other half experienced a harder version of the tests which could 
not be completed in time. Both groups of participants showed an increased SOL and 
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decreased REM density during the experimental night, although there were no 
differences shown in between the two groups of participants. It is possible that the 
participants who experienced the harder version of the tasks may not have 
considered these to be more stressful than the group of participants who were able to 
complete the tests in the allocated time.  
The effects of cognitive tasks upon sleep were examined by Wuyts and 
colleagues, who assessed the effects of 30 minutes of cognitive tasks prior to going 
to bed (Wuyts et al., 2012a). Participants slept for three nights in a sleep laboratory, 
with one night spent at home between each night in the laboratory. Sleep obtained 
during the experimental night, where the tasks were completed, was compared to 
sleep obtained during a reference night, where tasks were not required to be 
completed. There were no differences in subjective sleep continuity or quality 
compared to the reference night, however objective sleep following the tasks showed 
a longer sleep-onset latency. Differences were also shown in that a higher percentage 
of high frequency EEG activity was apparent in the first and second episodes of deep 
sleep following the tasks, indicating that stress can affect high frequency EEG 
activity. 
Other studies have examined the subsequent effects of emotionally-
challenging stress, although these studies show large variations in terms of how 
provocative these stressors could be perceived to be. In one study participants 
viewed either a psychologically stressful film, comprising a documentary detailing a 
subincision initiation ceremony, or a neutral film, detailing a London travelogue, 
before bedtime (Baekeland, Koulack, & Lasky, 1968). Those who watched the 
stressful film showed greater levels of REM density, however this study did not 
include an adaptation night and thus it cannot be ruled out that the findings were 
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influenced by the first-night effect and simply reflected the adaptation to the sleep 
laboratory environment.   
A separate study measured the effects of a negative emotional stressor on 
objective sleep, where healthy normal sleepers slept in a sleep laboratory for four 
nights (Vandekerckhove et al., 2011). The first night in the laboratory served as an 
adaptation night and the second night served as a baseline night, with no 
manipulation. Following the baseline night, participants were required to complete 
cognitive tasks during the evening before sleep. Participants were either placed into a 
neutral or a failure condition. In the neutral condition participants completed the 
tasks and were given neutral feedback afterwards. In the failure condition 
participants completed the same range of cognitive tasks, which included a semantic 
reasoning task that was impossible to complete. Importantly, participants were told 
that they would be completing a test that reflected both their level of intelligence and 
was a predictor of their future professional success. Between each task for those in 
the failure condition a researcher would enter the room and act in an irritated 
manner. Negative feedback was also given to participants in this condition following 
the completion of the tasks. In the failure group, EEG was also attached to 
participants during the task and they were informed that they were moving around 
too much and causing unobtainable physiological data. When the sleep obtained 
during the night following the task was compared between the failure and neutral 
groups, the failure group showed decreases in sleep efficiency, the percentage of 
REM sleep and TST, whilst they also showed increases in WASO, the total time 
awake, NWAK, NWAK from REM sleep and in the latency to SWS. 
 Vein and colleagues (2002) induced stress by asking participants 
emotionally-provocative questions immediately before sleep. Compared to a baseline 
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night of sleep following an adaptation night in the laboratory, sleep latency increased 
and the percentage of slow-wave sleep was increased in the second sleep cycle 
following the emotional stressful night (Vein et al., 2002).  
Other studies have induced stress by requiring participants to sleep with 
medical equipment attached, such as a catheter or blood pressure cuff. In one study 
Vitello and colleagues (1996) showed that participants who slept with an intravenous 
catheter had a reduced total sleep time, sleep efficiency, percentage of REM sleep 
and percentage of slow-wave sleep compared to the baseline night. They also 
demonstrated increased sleep latencies, total wake time and the number of 
awakenings (Vitiello et al., 1996).  
Adam (1982) also reported that blood sampling during the night in older 
adults (aged 53-63 years) resulted in a reduction in total sleep time, sleep efficiency, 
REM sleep and an increase in wake after sleep onset. Where the effects of blood 
pressure cuff inflation upon objective sleep were examined, a greater amount of 
arousals (changes in EEG frequency) and awakenings were shown in the minute of 
sleep after the cuff inflation compared to the minute of sleep before the inflation. 
Participants showed some evidence of habituation on a second night of monitoring, 
as the percentage of arousals was lower following cuff inflation on the second night 
(Dimsdale, Coy, Ancoli-Israel, Clausen, & Berry, 1993). However, these studies 
cannot determine whether the effects upon sleep are due to discomfort or due to the 
fear of disturbing the medical equipment, or whether they are due, as the authors 
suggest, to psychological anxiety.  It is also not known whether these effects 
continue over multiple nights of monitoring (Kim & Dimsdale, 2007). 
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One experimental stress study has assessed the effects of parachute jumping 
upon sleep, where novice and experienced parachute jumpers were studied in a sleep 
laboratory four nights before a scheduled parachute jump and one night following 
the jump (Beaumaster, Knowles, & MacLean, 1978).  These parachute jumpers were 
compared to a control group of parachute jumpers who had no scheduled parachute 
jump during the same period.  PSG was recorded for five consecutive nights and all 
participants were due to complete their jump between the fourth and fifth night of 
PSG. The effects of anticipation alone were also examined as due to poor weather 
half of the participants from each group were unable to complete the parachute jump. 
This showed that there were differences only in the latency to Stage 1 sleep, the 
latency to Stage 2 sleep and in the percentage of Stage 1 sleep, with experienced 
jumpers showing an increase in sleep onset latency compared to novice jumpers and 
novice jumpers showing a decreased amount of Stage 1 sleep compared to 
experienced jumpers.  
Anxiety levels indicated that novice jumpers had higher levels of anxiety 
compared to experienced jumpers on the night prior to the jump, indicating that the 
anticipation of the jump provoked stress. In order to examine whether the parachute 
jump acted as a stressor, PSG data from the third, fourth and fifth nights were 
compared by group.   Sleep the night following the jump showed no differences, 
suggesting that the parachute jump did not affect sleep. One drawback of this study 
is that although inexperienced jumpers were included, the study did not use a control 
group of participants who had never performed a parachute jump. In this case the 
control group was comprised of experienced jumpers selected at random (who had 
experience ranging from three to 287 completed parachute jumps). This suggests that 
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the anticipation of the parachute jump affected sleep but that the demand itself, in 
terms of the parachute jump, did not.  
Aside from the inconsistencies in the nature of the stressor employed within 
stress studies, it is possible that individual differences in the response to stress may 
also play a role in the relationship between stress and sleep disturbances.  Drake and 
colleagues assessed sleep during the first night in a sleep laboratory. Participants 
completed the Ford Insomnia Response to Stress Test (FIRST), which assessed their 
likelihood of experiencing sleep disturbances in response to a host of common 
stressful situations. Based on these scores participants were split into two groups 
(low vulnerability or high vulnerability). Those with a high vulnerability had a lower 
sleep efficiency and a longer latency to Stage 1 and persistent sleep. These effects 
remained even after controlling for a history of insomnia symptoms.  Insomnia 
symptoms were more common in those reporting high FIRST scores, with insomnia 
being reported in a higher proportion of individuals who scored higher on the FIRST 
(Drake, Richardson, Roehrs, Scofield, & Roth, 2004). A follow-up study showed 
that healthy sleepers who scored high on the FIRST displayed differences in their 
reaction to caffeine, in that they displayed an increased latency to persistent sleep, 
compared to low scorers (Drake, Jefferson, Roehrs, & Roth, 2006). This suggests 
that the stressor may impact individuals in different ways, resulting in sleep 
disturbances for one person and not another. In order to examine these potential 
influences further, a standardised protocol for assessing the effects of sleep and 
stress is necessary.   
Overall, whilst experimental stress does appear to disrupt subjective and 
objective sleep, the effects of experimental stress upon sleep have been inconsistent. 
As with studies which have examined the effects of naturalistic stress upon sleep, 
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this may be due to the wide variety of stressors employed. These have, for example, 
ranged from intelligence tests (Koulack et al., 1985) and cognitive tasks (Wuyts et 
al., 2012a) to showing participants psychologically stressful films (Baekeland et al., 
1968).  The type of task used as a stressor may also affect sleep, potentially 
accounting for some of the inconsistent findings observed. Kobayashi and colleagues 
(Kobayashi, Ishikawa, & Arakawa, 1998) asked participants to complete different 
types of daytime tasks on different days, with four mental tasks (a relaxation task; 
low-vigilance desk work; high-vigilance desk work; a 600km car driving task) and 
one physical task. The latency to four separate cycles of REM was measured during 
the night after each task. The standard deviation of the latencies to the third and 
fourth REM cycle were significantly larger following the car task than observed 
following any other task, suggesting that the type of task given may affect objective 
sleep. This study was limited by the small sample size (n = 5) but it does suggest that 
the type of task may influence sleep. 
 In order to overcome the inconsistencies shown in previous experimental 
studies assessing the impact of stress upon sleep, it will be necessary to measure the 
effects by standardising the manner in which sleep and stress are measured within 
the same context. Where naturalistic studies of stressors and their effects upon sleep 
have been examined, such as bereavement, war and natural disasters, these are also 
associated with demand. For example, in the case of bereavement, the emotional 
stress of the bereavement will also be associated with practical demands related to 
the bereavement. This is also the case with natural disasters such as earthquakes or 
war, as the emotional stress of the event is also associated with a variety of demands 
related to the event.   
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Other naturalistic studies are also associated with demand. Where the 
objective sleep of teachers was measured by Petersen and colleagues during a low-
stress and high-stress period, estimated by the teachers in advance, (Petersen et al., 
2013) this study did not disentangle the effects of stress from demand, as a high-
stress week could have included a week with high levels of demand. The study 
involving parachute jumpers conducted by Beaumaster and colleagues (Beaumaster 
et al., 1978) did separate the stress from the demand, requiring participants to 
complete a parachute jump, where sleep was not affected following the stress of a 
parachute jump. Interestingly, this study indicated that the anticipation of stress may 
affect sleep.  
The nature of the control group used in demand studies may also be 
problematic, for example, whilst Beaumaster and colleagues (Beaumaster et al., 
1978) examined the effects of a parachute jump between experienced and novice 
jumpers,  in this case the control group included novice jumpers who still had 
experience of completing parachute jumps.  The anticipation of stress may also have 
affected naturalistic studies as where Petersen and colleagues required teachers to 
estimate a low-stress and high-stress week in advance, it may have been the case that 
the teachers were estimating a low-demand and high-demand week in advance 
(Petersen et al., 2013). A series of naturalistic and experimental studies have 
explicitly examined the effects of the anticipation of stress upon sleep and these are 
described in the following section. 
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1.7.3. The impact of anticipation upon sleep 
Anticipation has also been shown to affect both subjective and objective 
sleep, in both naturalistic and experimental stress studies. Torsvall and colleagues 
examined the effects of on-call duty in a group of Swedish ship engineers. The 
engineers were asked to complete a sleep diary during a tour of duty, lasting between 
one and three months, whilst they were aboard ships, measuring sleep quantity and 
quality (Torsvall, Castenfors, Åkerstedt, & Fröberg, 1987). When the engineers were 
on watch duty every two to four nights they were allowed to sleep but were 
awakened by automatic alarms when there was a malfunction in the machinery. 
Whilst on watch duty engineers exhibited disturbed sleep, showing a reduced total 
sleep time of more than 90 minutes per watch night. The engineers also reported 
poorer perceived quality of sleep compared to free nights. Interestingly, it was 
reported that when the engineers were on watch duty, but where no alarms occurred, 
the engineers still showed greater difficulties in falling asleep, less sleep and a poorer 
sleep quality compared to a free night. The engineers also found it more difficult to 
rise in the morning and reported feeling less refreshed with higher levels of 
sleepiness following a night on watch with no alarms compared to a free night.  
Wright and colleagues (Wright, Schnur, Montgomery, & Bovbjerg, 2010) 
assessed objective sleep in women the night before breast cancer surgery and 
observed that a higher number of intrusive thoughts were associated with a lower 
total sleep duration and a reduced sleep efficiency. However, this study did not have 
a control group. 
The effects of acute demand upon heart rate during sleep were investigated in 
a study which used a control group of normal sleepers and a ‘stress’ group (Hall et 
al., 2004). Those in the stress group were told immediately before lights out that they 
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would have to give a 15-minute speech upon awakening the following morning, to 
be rated for both content and quality, with two minutes preparation time for the talk. 
The heart rate of participants was recorded during the night, and the demand resulted 
in a decrease in levels of heart-rate variability, a measure of parasympathetic 
modulation, during both REM and NREM sleep. However, there were no differences 
between the groups in measures of objective sleep continuity or sleep architecture.  
In a further study, Hall and colleagues (Hall, Buysse, Reynolds, Kupfer, & 
Baum, 1996) instructed healthy young participants that upon awakening the 
following morning, they would either experience a demand condition of having to 
give a 15 minute speech which would be evaluated or a control condition of reading 
magazines. Intrusive thoughts, related to the stress of the task, were shown to 
interfere with sleep, resulting in an increased sleep latency and an increased number 
of awakenings during the final two hours of sleep. However, stress-related thoughts 
showed no relationship with measures of sleep architecture, although these were 
associated with a lower delta wave generation during the first cycle of sleep. Overall, 
this indicated that stress-related intrusive thoughts delayed the onset of sleep and 
disrupted sleep continuity in the second half of the night, with the reductions in delta 
sleep possibly reflecting the effects of stress.  
An additional study, using a similar method of inducing demand, showed 
there to be a lower REM count during the last (fourth) REM cycle in the demand 
group compared to the control group (Germain, Buysse, Ombao, Kupfer, & Hall, 
2003). REM count was used as a marker of REM density, where this referred to the 
number of computer-detected rapid eye movements divided by the number of REM 
minutes. Subjective ratings of stress were shown to mediate the effects of acute 
stress exposure on the REM count during the final REM period and that these 
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subjective stress ratings were partially determined by the interaction between 
exposure to the stressor and the seeking of social support as a method of coping. In 
addition, changes in state anxiety were shown to predict REM latency and that the 
changes in state anxiety were partially moderated by interactions between the 
exposure to stress and seeking social support, and also by the interaction between the 
stress exposure and avoidance. However, the effects upon objective sleep were 
indirect and whilst it is likely that participants found the anticipation of the 
upcoming speech to be uncomfortable, the task was extremely short. As such, 
participants may only have been preparing for a low-intensity short period of 
demand and the lack of any direct effects upon sleep are likely to have been due to 
the task not being demanding enough to disrupt sleep.  
Wuyts and colleagues (2012b) investigated the effects of a simulated on-call 
situation where participants (n = 16) spent three nights within a sleep laboratory. The 
sequence of the nights was counterbalanced and participants had a one night wash-
out period between each night. On one night participants were informed, 
approximately half an hour before going to bed, that they would hear an unspecified 
sound at randomly determined time intervals during the night. Participants were 
required to respond by pressing a button three times as quickly as possible otherwise 
sounds would be played for the rest of the night. However, no sounds were actually 
played at any time point during the night. Compared to the control night, participants 
displayed a significantly lower sleep efficiency, a trend towards a greater sleep onset 
latency and a greater percentage of wake during the simulated on-call night. Analysis 
of subjective sleep diaries showed trends towards a lower sleep duration during the 
on-call night, with participants claiming to have slept 27 minutes less during this 
night and the length of wake after sleep onset periods were significantly longer. 
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Additionally, there were trends towards a greater percentage of wake after sleep 
onset and towards a lower sleep efficiency during the on-call night. Whilst this 
suggests that upcoming demands can disrupt subjective sleep, these were only trends 
(Wuyts et al., 2012b).  
 Objective methods of measuring sleep have also been employed to examine 
the effects of real-world anticipation upon sleep. Torsvall and Akerstedt (1988) 
conducted a pilot study, in order to examine the effects of on-call duty on objective 
sleep and wake, as on-call nights have previously been associated with disturbed 
sleep and apprehension. In the study, five male ship engineers underwent PSG whilst 
on-board, during both free nights and on-call nights that involved attending to 
alarms. On-call nights resulted in a shorter duration of sleep and reduced amounts of 
REM and slow-wave sleep (SWS), compared to free nights. On-call nights were also 
associated with increased sleepiness the following day. Reductions in EEG power 
density, which are a measure of EEG variability and which are sensitive to the 
effects of sleep loss, were also observed during the first cycle of sleep. This was 
shown even when no alarms occurred; suggesting that even the anticipation of an 
interruption can disrupt sleep. However, one limitation of this particular study is the 
small sample size (n =  5). Kecklund and Åkerstedt (2004) used a combination of two 
studies involving normal sleepers in order to investigate whether the apprehension of 
the next working day affected objective sleep and subjective sleep quality. One of 
the studies recorded sleep in the homes of participants and the second study recorded 
the sleep of participants in a truck berth. Objective sleep was measured using one 
night of PSG. Subjective measures were also assessed, where participants were 
required to rate mood and levels of apprehension assessed by how pleasant or 
difficult they expected their next day to be. Levels of tension, nervousness, 
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uneasiness and stress, and the expected difficulty in awakening the next morning 
were also assessed. Subjective measures of sleep quality were obtained upon 
awakening. The relationship between subjective mood before sleep and objective 
sleep was examined. Greater levels of apprehension at bedtime were significantly 
related to a decreased duration of slow-wave sleep. This was also related to an 
increased percentage of Stage 2 sleep. As the apprehension of the next day showed a 
high level of co-variation with tension, nervousness, uneasiness and stress, the 
researchers concluded that the apprehension was related to bedtime state anxiety and 
to levels of stress.   
However, disadvantages of the study include that PSG was only measured on 
one night, meaning results may have been influenced by the ‘first-night effect’, 
which may have acted as a stressor in itself.  In addition, the combination of studies 
included shift workers and the measurement environment differed between studies. 
As the study was correlational in nature it cannot be definitively concluded that the 
effects upon sleep were due to apprehension or stress. In this case it may simply have 
been the effects of the apprehension of work activities the following day which 
affected sleep, rather than a direct stressor.  
The anticipation of work stress has also been examined. In one study 
participants were asked to log their levels of stress at bedtime, and ambulatory PSG 
recorded sleep parameters over: a) a night before a day with low levels of expected 
stress; b) a night before a normal work day; and c) a night before a day with high 
levels of anticipated stress (Åkerstedt, Kecklund, & Axelsson, 2007). The sleep 
associated with a low-level stress day was compared to that of a high-level stress 
day. The high stress nights showed reduced sleep efficiency, a higher percentage of 
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WASO and a longer latency to slow-wave sleep compared to the low-stress nights 
(Åkerstedt et al., 2007).  
Experimental studies have also shown that the potential effects of 
anticipation upon sleep should be taken into consideration and this presents an 
opportunity for further research. Wuyts and colleagues required good sleepers to 
complete 30 minutes of cognitive tasks before going to bed within a sleep laboratory, 
comparing subjective and objective sleep to a reference night (Wuyts et al., 2012a). 
Subjective sleep continuity or quality did not change compared to the reference 
night, although differences in objective sleep were shown through a higher 
percentage of high frequency EEG activity in the first two episodes of deep sleep 
after the tasks. However, participants slept in their own home between the reference 
and the cognitive task night and the order to the reference and task night were 
counterbalanced. As there was a delay between sleep measured during the reference 
night and task night in the laboratory, it is possible that the anticipation of 
forthcoming activities and obligations during the day at home may have influenced 
the result of this study.   
 Overall, naturalistic and experimental stressors do appear to disrupt 
subjective and objective sleep, however the results are inconsistent. These 
inconsistent findings may be due to the wide variation in the nature of the stress 
employed. Within naturalistic stress studies, these have included stressors such as 
natural disasters, war, health events and financial problems; within experimental 
stress studies these have included stressors such as intelligence tests, cognitive tasks 
and emotional films. Moreover, both naturalistic and experimental studies have 
shown that the anticipation of stress can affect subjective and objective sleep 
although these results are also inconsistent. However, experimental studies which 
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have assessed the effects of stress upon sleep have typically done so using a variety 
of demands, whereas naturalistic and experimental studies suggest that anticipation 
may also affect sleep, albeit with inconsistent results.  
Taken together, there is a wide variation in the measurement of stress and sleep. 
Furthermore, anticipation may affect sleep alongside demand. Therefore, in order to 
accurately assess the effects of stress upon sleep there is a clear need to standardise a 
protocol by which stress and sleep can be measured within the same context. As 
demand and anticipation both appear to affect subjective and objective sleep, this 
thesis will assess the impact of stress upon sleep by standardising the measurement 
protocol. This will separate out the effects of anticipation and demand, where 
subjective and objective sleep will be measured.  
 
1.8. Physiological markers of stress 
 
Whilst experimental studies have assessed the effects of stress upon sleep, 
these studies have not incorporated the simultaneous measurement of a physiological 
marker of stress. For this reason it is unclear whether the stressor employed is 
objectively stressful or whether the chosen stressor is only subjectively stressful. 
Furthermore, physiological markers of stress are of relevance to insomnia. Bonnet & 
Arand (2010) state that whilst there is evidence of physiological arousal in various 
systems during sleep in patients with insomnia, the causal nature of the arousal is 
unclear. Physiological arousal has been shown in individuals with insomnia in terms 
of heart rate (Bonnet & Arand, 1998), where increased heart rate was shown in all 
stages of sleep in those with insomnia. Differences were also shown when the heart 
rate data were analysed using spectral analysis. Those with insomnia showed 
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increased low frequency power and decreased high frequency power in all stages of 
sleep, indicating increased sympathetic nervous system activity within insomnia. 
Evidence of increased arousal within insomnia has also been shown in other 
physiological markers. Bonnet and Arand showed that individuals with insomnia 
displayed an increased metabolic rate, shown through increased oxygen use, 
compared to control individuals (Bonnet & Arand, 1995).  
The hyperarousal concept of insomnia, which assumes that insomnia results 
from an interaction between psychological and physiological variables, has a 
potential role for increased cortisol levels (Perlis, Giles, Mendelson, Bootzin, & 
Wyatt, 1997; Perlis, Pigeon, & Drummond, 2006; Riemann et al., 2010) Similarly, 
the Cano-Saper animal model of insomnia showed that a psychosocial stressor in the 
form of a dirty cage exchange resulted in increased HPA axis activity (Cano et al., 
2008). Although the use of neuroendocrine research within insomnia is not yet well-
established (Riemann et al., 2010), cortisol has previously been examined in 
individuals with insomnia as a marker of HPA axis activity, in a series of studies.  
Vgontzas and colleagues examined urinary levels of cortisol in individuals 
with insomnia, where sleep was measured objectively and 24-hour cortisol levels 
showed a positive relationship with the level of WASO, suggesting cortisol was 
related to the extent of the sleep disturbance  (Vgontzas et al., 1998). Other studies 
have compared the degree of HPA axis activity between those with insomnia and 
healthy controls. In a later study examining blood levels of cortisol, those with 
insomnia showed significantly higher levels of cortisol during the evening and early 
part of the night (between 2100h and 0030h) compared to healthy controls (Vgontzas 
et al., 2001).  
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Similarly, Rodenbeck and colleagues (Rodenbeck, Huether, Rüther, & Hajak, 
2002) also showed that those with insomnia displayed higher levels of nocturnal 
cortisol as compared to a healthy control group. Nocturnal awakenings showed a 
significant relationship with evening cortisol levels in both controls and those with 
insomnia. Those with insomnia also showed a relationship between the first four 
hours of nocturnal cortisol and sleep, where TST, SE, the percentages of Stage 1 and 
slow wave sleep, and the number of sleep cycles were negatively related to total 
cortisol secretion and where WASO, the latency to slow wave sleep and REM sleep 
were positively related to total cortisol secretion in the first four hours of the night.  
Overall, this potentially reflected altered HPA axis activity within individuals 
with insomnia. In contrast, Riemann and colleagues did not observe any differences 
in nocturnal levels between those with insomnia and healthy controls  (Riemann et 
al., 2002). 
Studies have also measured cortisol through saliva sampling. Backhaus and 
colleagues focused on salivary cortisol levels and compared levels of cortisol in the 
morning between those with insomnia and healthy sleepers (Backhaus, Junghanns, & 
Hohagen, 2004). Cortisol levels were collected in the home at awakening, 15 
minutes later and at bedtime, over a period of seven consecutive days. Individuals 
with insomnia displayed lower cortisol levels at awakening than healthy controls did.  
Awakening cortisol levels showed a negative relationship with the number of 
nightly awakenings across both groups, as assessed using subjective sleep measures 
during the seven day sampling period, potentially suggesting a link between sleep 
and cortisol. Taken together, the links between stress, sleep, cortisol and insomnia 
suggests that cortisol is an ideal measure of stress to examine alongside sleep 
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disturbances. Cortisol can be reliably measured in saliva in a non-invasive manner 
and is representative of plasma cortisol levels (Wetherell et al., 2006). As cortisol 
can be measured non-invasively, it is an ideal candidate for use as a physiological 
marker of stress within the thesis.  
 A range of studies which have examined stress have used cortisol as an 
outcome measure in relation to psychosocial stress tasks within the laboratory. For 
example, Kirschbaum and colleagues assessed the effects of psychosocial stress 
upon cortisol levels using a stressful psychosocial task known as the Trier Social 
Stress Test  (TSST; Kirschbaum, Pirke, & Hellhammer, 1993), which has an 
anticipation period and a test period.  
The TSST involves placing participants in a situation where they are 
instructed to assume the position of a job applicant within an interview. The test 
comprises a 10-minute anticipation period and a 10-minute test period, in which 
participants are required to deliver a speech and perform a verbal mathematical 
subtraction task as quickly as possible. The TSST has been shown to be stressful, in 
terms of plasma and salivary cortisol levels, and more than 70% of participants 
showed an increase in cortisol levels of 2.5 nanomoles per litre (nmol/l), representing 
a two to four-fold increase from  baseline cortisol levels (Kirschbaum et al., 1993).  
A meta-analysis of 208 cortisol studies (Dickerson & Kemeny, 2004) showed 
that acute psychological stress resulted in increased cortisol, however, this varied 
depending on the nature of the stress, where larger reactions were shown in 
performance tasks with elements of socio-evaluative threat or uncontrollability. 
Tasks which combined both of these elements provoked the largest increases in 
cortisol levels. Overall, cortisol is an easy to measure marker of physiological stress, 
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is relevant to insomnia and is therefore an ideal measure to include within the thesis 
to confirm that the protocol elicits stress.  Furthermore, cortisol has been shown to 
increase in relation to psychosocial tasks including the TSST and, as such, represents 
an ideal physiological marker of HPA axis function. 
Cortisol secretion shows a marked circadian pattern and sharp increases in 
cortisol levels are observed immediately upon awakening, known as the cortisol 
awakening response (CAR). This is an ideal physiological parameter for the study of 
the effects of stress within the thesis, as this appears to be a reliable marker of the 
circadian system which is one of the processes involved in sleep-wake regulation. As 
will be discussed in the following chapter, the CAR may function as a marker of 
anticipation or as a marker of demand. The following chapter will discuss the 
potential use and application of the CAR within the thesis as a physiological marker 
of HPA axis function. A devised standard protocol for the measurement of the CAR 
within the thesis will also be outlined. 
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CHAPTER 2.  
Cortisol and the cortisol awakening response 
 
2.1. Physiological stress and cortisol 
The term ‘stress’ refers to experiences which are considered to be challenging, 
either emotionally or physiologically (McEwen, 2007). As part of the primary 
response to stress, the sympathetic nervous system and HPA axis are activated, 
leading to the ‘fight-or-flight’ response where catecholamines, which increase heart 
rate and blood pressure, are released into the bloodstream alongside glucocorticoids 
(Lee & Harley, 2012; McEwen, 1998, 2007).The HPA axis is an endocrine system 
which allows adjustment and adaptation to the bodily and environmental challenges 
(Fries, Dettenborn, & Kirschbaum, 2009; Hucklebridge et al., 2005). When the HPA 
axis is activated, glucocorticoids, including corticosterone and cortisol are released, 
which redirect energy resources with the overall aim of restoring homeostasis (J. P 
Herman et al., 2003).   
Cortisol is essential to life and has a wide range of physiological effects, acting 
upon almost every cell within the body (Bamberger, Schulte, & Chrousos, 1996; 
Kudielka & Kirschbaum, 2005). Cortisol has a central role within metabolism as it 
mobilises resources to provide energy in response to the increased metabolic demand 
caused by challenge, may prevent arterial hypotension, and also inhibits the immune 
system; specifically inhibiting inflammatory and immune reactions, therefore 
preventing tissue damage. (Bamberger et al., 1996; Kudielka & Kirschbaum, 2005; 
Tsigos & Chrousos, 2002).  Cortisol also regulates other systems, including the 
sympathetic-adrenal-medullary (SAM) axis and the cardiovascular system (Kudielka 
& Kirschbaum, 2005). 
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The perception of an acute threat initiates the secretion of cortisol through a 
cascade of hormones in the HPA axis. This cascade commences with the release of 
CRH from the hypothalamus, which in turn triggers the release of 
adrenocorticotropin hormone (ACTH) from the anterior pituitary gland, terminating 
with the release of cortisol from the adrenal cortex (Clow, Thorn, Evans, & 
Hucklebridge, 2004). 
Importantly, unlike other indices of HPA axis function, cortisol can be reliably 
measured in saliva, levels of which are relative to those found in plasma. As such the 
measurement of cortisol in saliva provides a non-invasive index of HPA axis activity 
(Wetherell et al., 2006). Although considerable research exists on the causes and 
correlates of changes in neuroendocrine HPA axis activity, research regarding its 
role in the stress - sleep relationship is still in its infancy. More specifically, the 
cortisol awakening response (CAR), which refers to the sharp increase in cortisol 
levels observed immediately following awakening, provides an ideal parameter for 
the study of sleep and wakefulness as it is a reliable marker of the circadian system – 
one of the processes involved in sleep-wake regulation (Clow, Hucklebridge, 
Stalder, Evans, & Thorn, 2010; Kudielka, Hellhammer, & Wüst, 2009; Morris, 
Aeschbach, & Scheer, 2012; Wetherell et al., 2006).  
 
2.2. Patterns of cortisol secretion 
 The suprachiasmatic nucleus (SCN), the body’s central pacemaker, is 
responsible for the overall co-ordination of the HPA axis and links between the SCN 
and paraventricular nucleus of the hypothalamus (PVN) synchronise the time of day 
with neuroendocrine output (Buijs, van Eden, Goncharuk, & Kalsbeek, 2003). 
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Interestingly, the SCN pathway regulates the secretion of melatonin (Claustrat, Brun, 
& Chazot, 2005). The secretion of hormones in the HPA axis are subject to a 
regulatory negative feedback loop, in that the release of cortisol signals the inhibition 
of ACTH from the pituitary gland and subsequent inhibition of cortisol. A number of 
brain regions appear to be involved in the regulation of the HPA axis, including the 
hypothalamic sub-regions and the thalamus which connects to the PVN (Fries et al., 
2009). Other regions indirectly mediate HPA axis activity, including the 
hippocampus, amygdala and prefrontal cortex (J. P. Herman, Ostrander, Mueller, & 
Figueiredo, 2005), however the specific influence of these regions and of those 
which directly innervate the PVN upon the CAR are unknown (Fries et al., 2009). 
 In addition to its response to acute stressors, cortisol secretion fluctuates 
according to a marked circadian pattern, as shown in Figure 2.1. Over the course of a 
typical day, levels of cortisol increase during the hour post-awakening, followed by a 
steep decline over the next three hours after awakening. This is then followed by a 
more gradual decline over the remainder of the day, reaching the lowest point during 
the first half of the sleep period (Fries et al., 2009). During sleep, cortisol levels 
remain low and then rise again until morning awakening affording the production 
and regulation of melatonin (Edwards, Evans, Hucklebridge, & Clow, 2001; Fries et 
al., 2009; Wilhelm, Born, Kudielka, Schlotz, & Wust, 2007).   
Diurnal cortisol levels are a useful and important measure of HPA axis 
activity throughout the day and can provide information regarding the degree of 
change in cortisol levels from early morning to late evening, which typically show a 
decline (E. K. Adam & Kumari, 2009). Generally, a steeper diurnal decline is 
associated with better psychosocial and physical health and flatter slopes have shown 
an association with a greater number of adverse health outcomes and earlier 
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mortality (E. K. Adam & Kumari, 2009; Saxbe, 2008). Additionally, the diurnal 
decline shows a relationship with chronic stress, where chronic stress is associated 
with a flatter diurnal cortisol slope (G. E. Miller, Chen, & Zhou, 2007) Typically, the 
cortisol awakening response (detailed in Section 2.3) is not included when the 
diurnal cortisol slope is calculated (E. K. Adam & Kumari, 2009). Pre-sleep cortisol 
levels, which are generally measured at bedtime, are also an important measure of 
HPA axis activity since they are typically assessed as part of the diurnal slope. High 
levels of cortisol at bedtime can lead to flatter diurnal cortisol slopes (E. K. Adam & 
Kumari, 2009). However, the assessment of diurnal cortisol can place a high burden 
on participants and compliance is important (Saxbe, 2008). 
 
 
Figure 2.1: Typical cortisol awakening response (CAR) and diurnal cortisol profile over a 
twenty-four hour period in healthy individuals. The first shaded area represents the cortisol 
awakening response and the second shaded area represents cortisol levels during sleep. 
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2.3. The cortisol awakening response 
 The CAR refers to the sharp increase in cortisol levels observed immediately 
following awakening (shown as the first shaded area of Figure 2.1). The CAR is a 
distinct aspect of the diurnal cortisol profile and is considered a genuine response to 
awakening (Buckley & Schatzberg, 2005; Edwards et al., 2001; Fries et al., 2009; 
Schmidt-Reinwald et al., 1999; Wilhelm et al., 2007). During the CAR phase, 
cortisol levels increase by anywhere between 38%–75% compared to awakening 
levels, peaking approximately 30-45 minutes post-awakening (Clow et al., 2004; 
Fries et al., 2009). Whilst the CAR is dependent upon the transition from sleep to 
wake (Wilhelm et al., 2007), it appears to be significantly larger following morning 
awakenings compared to afternoon awakenings (Griefahn & Robens, 2008; Wilhelm 
et al., 2007). Interestingly, the CAR has been shown to be absent after an evening 
nap, suggesting both a role for the circadian rhythm of HPA axis in relation to the 
CAR, and a potential influence of light during morning awakening (Federenko et al., 
2004). The CAR is typical in healthy adults, demonstrable in approximately 73%-
77% of individuals, and has been shown to exhibit a moderate to high level of intra-
individual stability across two consecutive sampling days (r = .63) (Kunz-Ebrecht, 
Kirschbaum, Marmot, & Steptoe, 2004; Wüst et al., 2000b).  Despite this level of 
stability, daily fluctuations in the CAR have been associated with a range of 
psychosocial factors (E. K. Adam, Hawkley, Kudielka, & Cacioppo, 2006; Chida & 
Steptoe, 2009). Intriguingly, negative CARs, characterised by a decrease in levels of 
cortisol from awakening to post-awakening, have also been observed (Eek et al., 
2006). Although observed, it is possible that negative CARs occur due to 
methodological errors, including poor adherence to the sampling protocol, rather 
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than psychosocial influences (Wüst, Federenko, Hellhammer, & Kirschbaum, 
2000a).  
 
2.3.1. Measurement indices of the CAR 
 The CAR can be quantified and analysed in several ways. For example, at 
specified sampling time points (Backhaus et al., 2004; Junghanns, Horbach, 
Ehrenthal, Blank, & Backhaus, 2007), or averaged cortisol values over the whole 
CAR period (Dockray & Steptoe, 2011). Other techniques involve examining the 
total cortisol secretion over the CAR period, typically expressed as arbitrary units, 
using the area under the curve (AUC) (Wüst et al., 2000b).  This method is, 
however, only appropriate when three or more saliva samples from the CAR period 
are available (Pruessner, Kirschbaum, Meinlschmid, & Hellhammer, 2003). The 
AUC of the CAR can be calculated in two ways. Firstly, AUC can be examined in 
relation to zero (area under the curve with respect to ground: AUCG) which provides 
a measure of total cortisol output over the entire CAR period (Clow et al., 2004) (in 
this case the first and last CAR samples have a smaller contribution than other 
values) (Pruessner et al., 2003). Secondly, AUCI is calculated with respect to 
increases between the first CAR sample and all subsequent samples, providing a 
measure of the total cortisol secretion over the CAR period (Clow et al., 2004; 
Edwards et al., 2001; Pruessner et al., 2003). The area under the curve with respect 
to increase (AUCI ) identifies changes in the CAR over time, however, as would be 
expected, is particularly sensitive to the first awakening sample of the CAR (Clow et 
al., 2004). The CAR dynamic (i.e. the magnitude of change from awakening) can 
also be assessed and reported. For example, peak change levels can be assessed by 
calculating the difference between cortisol levels at awakening (i.e. the first sample 
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of the CAR) and the peak cortisol levels observed during the post-awakening CAR 
period (E. K. Adam et al., 2006; Dockray & Steptoe, 2011). Alternatively the mean 
increase during the CAR period with respect to the first awakening sample (known 
as the mean increase or MnInc) can be calculated based on the average of all post-
awakening samples (Wüst et al., 2000b).   
Each measure of the CAR is different and the choice of index should reflect the 
number of sampling points during the CAR period; however, measures of overall 
cortisol secretion and the dynamic of the response are typically reported (Clow et al., 
2004). In order to provide a comprehensive overview of the CAR in relation to the 
research question throughout the thesis, several indices will be used within analyses. 
These indices will include: cortisol levels at each sampling point, awakening values, 
total secretion during the CAR period (AUCG) the peak value within the CAR and 
the dynamic of the response (peak change). 
 
2.4. Potential functions of the CAR 
 Despite increasing numbers of studies focusing on the CAR, its precise 
function and purpose remains unclear (Clow et al., 2010). It has been suggested that 
the CAR has potential roles within the processes of arousal, energy boost, and/or 
anticipation. 
 
2.4.1. Termination of sleep inertia and arousal 
 Acute administration of cortisol can reduce feelings of fatigue, thus 
demonstrating its bioenergetic effects upon psychological functioning (Tops, Van 
Peer, Wijers, & Korf, 2006).  The typical incline of cortisol over the CAR period 
corresponds to increasing alertness over the period of sleep inertia, with cortisol 
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levels peaking with the timing of full alertness (Ikeda & Hayashi, 2008). The 
duration and severity of sleep inertia is, however, dependent on a number of other 
factors, including sleep duration, stage of sleep prior to awakening, time of day, and 
sleep deprivation, suggesting that these factors should be considered when assessing 
the relationship between the CAR, sleep inertia and stress-related sleep loss (Tassi & 
Muzet, 2000). The proposed relationship between the CAR and sleep inertia 
therefore suggests that the CAR may help to regain arousal upon awakening.  In 
support, associations between indices of the CAR and arousal have previously been 
demonstrated. For example, levels of self-reported arousal are positively related to 
the CAR, and a change in levels of self-reported arousal has been positively 
associated with changes in MnInc levels (Thorn, Hucklebridge, Esgate, Evans, & 
Clow, 2004; Thorn, Hucklebridge, Evans, & Clow, 2009).  Arousal–related 
performance has also been associated with the CAR. In one study, responsiveness, as 
measured by an auditory reaction time task, increased 15 minutes post-awakening in 
line with post-awakening increases in cortisol initially and continued in a dose-
response manner thereafter (Ikeda & Hayashi, 2008).  In contrast, lower levels of 
cortisol have been associated with perceived fatigue in older adults and subjective 
sleepiness and exhaustion in a sample of academics (E. K. Adam et al., 2006; 
Dahlgren, Kecklund, Theorell, & Åkerstedt, 2009). Overall, the evidence points to a 
relationship between the CAR, the end of sleep inertia, and increased arousal. 
 
2.4.2. Adaptation and anticipation 
 There is evidence that the CAR is an adaptive mechanism, either in aiding 
recovery from prior negative experiences and/or preparing the organism for 
forthcoming demands (Lovell, Moss, & Wetherell, 2011). In support of the recovery 
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hypothesis, subjective feelings of loneliness, sadness, threat and lack of control 
immediately before bed have been associated with a greater CAR the following day 
in a sample of older adults (E. K. Adam et al., 2006). In the same sample, self- 
reported fatigue was also associated with awakening cortisol levels but only on the 
first morning of sampling. The authors conclude that changes in the CAR occur in 
relation to the level of perceived challenge, demonstrating day-to-day variability (i.e. 
a state rather than trait adaptation process).  
The relationship between the anticipation of forthcoming events and CAR 
indices has also been examined. CARs, as determined by the mean increase between 
awakening and 30 minutes post-awakening, have been shown to be approximately 
three times greater on work days, characterised as more demanding, than non-work 
days (Kunz-Ebrecht et al., 2004; Thorn, Hucklebridge, Evans, & Clow, 2006).  
Similarly, higher levels of cortisol following awakening have been observed on 
workdays in those who report greater levels of perceived worry and chronic work 
overload (Schlotz, 2004), and greater MnInc levels have been observed on two 
consecutive work days as compared to levels during non-work-days (Thorn et al., 
2006). Further, Schlotz and colleagues (2004) observed weekday/weekend 
differences in the CAR measured over six consecutive days,  characterised by a 
steeper rise to peak levels and higher subsequent cortisol levels at each sampling 
point on weekdays compared to weekends (Schlotz, 2004).   
Similar findings have been observed in relation to differing types of background 
stress.  For example, in a sample of newly qualified doctors, greater CARs were 
observed at the beginning of a clinical rotation, characterised by greater uncertainty, 
perceived lack of control and greater perceived workload, compared with the end of 
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a rotation whereby perceived control and certainty had increased (Brant, Wetherell, 
Lightman, Crown, & Vedhara, 2010). Further evidence for the role of the CAR as an 
anticipatory mechanism is provided by Rohleder and colleagues (Rohleder, Beulen, 
Chen, Wolf, & Kirschbaum, 2007) who observed higher awakening cortisol levels 
on the day of a ballroom dancing competition compared to a practice day, despite 
similar levels of physical exertion. Competition studies have also shown effects upon 
the CAR, where cortisol levels were increased 30 minutes following awakening in 
tennis players and in motorcycle riders on the first day of a competition , compared 
to a rest day without competition (Filaire, Alix, Ferrand, & Verger, 2009; Filaire, 
Filaire, & Le Scanff, 2007). Judo athletes have also shown increased cortisol levels 
at awakening on the morning of regional and inter-regional competition when 
compared to a resting day three weeks prior to competition  (Filaire, Sagnol, Ferrand, 
Maso, & Lac, 2001).  
Finally, days off from work, associated with reduced demand and expectancy, 
are related to negative CARs, where cortisol levels decrease after awakening (Eek et 
al., 2006). Together, these studies demonstrate the adaptive nature of the CAR in 
relation to salient forthcoming challenges. Further, Hellhammer and colleagues 
(Hellhammer et al., 2007) conclude that the measurement of the CAR on any 
specific day is subject to the influence of greater situational than trait factors.  As 
such, the CAR should be measured on two or more consecutive days, and work days 
should be distinguished from non-work days.  
In support are findings from a novel methodology involving a single case study 
over a period of 50 consecutive days (Stalder, Evans, Hucklebridge, & Clow, 
2010a). Approximately 22% of the intra-individual variance in total cortisol 
secretion, over the CAR period, was explained by subjective levels of mood and 
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daily anticipation of activities and obligations. Together, these findings provide a 
compelling case for the CAR serving as a potential marker of anticipation.  
Furthermore, the role of the hippocampus in HPA axis function and its involvement 
in the processing of space, time, environmental cues and memory consolidation, 
provides a potential neurological basis for this proposed preparatory function (Fries 
et al., 2009; Sweatt, 2004). 
 
2.5. Sleep and the CAR 
In order to further understand the links between the CAR and sleep, it is 
necessary to investigate potential regulatory processes which influence cortisol 
secretion prior to initiation of the CAR (Clow et al., 2010).  In particular, the specific 
features of sleep including its duration, number and level of awakenings have been 
investigated in relation to the CAR. 
 
2.5.1. Sleep duration, sleep disturbances and sleepiness 
The relationship between sleep duration and the CAR has been examined, 
using both subjective and objective measures, albeit with mixed findings. 
Interestingly, the strength and direction of these findings appear to be influenced by 
measurement timings and CAR reporting indices. Self-reported short sleep duration 
has been associated with a steeper rise in cortisol from awakening to 30 minutes 
post-awakening in a large population (n = 2,751) of middle-aged adults (Kumari et 
al., 2009). Moreover, Stalder and colleagues (Stalder, Hucklebridge, Evans, & Clow, 
2009) showed a link between self-reported sleep duration and the CAR across 50 
measurement days. Awakening cortisol levels (i.e. the first CAR sample) were 
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positively related to sleep duration and time of awakening, although this was not the 
case for the AUCG underscoring the importance of the measurement indices used.  
Contrastingly, Zhang and colleagues found no differences in three-day 
awakening cortisol levels between short and long sleepers (assessed by actigraphy) 
(Zhang et al., 2011). That said, when assessing actigraphically measured time in bed 
rather than sleep duration, differences between short and long sleepers in CAR 
indices did emerge.  Lower cortisol levels at awakening were observed in those with 
a ‘shorter’ time in bed (conceptualised as < seven hours), compared to those with a 
‘normal’ or ‘longer’ time in bed (both conceptualised as > seven hours). A 
systematic review of 23 studies examining the relationship between subjective and 
objective sleep duration and the CAR confirms this relationship between longer 
sleep duration and increased cortisol levels at awakening although as the relationship 
with time in bed was unreported it is difficult to disentangle the relationship between 
sleep disturbance and the CAR (Garde, Karlson, Hansen, Persson, & Åkerstedt, 
2012). However, a negative correlation, albeit small, between self-reported sleep 
duration and the mean increase during the CAR (r = -.16) has also been observed 
(Wüst et al., 2000b).  
Confusingly, other studies have failed to find associations between self-
reported as well as actigraphically measured sleep duration and the CAR. For 
example, one study assessed the relationship between the CAR peak change at 
awakening, 20 minutes post-awakening and 40 minutes post-awakening, with sleep 
problems over a three-month period (Hansen et al., 2012). Self-reported sleep 
duration was not related to the CAR (either in terms of the maximum increase in 
levels from awakening to either the second or third sample, or in terms of the AUC). 
Finally, Stalder and colleagues found no relationship between the CAR awakening 
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sample or AUCG and sleep duration using actigraphy (Stalder, Evans, Hucklebridge, 
& Clow, 2010b).  
It is conceivable that the relationship between sleep duration and the CAR is 
mediated by stress as opposed to individual differences in sleep need, which could 
account for the inconsistency in the findings presented above. However, Dahlgren 
and colleagues (Dahlgren et al., 2005) examined work stress in relation to subjective 
and objective measures of sleep and the CAR. Office workers provided cortisol 
samples at 15 minutes post-awakening during one work day and during one non 
work-day, once during a working week of high stress and once during a working 
week of low stress, based on their predicted workload.  During the high stress week 
participants reported more problems falling asleep, and also reported feeling more 
subjectively sleepy at the end of the day. Furthermore, actigraphy indicated that less 
sleep was obtained during the high stress week and during work days. However, 
there were no differences in cortisol levels at 15 minutes post-awakening between 
the high and low stress weeks, or between a work day and a non-work day.  
These studies would have benefited from a more comprehensive assessment 
of the CAR through additional sampling points; however, these discrepant findings 
do suggest that the relationship between sleep duration and the CAR is complex. 
This also raises the possibility that perhaps the association between stress and the 
CAR may in fact be influenced by sleep disturbances, rather than duration per se. For 
example, in one study, self-reported sleep disturbances were related to both the 
maximum increase and the AUC during the CAR period; and frequency of 
awakening problems and exhaustion upon awakening  were associated with the 
maximum increase (Hansen et al., 2012).  That said, as there are few studies 
examining sleep disturbances in relation to the CAR, further research is needed, 
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including the objective monitoring of sleep and multiple sampling points in the CAR 
period, in order to clarify the inter-relationships between the CAR, stress, sleep 
duration and disturbances. 
The relationship between subjective sleepiness and the CAR has also been 
assessed. A sample of office workers were followed over four consecutive weeks, 
where participants provided cortisol samples at awakening and 15 minutes post-
awakening. After controlling for individual variation, higher levels of subjective 
sleepiness on awakening and reported levels of exhaustion from the previous day 
were associated with lower levels of cortisol at awakening. Moreover,  high levels of 
subjective sleepiness and anxiety at awakening were associated with lower levels of 
cortisol 15 minutes post-awakening (Dahlgren et al., 2009). However, the use of 
additional sampling points would have allowed for the calculation of a measure of 
total secretion during the CAR period and provide a more comprehensive overview 
of the relationship between subjective sleepiness and the CAR. 
 
2.5.2. Effects of nocturnal awakenings, morning awakenings and awakening 
time 
 Disturbed sleep through forced nocturnal awakening appears to have little 
effect upon the CAR in healthy individuals (Dettenborn, Rosenloecher, & 
Kirschbaum, 2007; Hucklebridge, Clow, Rahman, & Evans, 2000). For example, a 
single forced nocturnal awakening did not have an appreciable effect upon the CAR 
compared to a night of normal sleep (Hucklebridge et al., 2000). Moreover, no 
differences were observed in the CAR in participants who were awoken three times 
during the night by telephone calls compared to non-interrupted nights (Dettenborn 
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et al., 2007). That said, as CAR assessments were only taken 15 minutes post-
awakening, it is possible that the impact of the awakenings might have occurred later 
in the CAR period. The mode of awakening also appears not to affect the CAR, as no 
differences in CAR indices were observed between individuals who woke up 
naturally or those who used an alarm clock and these findings were mirrored in a 
single-subject study over multiple days (Stalder et al., 2010a).  
However, unexpected awakenings do appear to influence the CAR.  In one 
study participants were informed that they would have a short sleep (awakening at 
06:00h), or a long sleep (awakening at 09:00h), before lights out (Born, Hansen, 
Marshall, Molle, & Fehm, 1999). Greater increases in cortisol, in terms of cortisol 
concentrations compared before and after awakening, were observed following an 
unexpected awakening (awakening at 06:00h during an anticipated long sleep) 
compared to an expected awakening time. However, the time at which post-
awakening samples in this study were obtained is unclear, thus limiting the 
interpretation of these findings. A more comprehensive assessment of the CAR is 
needed in order to determine the direct effects of expected vs. unexpected awakening 
upon HPA axis function, and it is possible that any effects upon the CAR are also 
driven by architectural properties of the prior sleep period. 
 The time of awakening appears to have an impact upon the CAR. Thorn and 
colleagues showed that individuals who woke at an earlier time displayed greater 
AUC and a steeper increase in cortisol during the CAR period compared to those 
who woke later (Thorn et al., 2006). Another study confirmed this finding in that 
earlier awakening times (04:54h to 08:03h) were associated with higher awakening 
cortisol levels. As awakening time is typically linked to sleep duration, this finding 
may be a potential artefact of sleep duration. That said, two studies have reported 
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negative associations between awakening time and cortisol after controlling for sleep 
duration (Edwards et al., 2001; Kudielka & Kirschbaum, 2003).  However, no 
effects of awakening time on dimensions of the CAR have been observed elsewhere 
(Kunz-Ebrecht et al., 2004; Pruessner et al., 1997).   
 
2.5.3. Relationships with sleep architecture 
The relationship between sleep architecture and the CAR is unclear. The 
duration of REM sleep has been shown to negatively relate to cortisol levels 
measured immediately at awakening (Junghanns et al., 2007).  That said, as this 
sample were a group of alcohol-dependent inpatients, generalizations to other 
populations are difficult. One study of caregivers and non-caregivers, demonstrated 
that overall lower awakening cortisol levels were associated with increased 
percentages of Stage 1, Stage 3 and REM (Fonareva, Amen, Zajdel, Ellingson, & 
Oken, 2011). Further, in a sample of veterans with PTSD and a sample of healthy 
controls, no measures of sleep architecture were related to the CAR across both 
groups, in terms of the AUCG (van Liempt et al., 2013). Considering these 
inconsistencies, especially within such diverse populations, the specific relationship 
between the CAR and sleep architecture needs to be thoroughly investigated in 
normal sleepers before being extended to other populations. Additionally, it is 
difficult to determine whether changes to the HPA axis alter sleep architecture, or 
whether it is sleep architecture that drives HPA axis activity. It is possible that this 
relationship is bi-directional, since the administration of cortisol appears to increase 
slow-wave sleep (SWS) and decrease REM sleep; whilst it has also been shown that 
the number of episodes of SWS and REM sleep are both related to decreases in 
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nocturnal cortisol levels (Follenius, Brandenberger, Bandesapt, Libert, & Ehrhart, 
1992; Steiger, 2002). 
 
2.6. Changes to sleep  
2.6.1. Shift patterns 
 Shift work results in significant alterations in a range of sleep parameters, all 
of which have also been associated with modifications to the CAR.  In line with the 
observed relationship between early awakening and an increased CAR, early shift 
patterns have been associated with greater CARs compared to working late or night 
shift patterns in nurses  (Federenko et al., 2004). Public transport workers also 
showed a greater CAR on early shifts compared to either day shifts or days off, both 
in terms of the MnInc and AUCI. Interestingly, these differences in the CAR were no 
longer apparent when controlling for perceived levels of stress and perceived sleep 
quality (Williams, Magid, & Steptoe, 2005). Abrupt changes in shift patterns also 
appear to influence the CAR, for example, one study assessed the CAR in permanent 
day-shift and night-shift employees after changing to a schedule of quickly-rotating 
mornings, evenings and night-shifts (Kudielka, Buchtal, Uhde, & Wüst, 2007). 
Although the CAR was still observable across the groups, day workers shifted to 
permanent night-shift displayed more blunted CARs (i.e. a reduced magnitude of 
response in cortisol levels from awakening to peak).  It is difficult to determine 
whether shift work has a direct effect upon the HPA axis and the CAR, or whether 
subsequent effects upon the HPA axis are mediated by changes in sleep. Sleep 
disturbances are commonly observed as a result of shift work, and the level of 
disturbance resulting from irregular work hours is similar to the level of disturbance 
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observed in those with insomnia (Åkerstedt, 2003). Further research will be needed 
to examine this relationship after controlling for the sleep disturbances apparent in 
shift work. 
 
2.6.2. Sleep deprivation 
Attempts have been made to assess the effects of both sleep restriction and 
deprivation on HPA axis function and the diurnal rhythm of cortisol, with mixed 
results. Following a four-day baseline period (eight hours of sleep per night), an 
enforced sleep restriction of two hours per night for a period of eight days (six hours 
of sleep per night) resulted in reduced post-awakening peak cortisol responses 
(Vgontzas et al., 2004). Contrastingly, Voderholzer and colleagues found no effects 
of different amounts of sleep restriction (varying from five to nine hours) on the 
AUC during the CAR period in a group of adolescents (Voderholzer et al.). This 
raises the issue of age-related changes in the CAR which will be considered later. In 
terms of sleep deprivation, no differences were observed in the absolute cortisol 
levels of individuals experiencing partial (four hours sleep per night) and total sleep 
deprivation over a 32-hour period when compared with those maintaining a normal 
sleep/wake schedule (Leproult, Copinschi, Buxton, & Van Cauter, 1997). Likewise, 
Cote and colleagues (2013) found no differences in awakening cortisol levels after a 
normal night of sleep compared to sampling at the same time following a night of 
sleep deprivation. However, it is possible that any potential effects of sleep 
deprivation on the CAR may have occurred later in the CAR phase, since only a 
single awakening sample was collected. Taken together, these studies suggest that 
sleep restriction and partial or total sleep deprivation have little impact upon cortisol 
levels during the CAR period. The latter finding is somewhat surprising, given that 
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the CAR is considered to occur exclusively as a response to awakening. Further 
research using more a rigorous protocol is therefore required in order to clarify the 
effects. 
 
2.7. Methodological considerations 
 The CAR, given its finite sampling period, is particularly sensitive to the 
influence of a range of methodological factors that should be carefully considered 
both in interpreting the existing literature and in the design of future studies. 
 
2.7.1. Age, sex differences and menstrual cycle phase 
 The CAR has been observed in infants as young as two months of age, which 
coincides with the emergence of circadian rhythmicity (Stalder et al., 2013). More 
generally, HPA axis activity has been shown to decline across the lifespan, although 
this is not consistently agreed upon (Hatzinger, Brand, Herzig, & Holsboer-
Trachsler, 2011). Two cross-sectional studies observed no differences in CAR 
indices, including the AUC and mean increase, between children, younger, and older 
adults (Pruessner et al., 1997; Wüst et al., 2000b). However, other studies suggest 
the association between the CAR and age is apparent but more complex. For 
example, one study demonstrated a weak positive relationship between age and 
cortisol levels immediately after awakening (r = .20), in a sample aged between 4–75 
years, but a weak negative correlation with the total amount of cortisol secreted 
during the CAR period (r = -.20) such that older individuals show greater cortisol 
levels on awakening, yet lower levels of secretion during the CAR period (Kudielka 
& Kirschbaum, 2003). Furthermore, in a sample of older adults aged from 60 - 91 
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years, increasing age was weakly associated (r = -.28) with a reduction in the rise in 
cortisol levels from awakening to the peak response (Evans et al., 2011). Overall, it 
would appear that the impact of age upon the CAR, if any, is minimal. 
 Some studies have reported sex differences in the CAR. For example, during 
workdays females have been shown to display a greater increase in cortisol levels 
between awakening and 30 minutes post-awakening, compared to males (Kunz-
Ebrecht et al., 2004). Despite this, others have failed to observe any differences in 
CAR indices between males and females (Kudielka & Kirschbaum, 2003). Overall, 
the effects of sex appear to be minimal, and explain only between one to three per 
cent of the variability in levels of cortisol secretion during the CAR (Fries et al., 
2009; Pruessner et al., 1997).  However, sex differences in the CAR have been 
observed in the presence of illness. Bengtsson and colleagues (Bengtsson et al., 
2010) measured the CAR in healthy controls and individuals with metabolic 
syndrome. No sex differences were apparent in healthy controls, however in 
individuals with metabolic syndrome, women displayed a greater relative CAR than 
men. These apparently contradictory findings in relation to sex differences could be 
explained by menstrual cycle phase. One study showed that the increase in cortisol 
levels during the CAR, in terms of the difference between the maximum cortisol 
value and cortisol levels at awakening, was elevated during ovulation (Wolfram, 
Bellingrath, & Kudielka, 2011). However, other studies report no effects of cycle 
phase upon the CAR (Kirschbaum, Kudielka, Gaab, Schommer, & Hellhammer, 
1999; Kudielka & Kirschbaum, 2003). Another study investigated the effect of 
contraceptive use on the CAR and found that the effects were minimal, accounting 
for approximately four per cent of variability (Pruessner et al., 1997). As such the 
evidence of sex difference on the CAR appears equivocal at best. 
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2.7.2. Adherence  
 Many of the inconsistencies observed in CAR studies, the majority of which 
are performed in ambulatory settings, may be attributed to methodological issues, 
specifically pertaining to adherence to sampling protocols. It is possible that reliance 
upon self-sampling at the required times could lead to difficulties. A failure to 
comply with correct sampling times can lead to invalid results, or at worst, data that 
could be misinterpreted.  For example, negative CARs, characterised by a decrease 
in levels of cortisol from awakening during the CAR period are associated with days 
off from work (Eek et al., 2006).This association may be valid, however, it may also 
reflect poor adherence to the timing of sampling protocol during the CAR period. 
That is delays between awakening and the collection of the awakening sample are 
more frequent in those showing negative CARs (Eek et al., 2006). Adherence is 
particularly important during the CAR period following the awakening sample. The 
rate of increase of cortisol levels is typically between 38%-75% in this time, 
although increases greater than 100% have also been shown, and any deviation from 
the required sampling times can therefore significantly increase measurement error 
(Clow et al., 2004).  
 Techniques can be employed to provide more objective checks on levels of 
adherence to protocols in ambulatory settings.  For example, some studies employ 
the use of devices such as Medication Events Monitoring System (MEMS) track 
caps, which time-stamp the opening of saliva collection bottles and therefore log 
sampling times (Kudielka, Hawkley, Adam, & Cacioppo, 2007). One study which 
measured the CAR at wake and 30 minutes post-awakening using MEMS observed 
an adherence rate of 74% (Kudielka, Broderick, & Kirschbaum, 2003).  Of the non-
compliant participants, the majority (82%) failed to collect two or more samples at 
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the required time, significantly impacting the subsequent CAR data. Specifically, the 
net increase in cortisol levels from awakening to 30 minutes post-awakening was 
more than three times greater in adherent participants. Whilst adherent participants 
showed a typical increase from awakening to 30 minutes post-awakening, non-
adherent participants showed a blunted CAR that was directly related to increasing 
delays in sampling. As the CAR typically peaks approximately 30 minutes following 
awakening, any delays in the collection of this first awakening sample will distort the 
CAR, typically resulting in a flattening of the peak response relative to awakening 
and blunting the overall CAR (Griefahn & Robens, 2010; Thorn et al., 2006).  There 
is also evidence that self-reported awakening and sampling times are good indicators 
of adherence and are equally as reliable as electronic measures of compliance 
(Kraemer et al., 2006; Okun et al., 2010).  
Actigraphy has also been used to compare self-reported awakening times 
with actual awakening times. Self-reported awakening times were accurate, with 
92% showing a deviation of less than 15 minutes from the objective awakening 
times. That said, there was a trend towards reduced CARs in those with differences 
between objective and subjective awakening times of between five and 15 minutes 
(DeSantis, Adam, Mendelsohn, & Doane, 2010). Moreover, studies employing the 
use of polysomnography (PSG) have shown that delays of longer than 15 minutes 
between the time of awakening and the first awakening sample of the CAR can result 
in a reduced CAR indices (Okun et al., 2010).  
Adherence may also be an issue in terms of sample contamination. It is 
important that participants have nil by mouth, except water, at least 30 minutes prior 
to, and during, the CAR sampling period. In addition, participants must avoid 
smoking or brushing their teeth to avoid sample contamination through abrasion and 
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vascular leakage (Clow et al., 2004). Rarely have these factors been reportedly 
assessed or controlled for. 
 
2.7.3. Light 
 As the SCN is responsible for overall co-ordination of the HPA axis and 
receives light information from the retina (Buijs et al., 2003) various studies have 
specifically examined the effects of light upon the CAR. Figueiro and Rea (2012) 
sampled cortisol at awakening and every 20 minutes thereafter between 06:00h and 
07:20h in a sample of sleep-restricted adolescent participants (aged 12-17 years) who 
had slept for four and a half hours. Participants were either exposed to dim light of 
less than five lux or short wavelength blue light, immediately after the first 
awakening sample of the CAR phase. Those exposed to blue light displayed an 
enhanced CAR and a greater level of cortisol secretion throughout the CAR period, 
expressed as the AUCI, compared to dim light-exposed participants.  
A separate study also examined the effects of light in sleep-deprived 
participants. In this case participants experienced a baseline period of dim light of 
less than 150 lux and were gradually exposed to increasing bright light over a period 
of three hours, which was then reversed. This occurred either in the morning after 20 
hours or 30 hours of constant wakefulness. A rapid elevation in blood cortisol levels 
was observed, but only when participants were exposed to light in the morning rather 
than in the afternoon (Leproult, Colecchia, L’Hermite-Balériaux, & Van Cauter, 
2001). Of note, participants were kept fully awake, and so would have been acutely 
sleep deprived when the light exposure occurred. This may have confounded cortisol 
production during the CAR period.  
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Following a normal sleep period, Thorn and colleagues (Thorn et al., 2004) 
employed the use of a dawn simulation light device, which increased in intensity to 
levels of approximately 250 lux in the 30 minutes prior to awakening. Both an 
increased CAR and increased levels of total cortisol output in terms of the AUCG 
were observed for the dawn simulation condition compared to normal awakening. 
Likewise, Scheer and Buijs (Scheer & Buijs, 1999) found that participants exposed 
to 800 lux of light during the CAR period using light goggles had increased cortisol 
levels at 20 minutes post-awakening and 40 minutes post-awakening compared to 
those who remained in darkness. Due to the potentially confounding effects of light, 
it will be extremely important to control for light during the measurement of the 
CAR.  
 
2.8. Summary  
The CAR is a useful marker of stress and does appear to show a relationship 
with measures of sleep, albeit with mixed findings. This is particularly apparent with 
regards to sleep duration and in order to clarify the relationships between the CAR, 
stress, sleep duration and disturbances a more comprehensive and rigorous 
measurement of the CAR will be necessary, alongside objective monitoring of sleep. 
This will also enable the relationships between measures of objective sleep 
architecture, sleep continuity and the CAR to be examined in more detail.  
As the CAR may have a function relating to the anticipation of upcoming 
demand  (Filaire et al., 2009; Filaire et al., 2007; Filaire et al., 2001; Fries et al., 
2009; Rohleder et al., 2007; Sweatt, 2004) and/or may function as a mechanism to 
assist the regaining of arousal upon awakening (Thorn et al., 2004; Thorn et al., 
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2009), the CAR will be an ideal physiological marker for examining the 
physiological effects of demand and the anticipation of demand.  
However, there are potential factors which may impact upon the accurate 
measurement of the CAR, including light (Figueiro & Rea, 2012; Scheer & Buijs, 
1999; Thorn et al., 2004), unexpected awakenings (Born et al., 1999), the time of 
awakening (Stalder et al., 2009; Thorn et al., 2006) and the deviation from required 
sampling times (Clow et al., 2004). As the relationship between these variables and 
the CAR is complex and comparisons across studies are limited by differing 
measurement protocols and methods, a standard protocol for the measurement of the 
CAR will be necessary in order to assess the physiological effects of stress upon the 
CAR within the context of the thesis.  The use of a consistent and controlled 
measurement protocol will also provide further information regarding the function of 
the CAR. The following section describes a suggested protocol for measurement of 
the CAR on the basis of previous studies. 
 
2.9. Suggested standard measurement protocols 
 In order to assess the relationships between sleep factors and subsequent 
effects on the CAR, it is recommended that samples are measured immediately upon 
awakening and 15, 30, 45 and 60 minutes post-waking (Elder, Wetherell, Barclay, & 
Ellis, 2014). The use of these time points will allow for the assessment of an 
individual’s peak response during the CAR period whilst providing sufficient 
samples to calculate total cortisol secretion (as measured by the AUCI and AUCG) 
and the mean increase in levels (MnInc) (E. K. Adam et al., 2006; Clow et al., 2004; 
Dockray & Steptoe, 2011; Pruessner et al., 2003; Wüst et al., 2000b).  Despite the 
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moderate to high levels of intra-individual stability within the CAR, it is 
recommended that CAR measurements be taken on at least two consecutive days 
(Hellhammer et al., 2007). The CAR of a single day is largely determined by 
situational factors and this will help assess and disentangle trait rather than state 
influences.  Furthermore, sampling days should be typical in terms of activities, for 
example, protocols should account for differences observed in the CAR between 
work and leisure days (Kunz-Ebrecht et al., 2004; Schlotz, 2004; Thorn et al., 2006). 
Hansen and colleagues (Hansen, Garde, & Persson, 2008) note that researchers may 
wish to register and include the time of sampling within the statistical analysis of 
CAR data, or that samples are obtained at the same time each day in order to control 
for the diurnal variation in cortisol levels.   
 
2.10. Aim of the thesis 
The overall aim of the thesis is to assess the effects of stress upon subjective 
sleep, objective sleep and the CAR as physiological marker of HPA axis activity. 
Both the Spielman 3P and Cano-Saper models of insomnia (Spielman et al., 1987; 
Spielman & Glovinsky, 1991; Spielman et al., 1996) focus on the role of stress in the 
development of insomnia, however the effects of both naturalistic and experimental 
stressors, whilst disruptive to subjective and objective sleep, are largely inconsistent.  
As there is no standardised method for assessing the effects of stress upon sleep, 
these inconsistencies may arise from the wide variation in the stressor employed, the 
diverse nature of the participants and the method employed to measure the effects 
upon sleep. Furthermore, naturalistic and experimental studies have also shown that 
the anticipation of stress can disrupt sleep however these results are also 
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inconsistent, where diverse stressors and measurement protocols have been used. 
Moreover, studies which have examined the effects of stress upon sleep have tended 
not to include a physiological marker of stress within the protocol, where it cannot 
be objectively confirmed that the stressor employed is stressful.  
This thesis will therefore assess the effects of stress upon sleep by developing 
and testing a standardised measurement protocol. The protocol will measure the 
effects of stress upon subjective sleep, objective sleep and the CAR as an objective 
marker of HPA axis activity. As the anticipation of stress appears to disrupt sleep, 
the measurement protocol will tease apart the effects of anticipation. This will be 
done by measuring the effects of anticipation, or anticipation coupled with 
subsequent demand, upon subjective sleep, objective sleep and the CAR.   
Chapter 3 of the thesis will propose and outline a standardised method for 
measuring subjective sleep, objective sleep and the CAR. Chapter 4 describes an 
initial feasibility study conducted in order to examine the feasibility of using the 
protocol within a home environment and within a laboratory environment, with the 
aim of informing the location for later studies where the protocol includes a stressor. 
Chapter 5a and 5b describe the use of this protocol within a laboratory environment, 
with the aim of examining the interactions between subjective sleep, objective sleep 
and the CAR. Chapter 6 extends the protocol by examining the effects of stress upon 
subjective sleep, objective sleep and the CAR, where the anticipation is either not 
met or is met with subsequent demand. Chapter 7 summarises the results of the 
thesis and provides a general discussion, where the results are discussed in relation to 
the Spielman 3P and the Cano-Saper models of insomnia. The following chapter 
outlines the standardised method for measuring the effects of stress upon sleep in the 
same context. 
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CHAPTER 3.   
Method 
 
3.1. Introduction 
This chapter describes the standardised protocol developed in order to measure 
the effects of stress upon sleep, where subjective sleep, objective sleep and the CAR 
were measured. The standardised protocol was used within Study 1, which aimed to 
assess the suitability of the protocol and examine the relationship between subjective 
sleep, objective sleep and the CAR. The protocol was also used within Study 2, 
where the anticipation of stress was either met, or not met, with subsequent demand. 
 
3.2. Participants and recruitment 
Healthy, normal sleepers were recruited separately to Study 1 and 2 through 
emails sent to university staff and students. Potential participants were excluded if 
they were currently experiencing or if they had experienced any current sleep 
disorders or problems, on the basis of an initial screening questionnaire (Appendix 
A). Current smokers were not allowed to participate due to the negative effects of 
nicotine upon both subjective and objective sleep (Roehrs & Roth, 2011) and also to 
avoid any potential effects of cortisol sample contamination (Clow et al., 2004). 
Participants were also excluded if they were over 40 years of age, as HPA axis 
activity has been shown to decline across the life span (Hatzinger et al., 2011), if 
they reported a current complaint or a history of depression and/or anxiety, or if they 
reported the use of medication with the potential to affect HPA axis function. 
Participants were also unable to take part if they reported trans-meridian travel (i.e. 
travel across three or more time zones) in the preceding three month period in order 
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to control for any effects upon sleep, since symptoms of jet lag can persist for weeks 
after the flight (Drake & Wright Jr, 2011). 
 
3.3. Measures  
Participants completed measures of sleep quality, perceived stress in the past 
month, anxiety and depression, chronotype and vulnerability to stress-related sleep 
disturbances within Study 1 and Study 2. 
 
3.3.1. Pittsburgh Sleep Quality Index 
 The Pittsburgh Sleep Quality Index (PSQI; Buysse et al., 1989; Appendix B) 
is a self-rated questionnaire which assesses sleep disturbances over the past month. 
The PSQI consists of seven components, measuring subjective sleep quality, sleep 
latency, sleep duration, sleep efficiency and sleep disturbances, the use of any 
sleeping medication and the occurrence of any related daytime dysfunction (e.g. 
“during the past month, how would you rate your sleep quality overall?”). The PSQI 
gives seven component scores and these are summed to provide an overall score of 
between 0 and 21. The cut-off point for poor sleepers is a score of five, which 
provides a sensitivity of 89.6% and a specificity of 86.5% to correctly distinguish 
between good and poor sleepers. The PSQI is a reliable measure of sleep quality (α = 
.83)  (Backhaus, Junghanns, Broocks, Riemann, & Hohagen, 2002). 
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3.3.2. Perceived Stress Scale 
 The Perceived Stress Scale (PSS; S. Cohen, Kamarck, & Mermelstein, 1983; 
Appendix C) measures the extent to which life situations are perceived as being 
stressful and consists of 14 items (e.g. “in the last month, how often have you found 
that you could not cope with all the things that you had to do?”). These items are 
rated between zero (never) to four (very often). Total possible scores on the PSS 
range from zero to 56, with higher scores representing higher levels of perceived 
stress. The PSS has good reliability (α = approximately .85) (S. Cohen et al., 1983). 
 
3.3.3. Hospital Anxiety and Depression Scale 
 The Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 
1983; Appendix D) is a self-reported measure of anxiety and depression. Participants 
are asked to respond to a series of statements (e.g. “I feel tense or wound up)” with 
one of four possible responses. Each response is scored from zero to three. The 
HADS consists of two separate seven-item components, measuring anxiety and 
depression. The HADS provides a total score of between zero and 21. For both 
subscales, a score ranging between zero and seven is considered to be normal; eight 
to 10 is a considered to be borderline and 11 or above is considered to be abnormal. 
A meta-analysis found that the mean reliability of the anxiety component of the 
HADS to be α = .83 and the mean reliability of the HADS depression component to 
be α = .82 (Bjelland, Dahl, Haug, & Neckelmann, 2002). 
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3.3.4. Horne-Östberg Morningness-Eveningness Questionnaire 
 The Horne-Östberg Morningness-Eveningness Questionnaire (HÖ-MEQ; 
Horne & Ostberg, 1976; Appendix E) assesses self-reported chronotype, i.e. the  
preference for morningness or eveningness. The HÖ-MEQ consists of 19 items (e.g. 
“considering only your own ‘feeling best’ rhythm, at what time would you get up if 
you were entirely free to plan your day?”), which provide a total score ranging from 
16 – 86. Higher scores indicate an earlier chronotype: ‘definitely evening’ (16-30), 
‘moderately evening’ (31 - 41), ‘neither type’ (42 - 58), ‘moderately morning’ (59-
69) or ‘definitely morning’ (70 – 86). The HÖ-MEQ has a high level of consistency 
(α = .82) (Smith, Reilly, & Midkiff, 1989) and has been shown to negatively relate 
with bed times, wake times and the nadir for physical activity (Thun et al., 2012). 
The HÖ-MEQ is a widely used measure and appears to be a good predictor of 
circadian period or circadian phase (Sack et al., 2007). 
 
3.3.5. Ford Insomnia Response to Stress Test 
  The Ford Insomnia Response to Stress Test (FIRST; Drake et al., 2004; 
Appendix F) is a measure which assesses stress-related vulnerability to sleep 
disturbance. The FIRST consists of nine items which present hypothetical situations 
(e.g. “after a stressful experience during the day”), and individuals are asked how 
likely they are to experience difficulty sleeping under these situations. Respondents 
circle an answer on a one (not likely) to four (very likely) scale, with potential scores 
ranging from nine to 36. The FIRST has a good level of reliability (α = .83) (Drake 
et al., 2004). 
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3.3.6. Perceived Stress Reactivity Scale 
As Study 2 of the thesis assessed the effects of stress upon sleep and the CAR, 
participants in Study 2 completed the Perceived Stress Reactivity Scale (PSRS; 
Schlotz, Yim, Zoccola, Jansen, & Schulz, 2011; Appendix G). The PSRS is a 23-
item questionnaire which assesses perceived stress reactivity in a range of potentially 
stressful situations. Individuals are presented with a range of situations which they 
may have experienced in the past and are required to indicate which answer, from 
three possible responses, most closely matches their own response to that situation. 
The PSRS provides a total score ranging between zero and 46 which is given by the 
sum of the five subscales. Higher scores represent higher levels of reactivity to 
perceived stress. 
 
3.4. Procedure 
 Participants who expressed an interest in each study completed a brief 
screening form prior to their enrolment which was returned by email (Appendix A) 
All participants completed a two-week baseline monitoring period immediately prior 
to each study, in order to ensure that they had a stable sleep/wake cycle and that they 
did not display any potential sleep disorders or evidence of circadian rhythm 
problems. Participants were monitored during this period through the use of sleep 
and mood diaries and actigraphy. All participants provided written informed consent 
at the time of enrolment. Study 1 and Study 2 were approved separately by the 
Northumbria University Faculty of Health and Life Sciences Research Ethics 
Committee. The protocol is summarised in Figure 3.1. 
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Figure 3.1: Study 1 protocol 
Day -14 to 0 Day 1 Day 2 Day 3
PSG: Adapation CAR: Morning 1 PSG: Night 1 PSG: Night 2 CAR: Morning 3
Baseline monitoring period Cortisol awakening response
Questionnaire & Demographics Sleep and mood measurement
Overnight polysomography Participants remain in laboratory
Participants leave laboratory
CAR: Morning 2
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3.4.1. Baseline monitoring period 
Participants were required to complete a baseline monitoring period in the 14 
days immediately prior to participation, where they were monitored using sleep and 
mood diaries and actigraphy. These are described below. 
 
3.4.1.1. Sleep and mood diaries 
 Participants were provided with a sleep and mood diary (Appendix H) at the 
start of the baseline period and were instructed to complete this as soon as possible 
after awakening each morning. In the sleep diary, participants were required to 
record their waking time and the time at which they got out of bed each morning. 
Participants also recorded the time at which they went to bed the night before, and 
the time at which they turned out the lights to go to sleep the night before. 
Participants were also required to record how long it took them to fall asleep, how 
many times they woke up during the night, how long they were awake during the 
night, and estimated total sleep duration. From this information various sleep 
continuity parameters were derived. These parameters included total sleep time 
(TST), the total duration of time in bed (TIB), sleep efficiency (SE%), which refers 
to the percentage of time asleep from the amount of time spent in bed (SE% = TST / 
TIB × 100), wakefulness after sleep onset (WASO) which refers to the total duration 
of awakenings on each night and sleep-onset latency (SOL), which refers to the time 
taken to get to sleep from lights out (Buysse, Ancoli-Israel, Edinger, Lichstein, & 
Morin, 2006; Carney et al., 2012). Participants were also asked to indicate whether 
or not they used any sleeping pills or other over-the-counter medication during the 
baseline period. Participants were included within the study if a subjective inspection 
of their completed baseline sleep diaries indicated no evidence of any irregular sleep-
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wake patterns. The sleep diary also contained four questions asking about subjective 
sleep quality with each question being rated on a zero to four point Likert scale. 
These four questions were a) “how well do you feel this morning?” b) “how 
enjoyable was your sleep last night?” c) “how mentally alert were you in bed last 
night?” and d) “how physically tense were you in bed last night?”  
 The mood section of the diary presented participants with six statements (“I 
feel calm”; “I feel tense”; “I am upset”; “I feel relaxed”; “I feel content”; “I feel 
worried”) and asked them to mark how they felt at that particular moment on an 
100mm visual analogue scale (VAS), where 0mm indicated ‘not at all’ for the 
relevant statement and 100mm indicated ‘very much’. These six statements map onto 
the six-item short-form version of the state scale of the Spielberger State-Trait 
Anxiety Inventory (STAI; Marteau & Bekker, 1992) which assesses state anxiety 
and indicates how an individual feels at that moment. The original short-form 
version of the STAI requires participants to respond using a Likert scale rated 
between zero and four. Participants could attain a maximum score of 300 on this 
version of the short-form STAI, with higher scores reflecting higher levels of state 
anxiety (positive items were reverse scored as in the original version). Participants 
were also presented with the statement (“I feel stressed”) to which they were 
required to respond to in the same manner, marking on a 100mm VAS. 
 
3.4.1.2. Actigraphy  
Sleep/wake activity of participants during the baseline period was also 
monitored using actigraphy. Actiwatches measure activity using a piezo-electric 
accelerometer. This records the intensity, amount and duration of movement in all 
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directions, and stores an activity count within the memory of the actiwatch. The 
recorded activity is used as a gross indicator of wakefulness and sleep. Actigraphy is 
considered to be a reliable measure of sleep and wake in healthy, adult populations 
(Ancoli-Israel et al., 2003; Lichstein et al., 2006). Actiwatches (AW4, Cambridge 
Neurotechnology, United Kingdom) were worn on the non-dominant wrist and 
activity was recorded in one-minute epochs using a medium sensitivity setting. 
Actigraphy was used to confirm the relative circadian stability of participants. This 
was confirmed through subjective inspection of baseline actograms, which provided 
an indication of individual sleep/wake cycles during the baseline period. Actigraphy 
data was not used in any further analyses. 
 
3.4.2. Laboratory protocol 
 Participants arrived at the sleep laboratory between 8.00pm and 9.00pm on 
the adaptation night. The sleep laboratory (Northumbria Centre for Sleep Research; 
NCSR) consists of two separate, en-suite bedrooms with a kitchen, laboratory 
control room and a conference room/lounge, with the appearance of a comfortable 
home environment. Photographs and a diagram of the NCSR are included in 
Appendix I.  
Participants slept for three consecutive weekday nights (Adaptation, Night 1 
and Night 2) in the NCSR and remained in the sleep laboratory for a full day 
between Night 1 and Night 2. PSG was applied on each night in order to measure 
sleep). The CAR was measured on consecutive weekday mornings (Morning 1, 
Morning 2 and Morning 3) following each night of sleep. Saliva samples were 
obtained immediately upon awakening and at subsequent time intervals of 15 
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minutes until 60 minutes post-awakening.  Participants remained in bed during the 
CAR collection period in low ultraviolet light of approximately one lux. 
Immediately after the final sample lights were turned on and participants were 
required to complete a sleep and mood diary (identical to the diary completed during 
the baseline period) whilst still in bed. Participants were then allowed time to shower 
and dress before a further saliva sample was taken at 120 minutes post-awakening. 
Participants were provided with breakfast, were instructed to adhere to their usual 
daily routine and allowed to leave the laboratory after this point on Morning 1. 
Participants returned to the laboratory at the same time (between 8.00pm and 
9.00pm) on Night 1 and PSG was applied as before. Participants remained in the 
sleep laboratory during Day 2. This was done in order to ensure participants 
remained in a stable, consistent environment with control over factors such as light 
and daytime activity levels. 
 Participants were not allowed to exercise in order to minimise potential 
effects upon daytime cortisol levels or upon sleep (Driver & Taylor, 2000; Kudielka 
et al., 2009) . Participants were allowed to perform activities including reading, 
watching television or films or use of the internet if completing Study 1 or the 
anticipation condition of Study 2 (detailed in Chapter 6).  Saliva samples were 
obtained at time intervals of every 60 minutes (Study 1) or every four hours (Study 
2) and participants were provided with meals at standard time points (2 hours, 6 
hours and 10 hours post-awakening). Participants were allowed snacks if required 
during the day.  Participants were asked to refrain from consuming caffeinated 
drinks after 6pm before visiting the laboratory on the adaptation night and on Night 
1, as caffeine has a half-life of 3.5 to 5 hours and consumption has been shown to 
result in a delayed sleep onset (Nishino & Mignot, 2011).  Participants were also not 
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allowed to consume caffeinated drinks during the laboratory stay between Night 1 
and Morning 2. Participants were fully debriefed and thanked on Morning 3 
following the pre-breakfast saliva sample. Participants were paid £150 upon 
completion of each separate study (Study 1 or Study 2).  
 
3.4.3. Polysomnography 
 PSG was applied on each night (Adaptation, Night 1 and Night 2). Recording 
times were scheduled in accordance with habitual sleep/wake patterns from sleep 
diaries completed during the baseline monitoring period. Recording times matched 
habitual sleep/wake patterns as closely as possible. PSG included EEG electrodes 
placed at FP1, FP2, F3, F4, C3, C4, P3, P4, O1, O2, A1, A2 and Cz in accordance with 
the International 10-20 system (Jasper, 1958). The locations of the electrodes are 
indicated in Figure 3.2. 
EMG measurements were taken from the chin using submentalis electrodes 
and EOG measurements were taken 1cm below and lateral to the outer canthus of the 
left and right eyes.   Electrodes were referenced to linked mastoids with a forehead 
ground electrode placed at FPz. Impedance levels were maintained below 5 kΩ 
during the recording period. Additional EMG electrodes were placed on the left and 
right anterior tibialis muscles during the adaptation night in order to ensure that 
participants did not display any evidence of restless legs or excessive periodic limb 
movements. As participants were asked to detail any breathing or sleeping problems 
at the time of enrolment, breathing was not measured on the adaptation night. 
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Figure 3.2: EEG electrode locations used in all studies. Fp = frontopolar, F: frontal, 
C = central, P = parietal, O = occipital. A1 and A2 represent mastoid electrodes. 
Figure adapted from Berry (2012, p. 66). 
 
PSG was measured using a wireless, lightweight (weighing approximately 
220g, including the battery) ambulatory polysomnography system worn by 
participants (SOMNOscreen, SOMNOmedics GmbH, Randersacker, Germany). 
EEG/EMG/ECG electrodes were connected to a head box and main interface unit, 
which was secured using adjustable Velcro straps. As the system was wireless, 
participants were able to move around the sleep laboratory freely with the PSG unit 
attached. PSG data was recorded using software (DOMINO, SOMNOmedics GmbH, 
Randersacker, Germany) at a sampling rate of 128 Hz for all EEG channels and 
256Hz for EMG and ECG channels. All recordings were scored in 30-second epochs 
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in accordance with American Academy of Sleep Medicine guidelines (Iber et al., 
2007) by the same external scorer blind to the aims of each study. As PSG data 
obtained from healthy normal sleepers during the first night in a laboratory is 
typically altered, known as the ‘first-night effect’ (Agnew et al., 1966), adaptation 
night data were not scored or used in any further analyses. For example, PSG data 
obtained during an adapation night from healthy normal sleepers in a sleep 
laboratory environment typically shows alterations in REM sleep latency, increased 
levels of wake, a decrease in total sleep time and a reduction in sleep efficiency 
(Toussaint et al., 1995).   
Table 3.1:  
Description of polysomnographically-measured sleep continuity and architecture 
parameters (based on Keenan & Hirshkowitz (2011)) 
Measure Description 
Total sleep time (TST) The number of minutes scored as N1,N2, N3 or REM 
sleep 
Wake time after sleep onset 
(WASO) 
Minutes scored as wake from the first epoch of sleep 
to lights on. 
Sleep efficiency (SE%) Total sleep time (TST) as a percentage of total 
recording time (TRT) ((TST / TRT x 100) = SE%). 
Time in N1, N2, N3 and 
REM (%) 
Time scored individually as N1, N2, N3 and REM 
sleep as a percentage of total sleep time (TST). 
REM, N1, N2 or N3 latency 
(mins) 
The elapsed time from lights out to the first epoch of 
stage REM, N1, N2 and N3 sleep in minutes. 
Sleep onset latency (SOL) The elapsed time from lights out to the first epoch of 
stage REM, N1, N2 or N3 sleep in minutes. 
Number of awakenings Number of stage wake occurrences. 
REM = rapid eye movement sleep, N1 = Stage 1 sleep, N2 = Stage 2 sleep, N3 = 
Stage 3 sleep. 
 
Analysis of the PSG data examined measures of sleep continuity and of sleep 
architecture. Sleep continuity variables were total sleep time (TST), time in bed 
(TIB), sleep effiency (SE%), wake after sleep onset (WASO), sleep onset latency 
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(SOL) and the number of awakenings (NWAK).  Sleep architecture measures 
included the percentages of Stage 1 (N1), Stage 2 (N2), Stage 3 (N3) and rapid eye 
movement (REM) sleep and the latency to these stages (Lauer et al., 1991; 
Spiegelhalder et al., 2012).  An overview and description of these parameters are 
described in Table 3.1. 
 
3.4.4. Cortisol sampling 
 Cortisol samples were obtained using Salivettes (Sarstedt, Leicester, UK). 
These require the participant to chew on an absorbent piece of cotton, before 
depositing the cotton into a plastic storage tube.  All cortisol samples were collected 
by a researcher and participants were instructed to chew on the Salivette for a period 
of 1 minute, which was measured using a stopwatch. Cortisol samples were stored in 
a domestic refrigerator immediately following collection, and samples were frozen at 
-20°C at the earliest opportunity until assaying.  Samples were centrifuged at 3000 
rpm for 15 minutes and assays were performed in-house using the luminescence 
immunoassay method, in accordance with manufacturer instructions (Salimetrics, 
Newmarket, UK).  
 
3.4.5. Cortisol awakening response (CAR) 
The CAR was measured on Morning 1, Morning 2 and Morning 3, through 
cortisol samples collected from saliva  immediately at awakening and at subsequent 
time intervals of 15 minutes, between awakening and 60 minutes post-awakening 
(awakening, + 15 minutes, + 30 minutes, + 45 minutes, +60 minutes). CAR sampling 
occurred on three consecutive weekday mornings as a minimum of two CAR 
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measurements are needed to achieve reliable trait measures (Hellhammer et al., 
2007).  Awakening samples were obtained by a researcher waking the participant at 
the pre-determined awakening time and immediately collecting a saliva sample. 
Participants were allowed to return to sleep between samples and the researcher left 
the room between obtaining samples. PSG recording continued during the CAR 
period. All samples were collected in low-intensity ultraviolet light (approximately 
one lux). All participants were instructed to remain in bed unless it was absolutely 
necessary (e.g. to go to the toilet), and were not permitted to eat or drink, with the 
exception of a small amount of water, in order to avoid sample contamination. All 
cortisol samples were collected by a researcher and participants were instructed to 
chew on the Salivette for a period of 1 minute, which was measured using a 
stopwatch. This ensured consistency and ensured that a sufficient amount of saliva 
was collected. 
Cortisol levels during the CAR period were examined in four different ways. 
Cortisol levels at each time point of the CAR (measured in nanomoles per litre 
(nmol/l)), awakening cortisol levels (nmol/l), the peak value, the area under the 
curve with respect to ground (AUCG) and the CAR peak change were calculated. 
The peak value refers to the highest value of the CAR, observed between the sample 
taken at 15 minutes post-awakening and the sample obtained at 60 minutes post-
awakening. The area under the curve with respect to ground (AUCG) provides a 
measure of total cortisol secretion over the CAR period, from the first awakening 
sample until the final CAR sample) (Clow et al., 2004).  The AUCG formula1  places 
                                                          
1
 AUCG formula = 
((T1+T2)/2*15)+((T2+T3)/2*15)+((T3+T4)/2*15)+((T4+T5)/2*15) 
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less emphasis on the first and last CAR samples, since these have a smaller 
contribution to the area measure than other sample time points (Pruessner et al., 
2003). Total cortisol output was expressed in arbritary units. The peak change value 
provides a measure of increase during the CAR period and is calculated by 
subtracting awakening levels of cortisol from the peak cortisol value observed during 
the remainder of CAR period (between wake + 15 minutes and wake + 60 minutes) 
(E. K. Adam et al., 2006; Dockray & Steptoe, 2011). 
 
3.5. Feasibility study 
Whilst the protocol outlined in this chapter measures sleep and the CAR in a 
laboratory setting, a feasibility study was conducted with the aim of determining 
whether the protocol could be employed within a home environment. This is 
described in the following chapter. 
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CHAPTER 4.   
Feasibility Study 
 
4.1. Introduction 
The aim of the feasibility study was to test the suitability of the standard 
protocol within a home environment compared to a laboratory environment. The 
feasibility study examined whether it would be possible to introduce stress into the 
protocol, at a later stage, within a home environment, or whether the protocol was 
better suited to measurement within a laboratory environment.  
 
4.2. Method 
4.2.1. Participants and recruitment 
Eight healthy good sleepers (four male and four female, Mage = 31.91 years, 
SDage = 4.60 years) participated in the feasibility study. Four individuals participated 
in the laboratory study (Mage = 28.56 years, SDage = 1.17 years) and four individuals 
participated in the home study (Mage = 35.25 years, SDage = 4.27 years). Participants 
were recruited using advertisements placed around a university campus and through 
emails sent to university staff and students.  Inclusion and exclusion criteria are 
described in Section 3.2. 
 
4.3. Procedure 
The procedure for the laboratory group was identical to that described in 
Section 3.4.  The home group followed a similar procedure, however participants in 
the home group were not required to attend the sleep laboratory and underwent 
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ambulatory PSG recording in their own homes. The home group collected CAR 
samples in their own homes. Participants in the home group were able to carry out 
their normal daily activities immediately after the final CAR sample (wake + 60 
minutes) each morning and were not restricted in their activities between Day 2 and 
Night 2.  
 
4.3.1. Baseline monitoring period 
The baseline monitoring period was identical to that described in in Section 
3.4. Participants completed sleep and mood diaries for two weeks and underwent 
actigraphy for two weeks prior to participation. 
 
4.3.2. Polysomnography 
 The procedure for PSG within the laboratory group was identical to that 
described in Section 3.4.3. For the home group, ambulatory PSG was used to 
measure sleep in the homes of the participants and PSG was applied to participants 
by a trained researcher. Electrodes were placed at the same locations and recordings 
were obtained using the same equipment as previously described (Section 3.4.3). The 
researcher then left the home of the participants following PSG application, in order 
to allow them to sleep naturally, before returning during the CAR sampling period in 
order to remove PSG. Participants were instructed to adhere to their regular sleeping 
patterns and were responsible for scheduling their own sleep periods. Participants in 
the home group were instructed to press a button on the ambulatory PSG equipment 
immediately before lights off and immediately after lights on, which placed a time 
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marker on the PSG. This was used in order to accurately determine lights off and 
lights on times for use in further analyses.  
 
4.3.3. Cortisol awakening response sampling 
 The CAR of the laboratory group was measured as outlined in Section 3.4.5, 
where samples were collected by a researcher in low-intensity ultraviolet light 
(approximately one lux) and all samples were timed for 60 seconds. Participants in 
the home group were required to self-collect saliva samples during the CAR period 
and were provided with collection instructions (Appendix J). Participants were also 
required to record the time at which each sample was obtained during the CAR 
period. Participants were asked not to eat or to brush their teeth during the CAR 
period in order to avoid sample contamination but were free to get up and leave their 
bed during the collection period. Participants were asked to ensure that Salivettes 
were saturated and to estimate a collection time of 60 seconds. Following the 
collection period participants were instructed to refrigerate their samples until 
collected by a researcher.  
 
4.3.4. Treatment of results 
Due to the small sample size, the age of both groups was compared using a 
Mann-Whitney test. In order to ensure that the sleep of participants in the home 
group and laboratory group did not differ, data from the baseline monitoring period 
were averaged across non-work days. Subjective and objective sleep variables were 
compared between the two groups using descriptive statistics, due to the small 
sample size and as the feasibility of the using the standard protocol within a home or 
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laboratory environment was the primary aim of this study. Objective measures of 
sleep continuity (TST, SE%, WASO, SOL and NWAK) and sleep architecture 
(percentages of N1, N2, N3 and REM sleep and the latency to these stages) were 
summarised as described in described in Section 3.4.3. Objective measures of sleep 
were averaged across Night 1 and Night 2, for home and laboratory participants, as 
normal sleepers have previously shown low night-to-night variability in studies 
where sleep has been measured at home using PSG, even when measured up to four 
months apart  (Quan et al., 2002).  Analysis of the CAR focused on cortisol levels at 
each sampling time point and other parameters (awakening levels, peak value, peak 
change and AUCG) were not examined, due to the purpose of the study and the 
limited sample size. CAR data was unavailable for one participant due to the sample 
containing too little saliva for assaying and this participant was excluded from any 
further analyses. Due to the limited sample size, non-parametric analyses were used 
to compare the CAR between groups. As there is no non-parametric alternative to a 
mixed ANOVA (Field, 2013), a series of Mann-Whitney U tests were used to 
compare cortisol levels at each time point of the CAR between home and laboratory 
environments. Separate tests were performed for the CAR on Morning 2 and 
Morning 3. 
 
4.4. Results 
4.4.1. Demographics 
The laboratory group were significantly younger than the home group (U = 
1.00, Z = -2.03, p < .05). 
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4.4.2. Baseline subjective sleep and sleep quality data 
Baseline measures of sleep continuity, collected during the two-week baseline 
period, were broadly similar between the two groups.  Measures of sleep quality 
were also similar during the baseline period, although participants in the laboratory 
group reported that they felt better and rated their sleep to be more enjoyable than 
the home group. This indicated that the home and laboratory groups were well-
matched in terms of subjective sleep prior to the assessment of objective sleep and 
the CAR. This is summarised in Table 4.1. 
 
Table 4.1:  
Baseline subjective sleep continuity and quality for home and laboratory 
group  
 Home Laboratory 
Variable Mean SD Mean SD 
SOL 14.85 9.53 12.50 6.03 
NWAK 1.13 .88 1.20 .98 
WASO 9.75 12.23 7.59 8.98 
TST (mins) 488.25 31.60 478.97 83.32 
TIB (mins) 563.04 58.07 531.80 86.51 
SE (%) 89.63 6.53 93.35 2.57 
How well do you feel? (0 – 4) 2.46 .78 3.07 .66 
How enjoyable was your sleep?  
(0 – 4) 
2.58 .69 3.43 .45 
How mentally alert were you in 
bed last night? (0 – 4) 
1.22 .17 .81 .56 
How physically tense were you in 
bed last night? (0 – 4) 
.84 .28 .59 .40 
SOL: sleep onset latency, NWAK: number of awakenings, WASO: wake 
after sleep onset, TST: total sleep time, TIB: time in bed, SE: sleep 
efficiency. 
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4.4.3. Home and laboratory objective sleep comparisons 
Sleep continuity was similar between both groups and although home 
participants showed a higher WASO, this group showed a larger standard deviation 
compared to the laboratory group. This was also the case for SOL. Measure of sleep 
architecture showed that the percentage of sleep spent in each stage was largely 
similar, although the laboratory group showed a slightly longer latency to each stage 
of sleep. Objective measures of sleep continuity and sleep architecture are 
summarised in Table 4.2. 
 
Table 4.2:  
Summary of objective sleep continuity and architecture measures for home and 
laboratory participants 
 Home Laboratory 
 Mean SD Mean SD 
TST (mins) 444.38 51.63 439.13 29.80 
SE (%) 92.78 5.28 92.01 3.96 
WASO (mins) 23.56 23.18 16.50 8.87 
SOL (mins) 13.63 10.78 21.25 18.40 
NWAK 11.75 5.58 14.63 3.20 
Time in REM (%) 28.36 3.32 23.56 4.14 
Time in N1 (%) 2.96 .86 3.38 .92 
Time in N2 (%) 50.03 1.54 53.79 6.85 
Time in N3 (%) 18.63 2.28 19.26 6.03 
Latency to REM (mins) 70.31 44.41 100.44 46.50 
Latency to N1 (mins) 13.63 10.78 21.25 18.40 
Latency to N2 (mins) 17.06 11.29 26.63 16.34 
Latency to N3 (mins) 31.44 8.60 41.00 16.23 
TST = total sleep time, SE(%)= sleep efficiency (%), WASO = wake after sleep onset, 
SOL = sleep onset latency, NWAK = number of awakenings  
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4.4.4. Cortisol awakening response 
There were no significant differences in cortisol levels (all p-values > .05) 
between each group on the second or third morning of measurement. Overall, CARs 
obtained in a laboratory environment were very similar to CARs obtained in a home 
environment. Whilst the cortisol levels at each sampling point were lower within the 
laboratory group than the home group, these showed a large standard deviation, 
indicating a large amount of individual variability in cortisol levels, and were not 
statistically significant. The home group appeared to show a slightly delayed peak 
CAR on the final morning compared to the second morning, with cortisol levels 
peaking 45 minutes following awakening. The laboratory group also showed 
differences in their CAR between Morning 2 and Morning 3, where cortisol levels 
showed a secondary rise between the sample obtained at 45 minutes after awakening 
and the final sample. The CAR is summarised in Figure 4.1. 
 
4.4.5. Feasibility 
The standard protocol was well-suited to both a home and a laboratory 
environment and participants did not report any difficulties with regards to protocol 
adherence in either environment. Where the protocol was applied to the home 
environment, the measurement of sleep using ambulatory PSG did not present any 
problems in terms of feasibility or in terms of data analysis, and there were was no 
objective sleep data lost. One participant within the home group had a missing saliva 
sample during the CAR period, where the saliva sample did not contain enough 
saliva to allow subsequent assaying. 
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Figure 4.1: Mean (±SEM) Morning 2 CAR cortisol levels at each sampling time point for the laboratory or home group. 
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Figure 4.2: Mean (±SEM) Morning 3 CAR cortisol levels at each sampling time point for the laboratory and home group.
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4.5. Discussion 
The purpose of the feasibility study was to examine the suitability of the 
standard protocol within a home or a laboratory environment. Overall, the protocol is 
suitable for use in either environment. Measures of objective sleep were very similar 
between the home and laboratory groups, with minor differences where the home 
group showing a higher WASO and lower SOL compared to the laboratory group. 
The laboratory group also showed longer latencies to each stage of sleep although 
the percentage of sleep spent in each stage was similar and each measure was 
Table 4.3:  
Comparison of Morning 2 cortisol levels (nmol/l) at each time point of the cortisol 
awakening response between home and laboratory environments  
 Awakening +15 minutes +30 minutes +45 minutes +60 
minutes 
Condition Mean SD Mean SD Mean SD Mean SD Mean SD 
Home 12.75 5.00 17.26 10.03 17.39 12.70 16.99 13.33 12.18 7.38 
Laboratory 9.45 2.84 10.90 1.90 11.06 1.47 10.53 1.29 8.74 .98 
Table 4.4:  
Comparison of Morning 3 cortisol levels (nmol/l) at each time point of the cortisol 
awakening response between home and laboratory environments  
 Awakening +15 
minutes 
+30 
minutes 
+45 minutes +60 
minutes 
Condition Mean SD Mean SD Mean SD Mean SD Mean SD 
Home 10.00 6.02 12.58 5.77 14.34 9.76 18.18 14.94 12.51 8.87 
Laboratory 5.76 1.84 8.47 2.77 11.76 5.52 9.12 3.93 11.49 5.69 
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accompanied by a large standard deviation, potentially reflecting a high amount of 
individual variability. In terms of feasibility, no nights of sleep were lost in either 
environment and ambulatory PSG was suitable for recording objective sleep in a 
home environment.  
A home protocol is also suitable for measurement of the CAR. Whilst 
cortisol levels at each sampling point of the CAR within the laboratory group were 
lower compared to the home group, indicating that the CAR was lower in the 
laboratory, the differences between the groups were not significant and cortisol 
levels were accompanied by a large standard deviation in the home environment.  
However, one cortisol sample during the CAR period was unable to be included 
within analyses due to the sample containing too little saliva for analysis.  It is 
possible that as participants in the home condition self-collected saliva samples, this 
particular sample may not have been collected by the participant as requested.  
The effects of light may also account for the subjective differences shown in 
the CAR between the home and laboratory environments. No restrictions were 
placed upon the levels of light when the CAR was measured in a home environment; 
however the CAR was collected in extremely low light levels (approximately one 
lux) within the laboratory environment. This is a relevant factor as the SCN controls 
the overall co-ordination of the HPA axis  (Buijs et al., 2003) and whilst light has 
previously been shown to affect the CAR (Figueiro & Rea, 2012; Scheer & Buijs, 
1999; Thorn et al., 2004), the precise impact is not currently clear. In order to 
minimise the influence of light upon the CAR by measuring the CAR in consistently 
low light levels, it will be advantageous to adopt a laboratory protocol for the 
measurement of the CAR. An additional consideration is that whilst participants in 
the home measurement group were instructed to remain in bed wherever possible 
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during the CAR measurement period, they were not monitored during this point and 
it is possible that movement influenced the results. A further strength of measuring 
the CAR within a laboratory environment is that a laboratory environment offers a 
greater level of control over the activities of participants between Night 1 and Night 
2. As the anticipation of forthcoming stress appears to disrupt sleep (Torsvall & 
Akerstedt, 1988; Torsvall et al., 1987) and as the CAR may also function as a 
marker of anticipation (Filaire et al., 2009; Filaire et al., 2007; Filaire et al., 2001; 
Rohleder et al., 2007) it will be advantageous to use the protocol to measure sleep 
and the CAR within a laboratory situation. This will offer greater levels of control 
over factors which may affect the CAR, including light and movement.  
The following chapter outlines Study 1, where the aim of the study was to 
use the standardised protocol to examine the relationship between subjective sleep, 
objective sleep and the CAR, in the absence of stress, within a laboratory 
environment.  
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CHAPTER 5a.  
Study 1: Subjective sleep and the CAR 
 
5.1. Introduction 
The aim of Study 1 was to investigate the relationship between subjective sleep, 
objective sleep and the CAR, using the standardised protocol within a controlled 
laboratory environment, in the absence of stress. Overall, the relationship between 
subjective sleep and the CAR is currently unclear and may differ depending on the 
measure of the CAR reported. Kumari and colleagues (Kumari et al., 2009) showed 
that a shorter self-reported sleep duration was associated with a steeper rise in 
cortisol levels between awakening and 30 minutes post-awakening in middle-aged 
adults and Stalder and colleagues (Stalder et al., 2009) showed that awakening levels 
were positively related to both subjective sleep duration and the time of awakening; 
however total secretion was not related to these sleep variables.  
Another study showed a small negative correlation between subjective sleep 
duration and the mean increase in cortisol levels during the CAR (Wüst et al., 
2000b). Hansen and colleagues showed that when the relationship between the CAR 
peak change and sleep problems were examined over a three-month period, 
subjective sleep duration showed no relationship to the CAR. This was the case in 
terms of the increase in cortisol levels from awakening to the second or third sample 
and also in terms of total secretion during the CAR period. Taken together, the 
relationship between subjective sleep and the CAR appears to be inconsistent but 
this may be due to variations in CAR measurement techniques between studies. For 
instance, Kumari and colleagues (2009) examined the rise in cortisol between 
awakening and 30 minutes post-awakening in middle-aged adults, showing a shorter 
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sleep duration was associated with a steeper rise in cortisol. Stalder and colleagues 
(2009) showed that awakening cortisol levels were positively related to both sleep 
duration and the time of awakening, although there was no relationship between total 
secretion in terms of the AUCG and these measures. A small negative correlation 
between self-reported sleep duration and the CAR, as measured using the mean 
increase, has been shown elsewhere  (Wüst et al., 2000b). Study 1 overcame these 
limitations by examining multiple indices of the CAR. A further aim of Study 1 was 
to examine the relationship between indices of the CAR and mood. Hellhammer et 
al. (2007) determined that a CAR measured on a single day is largely subject to the 
effects of situational factors rather than trait factors, which implies that there may be 
a role for mood within the regulation of the CAR or that mood is associated with the 
CAR in some way. Further, a single case study determined that 22% of the intra-
individual variance within total levels of cortisol secreted during the CAR period 
was explained by subjective levels of mood and the daily anticipation of activities 
and obligations (Stalder et al., 2010a). An additional purpose of Study 1 was to 
collect baseline subjective sleep, CAR and cortisol data to allow comparisons with 
Study 2. 
 Another aim of Study 1 was to examine the relationship between measures of 
objective sleep continuity and sleep architecture and the CAR, within healthy, 
normal good sleepers. A meta-analysis of 23 CAR studies demonstrated that 
subjective and objective sleep duration was positively related to cortisol levels at 
awakening (Garde et al., 2012), however, as discussed in Chapter 2, the relationship 
between sleep architecture and the CAR is unclear. Few studies have a) examined 
this relationship in a sample of healthy good sleepers and b) within a controlled 
environment. No relationship was observed between sleep architecture and total 
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secretion during the CAR period in healthy controls and army veterans with post-
traumatic stress disorder (van Liempt et al., 2013). Elsewhere, the duration of REM 
sleep in alcohol-dependent inpatients has been shown to be negatively associated 
with awakening cortisol levels (Junghanns et al., 2007). An association between 
lower awakening cortisol levels and increased percentages of Stage 1, Stage 3 and 
REM sleep has also been demonstrated in a study of caregivers compared to non-
caregivers (Fonareva et al., 2011). However, differences in sleep architecture were 
shown between these groups, with caregivers showing an increased SOL and 
percentage of sleep spent in Stage 1, alongside a reduction in the percentage of sleep 
spent in REM compared to non-caregivers. It is possible that these between-group 
differences may have driven the relationship between sleep and the CAR rather than 
the differences between Stage 1, Stage 3 and REM sleep. In addition, these studies 
typically differ in the time at which CAR samples are obtained and show differences 
in the reported method of measurement and CAR indices, examining awakening 
levels (Fonareva et al., 2011; Junghanns et al., 2007) or total secretion (AUCG) over 
the CAR period (van Liempt et al., 2013). Due to these variations, it is difficult to 
determine the relationship between objective sleep and the CAR in good sleepers.  
The present study aimed to establish the relationship between objective sleep 
and various indices of the CAR within healthy, normal sleepers in a standardised 
sleep laboratory environment, with consistent light levels and objective monitoring 
of sleep. The relationship between subjective sleep and the CAR is discussed in the 
present chapter (Chapter 5a) and the relationships between objective sleep and the 
CAR are discussed in the following chapter (Chapter 5b). 
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5.2. Method 
5.2.1. Participants 
A total of 18 normal healthy sleepers, nine male and nine female, (Mage = 
23.46 years, SDage = 3.21 years) participated in Study 1. All participants were 
recruited and screened as described in Section 3.2.  
 
5.2.2. Treatment of results 
CAR data from three participants were excluded due to saliva samples 
containing an insufficient volume of saliva for analysis (n = 2) and excessively high 
(>75 nmol/l,Kunz-Ebrecht et al., 2004)  cortisol levels (n = 1). Cortisol levels during 
the CAR period were examined for normality using Kolmogorov-Smirnov tests. 
Since these were non-significant in each case (all values p > .05) non-transformed 
data were used in all analyses. Cortisol samples collected 120 minutes post-
awakening (n = 16) were analysed separately from the CAR sampling period and 
data was excluded (n = 2) due to saliva samples containing insufficient volume of 
saliva for analysis (n = 1) and excessively high (>75 nmol/l) cortisol levels (n = 1). 
As three participants were excluded from CAR analyses, demographic data for 
participants with complete CAR data (n = 15) were reported.  
In order to examine whether there were differences between the baseline 
period and laboratory period in terms of subjective sleep continuity and quality, 
these measures were compared using a series of paired-samples t-tests. 
Representative sleep continuity and quality data was calculated from the monitoring 
period using the average of the second, third, ninth and tenth day of sleep diary data 
as this corresponded with Night 1 and Night 2 of the laboratory protocol and 
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therefore provided a representive Night 1 and Night 2 during the baseline period. 
This was compared to subjective sleep from the second and third night of the 
laboratory period using a series of paired-samples t-tests. Subjective sleep continuity 
and quality were compared between Morning 2 and Morning 3 using paired-samples 
t-tests. Comparisons between subjective baseline and laboratory levels of anxiety 
and perceived stress, and differences between Morning 2 and Morning 3 levels of 
anxiety and perceived stress were examined using paired-samples t-tests.   
In order to investigate any differences in the overall CAR between each 
morning and at time point, a 3 (morning) × 5 (time point) mixed ANOVA was used 
and Greenhouse-Geisser adjusted degrees of freedom were reported where 
appropriate. (Kunz-Ebrecht et al., 2004).  In order to examine whether additional 
indices of the CAR (awakening levels, peak value, peak change and total secretion as 
measured using the AUCG value) differed between each morning, a series of one-
way ANOVAs were conducted on these measures. A one-way ANOVA was 
conducted on cortisol levels at wake + 120 minutes between Morning 1, Morning 2 
and Morning 3 (n = 16). ANOVA effect sizes were reported using partial eta squared 
(η²p) values, where η²p values of .01, .06 and .14 represent small, medium and large 
effect sizes respectively (J. Cohen, 1988). Relationships between CAR, sleep and 
mood variables were examined using a series of Pearson correlations.  
 
5.3. Procedure 
 All participants provided written informed consent, and the study was 
approved by the Northumbria University Faculty of Health and Life Sciences 
Research Ethics Committee.  Upon arriving at the laboratory on the adaptation night, 
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participants were asked to complete a questionnaire booklet containing a range of 
measures (PSQI, PSS, HADS, HÖ-MEQ and FIRST) and to provide their age as 
detailed in Section 3.3. The procedure for Study 1 was identical to that described in 
Section 3.4 and is summarised in Figure 5.1. Participants received a full debrief upon 
completion of the study on Morning 3 and received £150. 
 
5.3.1.  Cortisol awakening response sampling 
Laboratory CAR sampling was conducted as described in Section 3.4.5. 
Cortisol samples were obtained at intervals of every 15 minutes between awakening 
and one hour after awakening (wake, +15 minutes, +30 minutes, +45 minutes and 
+60 minutes) in order to obtain cortisol levels at each time point of the CAR and to 
determine additional indices of the CAR, including awakening levels, the peak 
change in levels, total secretion (AUCG) and peak value during the CAR period. 
 
5.3.2. Polysomnography  
The procedure for measuring PSG during Study 1 was identical to that 
described in Section 3.4.3.  
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Figure 5.1: Schematic of study protocol for Study 1 
 
 
 
Figure 5.2: Schedule of participant activities during the full day (Day 2) spent in the laboratory. 
 
Day -14 to 0 Day 1 Day 2 Day 3
PSG: Adapation CAR: Morning 1 PSG: Night 1 PSG: Night 2 CAR: Morning 3
Baseline monitoring period Cortisol awakening response
Questionnaire & Demographics Sleep and mood measurement
Overnight polysomography Participants remain in laboratory
Participants leave laboratory
CAR: Morning 2
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5.3.3. Daytime cortisol sampling 
 Cortisol samples were taken at wake + 120 minutes on Morning 1, Morning 2 
and Morning 3 in order to observe the diurnal profile following the CAR period.  
 
5.3.4. Daily activities 
After collection of the wake +120 minutes cortisol sample, breakfast was 
provided on each morning. Breakfast was standardised for all participants and was 
consistent across each morning, where participants were allowed a small bowl of 
cereal, a piece of toast with butter or jam or fruit. Participants were allowed to 
combine each item (e.g. they were permitted to have chosen both a bowl of cereal 
and toast) if they wished to do so. Participants were allowed to leave the laboratory 
on Morning 1 after this point and were instructed to adhere to their usual daily 
routines before returning on Night 1. Following breakfast on Morning 2, participants 
remained in the laboratory under observation throughout Day 2. Participants were 
not allowed to nap or exercise and remained in the meeting room area of the 
laboratory until Night 2 performing sedentary activities including watching TV, 
films and reading (Section 3.3). Two standardised meals were provided during Day 
2: lunch was provided six hours following awakening, which consisted of a 
sandwich and crisps, and dinner was provided 10 hours following awakening, which 
consisted of a microwave ready meal served with salad. Participants provided saliva 
samples every 60 minutes until lights out on Night 2.  Following the provision of 
breakfast on Morning 3, participants were fully debriefed and were allowed to leave 
the laboratory. 
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5.3.5. Pre-sleep cortisol sampling 
 On all three nights, pre-sleep cortisol sampling occurred immediately before 
lights out, whilst the participant was in bed. Samples were collected in normal 
bedroom lighting levels of approximately 240 lux. As Study 1 focused on the CAR, 
daytime cortisol and pre-sleep cortisol levels were not included in any further 
analyses within Chapter 5.  
 
5.3.6. Overnight awakenings 
 Participants were allowed 30 minutes in order to return to sleep if they 
awakened at least two hours before their scheduled waking time on the second or 
third night. If the participant did not return to sleep within this period, a saliva 
sample was obtained and they were allowed to return to sleep. If a participant woke 
within two hours of their scheduled wake time, they were allowed five minutes to 
return to sleep before saliva was sampled. This cut-off point of two hours before 
awakening was chosen due to the proximity of this time point to the scheduled CAR 
period, and if the participant did not return to sleep within 15 minutes of this point, 
the full CAR sampling procedure was followed. This was to minimise the chance of 
a participant awakening and the resulting CAR being missed or distorted, since the 
CAR appears to be a genuine response to awakening, although it is unclear whether 
this only refers to natural awakening (Buckley & Schatzberg, 2005; Edwards et al., 
2001; Fries et al., 2009; Wilhelm et al., 2007). This was also considered as the link 
between the SCN and PVN synchronises the time of day with neuroendocrine output 
(Buijs et al., 2003), meaning that unplanned early awakenings may have still resulted 
in a CAR. 
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5.4. Results 
5.4.1. Demographic and questionnaire data 
 Age and questionnaire data are presented in Table 5.1. PSQI data indicated 
the participants to be good sleepers (< 5) and HADS anxiety and depression scores 
were in the normal range (<7). 
 
  
5.4.2. Subjective sleep: baseline vs. laboratory comparison 
No significant differences were shown in measures of continuity with the 
exception of TST, as participants slept for a shorter period of time during the 
laboratory period compared to the two-week baseline monitoring period (t(17) = 
2.39, p < .05). When measures of sleep quality were compared between the 
baseline monitoring and laboratory period, participants reported that in terms of 
Table 5.1:  
Summary of demographic and questionnaire measures for full sample of 
participants (n =  18) and participants with complete CAR data (n =  15). 
Measure Mean SD 
Age 23.67 3.49 
PSQI 3.80 1.32 
ISI 3.00 2.27 
PSS  18.87 6.53 
HADS Anxiety 5.67 2.64 
HADS Depression 1.67 1.40 
HO-MEQ  50.57 8.53 
FIRST  19.36 4.89 
PSQI: Pittsburgh Sleep Quality Index,  PSS: Perceived Stress Scale, HADS: 
Hospital Anxiety and Depression Scale, HO-MEQ: Horne-Östberg 
Morningness-Eveningness Questionnaire, FIRST: The Ford Insomnia 
Response to Stress Test 
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their sleep quality, they felt slightly less well during the laboratory period (t(17) 
= 2.72, p < .05). The results are summarised in Table 5.2. 
 
5.4.3. Subjective sleep: representative baseline vs. laboratory comparison 
Whilst few differences were shown between the baseline period and the 
laboratory study in terms of subjective sleep continuity and sleep quality, the 
baseline period as a comparison also included weekends and thus may not have been 
representative of participant daily routines. Participants showed significant reduction 
in total sleep time (t(17) = 2.23, p < .05), sleep efficiency, (t(17) = 2.11, p = .05) and 
in how well they felt (t(17) = 2.79, p < .05) within the sleep laboratory. This 
indicated that there were subtle differences in subjective sleep continuity and quality 
between the representative Night 1 and Night 2 baseline period and the laboratory 
period. The results are summarised in Table 5.3. 
Table 5.2:  
Baseline and laboratory comparisons of subjective sleep data  (n =  18) 
 Baseline Laboratory 
Variable Mean SD Mean SD 
SOL 16.89 7.79 14.86 6.89 
NWAK .97 .76 1.35 1.15 
WASO (mins) 8.94 9.03 8.36 8.56 
TST (mins) 470.78 50.28 445.06 29.34 
TIB (mins) 544.94 67.57 521.81 25.54 
SE (%) 88.27 7.22 85.33 4.68 
How well do you feel? (0 – 4) 2.69 .64 2.42 .67 
How enjoyable was your sleep? (0 – 
4) 
2.81 .50 2.69 .71 
How mentally alert were you in bed 
last night? (0 – 4) 
1.23 .50 1.19 .55 
How physically tense were you in 
bed last night? (0 – 4) 
.77 .49 .67 .51 
SOL: sleep onset latency, NWAK: number of awakenings, WASO: wake after sleep 
onset, TST: total sleep time, TIB: time in bed, SE: sleep efficiency. 
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5.4.4. Subjective sleep: Morning 2 and Morning 3 laboratory comparisons  
  No differences were shown between each morning in either measures of 
sleep continuity or sleep quality (p > .05). The results are summarised in Table 5.4. 
 
5.4.5. Subjective state anxiety and perceived stress: baseline vs. laboratory 
comparisons 
Levels of state anxiety (t(17) = 3.05, p < .01) and subjective stress (t(17) = 
2.79, p < .05) were significantly lower during the laboratory period compared to the 
baseline period. Mean levels of state anxiety and subjective stress during the baseline 
and laboratory periods are shown in Figures 5.2 and 5.3.  
 
Table 5.3: 
Comparisons between baseline Night 1 and Night 2 and laboratory 
subjective sleep data  (n =  18) 
 Baseline Night 
1 and Night 2 
Laboratory 
Variable Mean SD Mean SD 
SOL 14.35 7.20 14.86 6.89 
NWAK .99 .99 1.35 1.15 
WASO (mins) 5.65 6.53 8.36 8.56 
TST (mins) 478.16 64.70 445.06 29.34 
TIB (mins) 552.07 99.19 521.81 25.54 
SE (%) 89.43 8.01 85.33 4.68 
How well do you feel? (0 – 4) 2.79 .71 2.42 .67 
How enjoyable was your sleep?  
(0 – 4) 
2.84 .54 2.69 .71 
How mentally alert were you in 
bed last night? (0 – 4) 
1.19 .64 1.19 .55 
How physically tense were you in 
bed last night? (0 – 4) 
.64 .54 .67 .51 
SOL: sleep onset latency, NWAK: number of awakenings, WASO: 
wake after sleep onset,  TST: total sleep time, TIB: time in bed, SE: 
sleep efficiency. 
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Table 5.4:  
Night 1 and Night 2 comparison of subjective sleep data  (n =  18) 
 Night 1 Night 2 
Variable Mean SD Mean SD 
SOL 15.00 6.64 14.72 9.31 
NWAK 1.47 1.36 1.22 1.22 
WASO (mins) 7.89 7.21 8.83 14.21 
TST (mins) 448.89 27.20 441.22 38.06 
TIB (mins) 521.67 26.40 521.94 25.39 
SE (%) 86.17 5.47 84.50 5.46 
How well do you feel? (0 – 4) 2.39 .85 2.44 .62 
How enjoyable was your sleep?  
(0 – 4) 
2.72 .75 2.67 .91 
How mentally alert were you in 
bed last night? (0 – 4) 
1.22 .65 1.17 .71 
How physically tense were you in 
bed last night? (0 – 4) 
.61 .50 .72 .57 
SOL: sleep onset latency, NWAK: number of awakenings, WASO: 
wake after sleep onset,  TST: total sleep time, TIB: time in bed, SE: 
sleep efficiency. 
162 
 
  
Figure 5.3: Mean (±SD) levels of state anxiety during baseline and laboratory 
periods (n = 18) *p < .05. 
 
Figure 5.4: Mean (±SD) levels of subjective stress during baseline and laboratory 
periods (n = 18) *p < .05. 
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5.4.6. CAR: temporal stability 
The CAR was compared across Morning 1, Morning 2 and Morning 3 in 
order to examine whether the CAR showed a different pattern depending on the 
morning of measurement.  The observed CAR patterns were as expected, with 
cortisol values peaking 30 minutes post-awakening. There was a significant main 
effect of time point (F(2.21, 31.03) = 7.47, p < .01, η²p = .35). The main effect of the 
morning of measurement was not significant (F(2,28) = .07, p > .05, η²p = .01). The 
morning × time point interaction (F(4.26, 59.63) = 2.03, p > .05, η²p = .13) was not 
significant. Overall, the shape of the CAR was not significantly different when 
compared across each morning. Cortisol levels during the CAR are displayed in 
Table 5.6 and in Figure 5.6. There were no significant differences observed in 
awakening cortisol levels (F(2,44) = 1.26, p > .05, η²p = .06), peak change values 
(F(2,44) = 3.05, p > .05, η²p = .13),  peak sample values (F(2,44) = .16 , p > .05, η²p = 
.01) or in AUCG values by morning (F(2,44) = .01, p > .05, η²p = .00). This indicated 
that there were no differences in the CAR each morning. Additional indices are 
summarised in Table 5.6. 
 
5.4.7. Relationship between the CAR and subjective sleep continuity and 
quality 
Cortisol levels at awakening were not associated with subjective sleep 
continuity or quality. The peak change showed a significant positive relationship 
with NWAK (r(15) = .51, p = .05). The negative relationship between the peak value 
of the CAR and how enjoyable the sleep of the previous night was rated showed a 
trend towards significance, (r(15) = -51, p = .052) and the negative relationship 
between total cortisol secretion and how well participants felt upon awakening 
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showed a trend towards significance, (r(15) = -.50, p  = .059). The results are 
summarised in Table 5.7.  
 
 
 
Table 5.6:  
Morning 1, Morning 2 and Morning 3 additional indices of the cortisol awakening 
response (n =  15) 
 Peak Change AUCG Peak Value 
Morning Mean SD Mean SD Mean SD 
Morning 1 2.58 3.49 573.64 233.03 11.55 4.32 
Morning 2  2.32 2.77 567.50 219.04 11.17 3.67 
Morning 3 5.22 4.26 562.35 199.78 12.03 4.43 
AUCG : area under the curve with respect to ground 
 
 
 
Table 5.5:  
Cortisol levels (nmol/l) at each time point of the cortisol awakening response by 
condition (n =  15) 
 Awakening +15 minutes +30 minutes +45 minutes +60 minutes 
Morning Mean SD Mean SD Mean SD Mean SD Mean SD 
Morning 1 8.96 4.46 9.54 4.36 10.38 4.26 9.69 4.50 8.29 3.56 
Morning 2 8.85 4.47 9.10 4.26 10.58 3.62 9.40 3.97 8.66 3.56 
Morning 3 6.80 3.61 8.58 3.71 10.47 3.98 10.03 4.33 10.01 4.08 
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Figure 5.5: Mean (±SEM) Morning 1, Morning 2 and Morning 3 CAR cortisol levels (n = 15). There were no significant 
differences between each morning shown in other indices (awakening levels, peak change, peak sample value or AUCG)  
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5.4.8. Cortisol: 120 minutes post-awakening samples 
 Cortisol levels measured at 120-minutes post-awakening were significantly 
different (F(2,44) = 3.82, p < .05) and Bonferroni-corrected post-hoc tests showed 
that cortisol levels were significantly higher on Morning 3 compared to Morning 2 (p 
= .029). 
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Figure 5.6: Comparison of mean (±SEM) cortisol levels at wake +120 minutes 
(n = 16).  *p <.05. 
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Table 5.7:  
Correlations between subjective sleep continuity and indices (awakening levels, peak change, AUCG and the peak value) of the cortisol 
awakening response (n =  15) 
 Awakening levels Peak Change AUCG Peak Value 
SOL -.11 -.02 -.12 -.18 
NWAK -.03 .51* .32 .22 
WASO (mins) -.01 .01 .00 -.04 
TST (mins) .03 .23 .19 .22 
TIB (mins) .02 .13 .11 .11 
SE (%) .01 .19 .14 .17 
How well do you feel? (0 – 4) -.37 -.18 -.49 -.50 
How enjoyable was your sleep?  
(0 – 4) 
-.35 -.23 -.51 -.49 
How mentally alert were you in bed last night? (0 – 4) -.44 .12 -.36 -.44 
How physically tense were you in bed last night? (0 – 4) .40 .11 .47 .48 
SOL: sleep onset latency, NWAK: number of awakenings, WASO: wake after sleep onset, TST: total sleep time, TIB: time in bed, 
SE(%): sleep efficiency.  AUCG: area under the curve with respect to ground. 
*p < .05 
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5.4.9. Relationship between the CAR and average laboratory levels of 
subjective anxiety and perceived stress 
A significant positive relationship was observed between cortisol levels at 
awakening and average laboratory levels of perceived stress, (r(15) = .55, p < .05) 
and a significant positive relationship between the peak value of the CAR and 
average laboratory levels of perceived stress, r(15) = .52, p < .05. This is 
summarised in Table 5.8. 
 
 
5.5. Summary of Chapter 5a 
Overall, subjective sleep did not differ between Night 1 and Night 2 and the 
CAR did not differ between the morning of measurement, indicating that both 
subjective sleep and the CAR are temporally stable within normal sleepers. For the 
CAR, this was the case for the profile of the CAR and across multiple indices, 
including awakening levels, the peak change, total cortisol secretion or in the peak 
value of the CAR. The only association observed between subjective sleep and the 
CAR was a positive relationship between the increase of the CAR, in terms of the 
 
Table 5.8:  
Correlations between average laboratory levels of anxiety and perceived stress and 
indices of the cortisol awakening response (n =  15) 
 Awakening Peak Change AUCG Peak Value 
Anxiety .45 -.20 .32 .37 
Perceived stress .55* -.08 .50 .52* 
AUCG: area under the curve with respect to ground 
*p<.05 
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peak change, and the number of awakenings. The following chapter summarises the 
relationship between objective sleep and the CAR shown in Study 1 before 
discussing the results. 
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  CHAPTER 5b.
Study 1: Objective sleep and the CAR 
 
5.6. Introduction 
Chapter 5b summarises the relationship between objective sleep and the CAR 
using the standard protocol in the absence of stress, before discussing the overall 
findings from Study 1.   
 
5.7. Treatment of results 
Analysis of the PSG data examined measures of sleep continuity and of sleep 
architecture. Sleep continuity variables were total sleep time (TST), sleep effiency 
(SE), wake after sleep onset (WASO), sleep onset latency (SOL) and the number of 
awakenings (NWAK).  Sleep architecture measures included the percentages of 
Stage 1 (N1), Stage 2 (N2), Stage 3 (N3) and rapid eye movement (REM) sleep, and 
the latency to these stages.  As the analysis of the CAR excluded three participants, 
PSG data from the same three participants were excluded from analyses. PSG data 
obtained during the adaptation night were excluded from further analyses due to 
potential first-night effects. The relationships between objective sleep continuity, 
objective sleep architecture and the CAR were analysed using Pearson correlations.  
The first morning CAR was excluded from analyses to allow comparisons with PSG 
data. 
 
5.8. Results 
5.8.1. Polysomnography 
171 
 
Objective measures of sleep continuity and sleep architecture are summarised in 
Table 5.9.  
 
5.8.2. Relationship between the CAR and objective sleep 
Objective measures of sleep continuity (WASO, SOL, TST, SE% and 
NWAK) were not significantly associated (all p values > .05) with the indices of the 
CAR. In terms of sleep architecture (% of REM, N1, N2, N3 and the latency to these 
stages), negative relationships were observed between awakening levels and the 
percentage of time spent in Stage 2 sleep, r(15) = -.53, p < .05, and between the 
CAR peak change and REM latency, r(15) = -.60, p < .05. These are summarised in 
Table 5.10. 
Table 5.9 
Summary of objective measures of sleep continuity and sleep 
architecture (n =  15) 
Variable Mean SD 
TST (mins) 430.12 26.46 
SOL (mins) 14.28 11.07 
NWAK 13.87 4.89 
WASO (mins) 13.12 6.59 
SE% 94.02 2.77 
Time in REM (%) 22.36 3.20 
Time in N1 (%) 3.60 1.20 
Time in N2 (%) 53.94 5.15 
Time in N3 (%) 20.10 5.02 
Latency to REM (mins) 105.87 33.79 
Latency to N1 (mins) 14.28 11.07 
Latency to N2 (mins) 20.73 12.59 
Latency to N3 (mins) 33.73 13.77 
TST: total sleep time, SOL: sleep onset latency, NWAK: 
number of awakenings, WASO: wake after sleep onset,  SE: 
sleep efficiency, REM: rapid eye movement sleep, N1: stage 1 
sleep, N2: stage 2 sleep, N3: stage 3 sleep. 
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Table 5.10:  
Correlation coefficients between measures of sleep continuity, sleep architecture and indices of the cortisol awakening 
response (n =  15) 
 
 WASO SOL TST SE(%) NWAK REM 
(%) 
N1 
(%) 
N2 
(%) 
N3 
(%) 
Latency 
to REM 
Latency 
to N1 
Latency 
to N2 
Latency 
to N3 
Awakening  
levels 
-.16 .18 .06 -.05 -.16 .31 .03 -.55* .37 .04 .18 .25 .14 
Peak 
change 
.31 -.30 .16 .12 .21 .01 -.12 .27 -.25 -.60* -.30 -.32 -.14 
AUCG 
 
-.05 .01 .19 .06 -.07 .33 .02 -.43 .23 -.24 .01 .07 .05 
*p < .05 
WASO: wake after sleep onset,  SOL: sleep onset latency, TST: total sleep time, SE (%): sleep efficency (%), NWAK: number of 
awakenings, REM: rapid eye movement sleep, N1: stage 1 sleep, N2: stage 2 sleep, N3: stage 3 sleep. 
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5.9. Discussion 
5.9.1. Subjective sleep and the CAR 
The main aim of Study 1 was to investigate the relationship between the CAR 
and subjective sleep continuity within healthy good sleepers in a laboratory 
environment. Temporal stability was shown in subjective sleep, as there were no 
differences between Night 1 and Night 2, and also in the CAR. The CAR was stable 
and did not differ across mornings, in terms of the profile and in terms of awakening 
levels, peak change, total cortisol secretion and in the peak value of the CAR.  
The only significant association observed between subjective sleep and the 
CAR was a positive relationship between the increase of the CAR, as indicated by 
the peak change, and NWAK. Where previous studies have examined the 
relationship between subjective sleep and the CAR, the findings have been mixed. 
The lack of relationship between subjective sleep duration and the CAR, in any 
indice of the CAR (awakening cortisol levels, peak change, total secretion and in the 
peak value) in Study 1 was consistent with a previous study (Hansen et al., 2012). 
However, studies measuring sleep subjectively using sleep diaries have shown 
conflicting results. A relationship between the CAR and sleep duration has been 
reported elsewhere both in terms the rise in the CAR and in the awakening sample 
(Kumari et al., 2009; Stalder et al., 2009)  and also in terms of the mean increase 
during the CAR period, although the reported correlation was small (r = -.16) (Wüst 
et al., 2000b).   
Generally, the strength and direction of the relationship appears to be 
influenced both by the measurement timings and the reporting indices of the CAR. 
Therefore, the differences between studies may reflect differences in the 
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measurement of the CAR between studies. It is a strength of the current study that 
although sleep was measured subjectively, the CAR was measured in a controlled 
sleep laboratory environment where the relationship between the sleep and the CAR 
was not influenced by methodological factors relating to participant adherence. 
Associations between the CAR and subjective anxiety and stress were also 
examined in Study 1, where subjective anxiety and perceived stress were measured. 
Overall perceived stress at awakening was related to two indices of the CAR, being 
positively related to both awakening cortisol levels and to the peak of the CAR, 
potentially indicating a relationship between daily activities and  the CAR. 
Whilst not part of the CAR, cortisol levels measured at wake +120 minutes 
were significantly higher on Morning 3 compared to Morning 2. Participants 
remained in the laboratory between Morning 2 and Morning 3 under controlled 
conditions and followed the same routine. It is possible that the increased cortisol 
levels at this point on Morning 3 reflect the anticpation of leaving the sleep 
laboratory and  preparing for activities and obligations upon leaving, but that the 
anticipation of these upcoming demands was not strong enough to disrupt the CAR.   
There appears to be some evidence to suggest that the CAR is a marker of 
anticipation (Fries et al., 2009). CARs (measured on the basis of the mean increase 
between awakening and 30 minutes post-awakening) have been shown to be 
approximately three times greater on work days which were characterised as being 
more demanding than non-workdays (Kunz-Ebrecht et al., 2004; Thorn et al., 2006). 
As there were no differences in levels of state anxiety or in perceived stress between 
Morning 2 and Morning 3, this would suggest that it is not the anticipation of a 
negative or stressful event/series of demands which has affected cortisol levels at 
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wake + 120 minutes. Instead this suggests that it is the anticipation of an upcoming 
demand which has affected cortisol levels and that the valence (i.e. whether it is 
positive or negative) is unimportant, as indicated by the lack of differences shown in 
negative states.  
A single case study has previously shown that subjective mood and the daily 
anticipation of activities and obligations (irrespective of valence) influence the CAR, 
explaining approximately 22% of the intra-individual variance in total cortisol 
secretion over the CAR period (Stalder et al., 2010a).  Furthermore, examples from 
competition studies have shown that demand can affect the CAR, irrespective of 
whether the upcoming demand is positive or negative.  Rohleder and colleagues  
(Rohleder et al., 2007) observed that awakening cortisol levels were increased on the 
day of a ballroom dancing competition compared to a practice day, despite similar 
levels of physical exertion. Other competition studies have shown elevated cortisol 
levels at 30 minutes post-awakening in male and female tennis players on the first 
day of a competitive tennis match, compared to a sample obtained from a rest day 
during a period without competition (Filaire et al., 2009). Similarly, elevated 
awakening cortisol levels have been shown in judo athletes on the morning of 
regional and inter-regional judo competitions compared to a resting day three weeks 
before competition (Filaire et al., 2001) and elevated +30 minutes levels in 
motorcycle riders before a qualifying trial and race compared to a resting day two 
weeks previously (Filaire et al., 2007).  Taken together, these studies suggest that the 
anticipation of upcoming demands can affect the indices of the CAR. That said, in 
these studies the CAR was not typically measured in a comprehensive manner and 
the relationship observed between demand and various indices outlines the 
importance of measuring multiple indices of the CAR in the context. As these 
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studies suggest a link to the anticipation of forthcoming demands as reflected in 
different indices of the CAR, it will be important to measure multiple CAR indices.  
Accordingly, the lack of controlled conditions in previous studies may mean that 
their results are subject to methodological limitations, as discussed in Chapter 2. For 
example, the findings may have been  influenced by factors including light (Figueiro 
& Rea, 2012; Scheer & Buijs, 1999; Thorn et al., 2004), unexpected awakenings 
(Born et al., 1999), the time of awakening (Stalder et al., 2009; Thorn et al., 2006) 
and the deviation from required sampling times (Clow et al., 2004).  
Whilst overall sleep within the laboratory was largely representative when 
compared to the baseline period,  total sleep time and sleep efficiency were reduced 
during the laboratory period. However, participants reported significantly lower 
levels of state anxiety and lower levels of perceived stress within the laboratory 
environment, therefore the subjective differences in sleep may not have occurred as a 
result of anxiety or perceived stress.  The perceived reduction in total sleep time and 
reduction in sleep efficiency may have occurred due to the enforced sleep/wake 
schedule, despite the efforts made to schedule the sleep/wake episodes in accordance 
with each participant’s habitual routine. It is possible that the lower levels of state 
anxiety and perceived stress may have been due to the sleep environment. Subjective 
sleep did not differ between the second and third morning within the laboratory. The 
lack of relationship between subjective sleep and indices of the CAR may also have 
been due to the limited sample size employed within Study 1, reducing the statistical 
power.  
Overall, Study 1 indicated that the only relationship observed between 
subjective sleep and the CAR was a relationship between perceived NWAK and the 
dynamic of the CAR. Future studies should explore this relationship using objective 
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methods of sleep, in order to confirm whether there is an underlying casual 
mechanism. Few studies have examined the relationship between the CAR and 
objective measures of sleep architecture or sleep continuity and the CAR in normal, 
healthy sleepers. Negative associations between the duration of REM sleep and 
awakening levels of cortisol have been shown in alcohol-dependent inpatients 
(Junghanns et al., 2007) and lower awakening cortisol levels were associated with 
percentages of Stage 1, Stage 3 and REM in a study of caregivers and non-caregivers 
(Fonareva et al., 2011). No associations have been shown between measures of sleep 
architecture and the CAR in a sample of veterans with PTSD and healthy controls, 
where the CAR was measured in terms of the AUCG (van Liempt et al., 2013).  
 
5.9.2. Objective sleep and the CAR 
A further aim of Study 1 was to examine the relationship between objective 
measures of sleep and the CAR, in a highly-controlled sleep laboratory environment. 
Overall, certain measures of sleep architecture were associated with the CAR as 
lower awakening cortisol levels were associated with a greater percentage of Stage 2 
sleep and a greater decrease in the dynamic of the CAR was associated with a greater 
latency to REM sleep.  
The current study also showed there to be no relationship between objective 
sleep duration and cortisol levels at awakening, in contrast to a meta-analysis which 
showed that previous subjective and objective sleep duration was positively related 
to cortisol levels at awakening (Garde et al., 2012). Total cortisol secretion and sleep 
architecture were unrelated, a pattern shown elsewhere in healthy controls and army 
veterans (van Liempt et al., 2013).  
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The current study showed that awakening levels were positively associated to 
Stage 2 sleep and that the peak change, representing the dynamic of the CAR, was 
negatively related to REM latency. This was in contrast to the relationship 
previously shown in caregivers and non-caregivers and in alcohol-dependent 
inpatients, where lower awakening cortisol levels were associated with increased 
percentages of Stage 1, Stage 3 and REM sleep (Fonareva et al., 2011) and where the 
duration of REM sleep was shown to negatively relate to cortisol levels at awakening 
(Junghanns et al., 2007).These discrepant findings may have been due to the fact that 
previous studies did not only examine healthy good sleepers, with between-group 
architectural differences potentially acting as a confound. It is a strength of the 
current study that only healthy good sleepers were assessed. That said, as Study 1 
indicated that different measures of subjective and objective sleep were related to 
different indices of the CAR, it may be the case that gross EEG is not a sensitive 
enough measure to accurately examine the relationship between objective sleep and 
the CAR. One way in which this could be overcome is through the use of more 
sophisticated techniques such as power spectral analysis, which would provide an 
insight into the discrepancies between subjective and objective sleep. 
An advantage of the current study is that the study had an extremely high 
level of control over factors known to affect the CAR. Saliva samples were obtained 
by a researcher, meaning that participants were not relied upon to self-collect saliva 
samples. This offered advantages over a home-based protocol as sampling times 
were strictly adhered to and participants complied with sampling instructions. This is 
of particular importance since deviation from the required sampling time can affect 
the CAR (Clow et al., 2004).  The collection of the awakening sample is particularly 
important as a delayed awakening sample can distort the CAR, by flattening the peak 
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and blunting the overall shape of the CAR (Griefahn & Robens, 2010; Thorn et al., 
2006).   
A further strength is that there was no variation in the time of awakening 
each morning and that the scheduling of sleep and wake was as closely matched to 
each participant’s habitual schedule as was possible. An advantage of this was that 
the influence of the awakening time would have been minimised (Stalder et al., 
2009; Thorn et al., 2006).  
In addition, the laboratory environment offered high levels of control over 
environmental factors known to affect the CAR. Light has been shown to affect the 
CAR (Figueiro & Rea, 2012; Scheer & Buijs, 1999; Thorn et al., 2004). As the CAR 
was sampled in extremely low ultraviolet light conditions, the relationship between 
objective sleep and the CAR was not influenced by variations in light levels. 
Furthermore, the laboratory environment ensured that participants were monitored at 
all times, minimising potential sample contamination  (Clow et al., 2004).  It is 
possible that discrepant findings from other studies may have been influenced by 
these environmental differences between studies.  
The results of Study 1 may also provide preliminary evidence that the CAR 
has a function related to memory consolidation during sleep. The current study 
showed that lower cortisol levels at awakening were associated with a greater 
percentage of Stage 2 sleep.  As Stage 2 sleep may enhance memory consolidation , 
either individually or in conjuction with REM and slow-wave sleep (Marshall & 
Born, 2007),  it is possible that the CAR is related to memory consolidation or has a 
function within consolidation. The current study showed that the dynamic of the 
CAR was also shown to be related to REM latency, as a greater decrease in the 
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dynamic was associated with a greater latency to REM sleep. Vandekerckhove & 
Cluydts (2010) suggest that the the effects of sleep upon mood and emotion of the 
following day are thought to be affected via REM sleep and that there is a 
relationship between emotional experience and changes in REM sleep. The 
relationship between the dynamic of the CAR and REM latency may represent the 
effects of emotional regulation upon the CAR. Another possibility is that this 
represents emotional memory consolidation, as REM sleep has been speculated to 
support consolidation of these memories (Diekelmann, Wilhelm, & Born, 2009). It is 
an advantage of the current study that healthy individuals remained in a highly 
controlled environment and that the CAR was examined using multiple indices.  
These findings suggest that the relationship between sleep architecture and 
the CAR may affect measurement indices of the CAR in a different manner. 
Limitations of the present study include the correlational nature of the study, 
meaning the causal relationships between sleep architecture and the CAR have yet to 
be clarified and a further limitation is the relatively small sample size. As discussed 
earlier in Chapter 5, previous studies have demonstrated an association between 
forthcoming demands and indices of the CAR, in terms of awakening levels (Filaire 
et al., 2001; Rohleder et al., 2007) and 30 minutes post-awakening (Filaire et al., 
2009; Filaire et al., 2007). Furthermore, Study 1 has demonstrated that cortisol levels 
were greater immediately prior to leaving the laboratory on the final day. It is 
possible that these increased levels reflect the anticipation of forthcoming demands, 
following a day in a highly-controlled environment with no external stimuli and the 
completion of sedentary activities. If indices of the CAR are subject to the influence 
of forthcoming demand, this can be experimentally manipulated using a similar 
protocol to Study 1. Study 2 will explicitly include forthcoming demand within the 
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protocol and examine the subsequent effects upon multiple indices of the CAR. This 
will overcome the limitations of previous studies where the CAR was not measured 
in a comprehensive manner, and will allow us to determine whether the CAR is 
indeed a biological marker of anticipation or demand.  
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CHAPTER 6.   
Study 2 
 
6.1. Introduction 
The Spielman 3P model of insomnia (Spielman et al., 1987; Spielman & 
Glovinsky, 1991; Spielman et al., 1996) and the Cano-Saper animal model of 
insomnia (Cano et al., 2008) both have a role for stress in the disruption of sleep and 
in the development of insomnia. Previous research has assessed the effects of 
naturalistic stressors and have shown that subjective and objective sleep disturbances 
are commonplace, however, whilst disruptive to sleep, the findings are inconsistent 
(Askenasy & Lewin, 1996; L. M. Davidson et al., 1987; Dooley & Gunn, 1995; Kato 
et al., 1996; North et al., 1999; Schuster et al., 2001). The inconsistencies may in 
part be due to the wide range of stressors employed, including financial strain, health 
events, bereavement and examinations (Hall et al., 2008; Hall et al., 2009; Hardison 
et al., 2005; Palesh et al., 2007; Reynolds 3rd et al., 1992; Reynolds 3rd et al., 1993; 
Wright et al., 2010). In addition to the diverse stressors employed and in the diverse 
nature of participants, there is a typically a time lag between the stress and the 
measurement of sleep.  
The effects of experimental stress studies have also shown inconsistent effects 
upon subjective sleep and objective sleep. As with naturalistic stressors, whilst 
disruptive, these inconsistent findings may be due to the wide variation in the nature 
of the stress employed, which has included tasks such as intelligence tests, cognitive 
tasks or where participants have viewed psychologically stressful films (Baekeland 
et al., 1968; Koulack et al., 1985; Vandekerckhove et al., 2011; Wuyts et al., 2012a). 
This wide variation in the nature of demand may influence sleep since the type of 
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task employed may differentially affect sleep (Kobayashi et al., 1998). As well as the 
wide variation in the nature of the demand, other potential confounding variables 
include where the stress is experienced during the first night (Baekeland et al., 
1968). Stress studies typically do not separate the effects of demand from the stress, 
with the exception of Beaumaster and colleagues (Beaumaster et al., 1978) which 
assessed the effects of the anticipation and effects of a parachute jump in novice and 
experienced parachute jumpers, showing that the anticipation of the jump affected 
the latencies to Stage 1 and Stage 2 sleep, where experienced jumpers displayed an 
increased SOL compared to novice jumpers and where novice jumpers showed a 
decreased amount of Stage 1 sleep. Following the jump, there were no differences in 
sleep between the two groups indicating that the demand did not affect sleep. A 
further limitation of studies assessing the effects of stress upon sleep is that they do 
not typically include a physiological marker of stress, meaning that it is difficult to 
verify that individuals find the stress paradigms used to be stressful. 
Anticipation has been shown to affect subjective and objective sleep, in both 
naturalistic and experimental studies. Anticipation has been shown to affect the sleep 
of a group of engineers during watch duty (Torsvall et al., 1987). Whilst on duty, the 
engineers displayed a sleep loss of more than 90 minutes per night and reported a 
poorer perceived sleep quality. Engineers also reported greater difficulties in falling 
asleep, less sleep and poorer sleep quality during watch duty nights, even when no 
alarms occurred, compared to a free night. Similarly, a study of five male ship 
engineers on-call showed a shorter duration of sleep and reduced periods of REM 
and slow wave sleep, compared to free nights. On-call nights also led to reductions 
in EEG power density during the first cycle of sleep, when no alarms occurred, 
which suggested the anticipation of upcoming demands disrupted sleep (Torsvall & 
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Akerstedt, 1988). Since anticipation can affect subjective and objective sleep, the 
influence of anticipation needs to be taken into account within studies assessing the 
effects of stress upon sleep. In one study good sleepers completed 30 minutes of 
cognitive tasks before going to bed within a laboratory environment, where 
subjective and objective sleep was compared to a reference night (Wuyts et al., 
2012a). There were no differences in subjective measures of sleep continuity or 
quality compared to the reference night, however objective sleep-onset latency was 
greater following the tasks. Objective differences were also shown in that a higher 
percentage of high frequency EEG activity was apparent in the first and second 
episodes of deep sleep following the tasks. Participants spent a night in their own 
home between the reference and task night, and the order of the reference night and 
task night was counterbalanced between participants. Due to the delay between the 
reference night and the task night, it is possible that the anticipation of forthcoming 
demands may have influenced the results. 
Anticipation may also affect the CAR, with evidence coming from studies 
showing that the mean increase of the CAR is greater on more demanding work days 
than non-workdays (Kunz-Ebrecht et al., 2004; Thorn et al., 2006). As discussed in 
Chapter 2, competition studies have shown that demand can affect indices of the 
CAR, irrespective of the valence of the upcoming demand (Filaire et al., 2009; 
Filaire et al., 2007; Filaire et al., 2001; Rohleder et al., 2007). In addition, Study 1 
showed that cortisol levels were higher at 120 minutes following awakening on 
Morning 3, immediately prior to participants leaving the sleep laboratory. Although 
this time point would be viewed as outside that of the typical CAR period (60 
minutes), it is possible that the increased cortisol levels observed at this point 
reflected the anticipation of activities and obligations upon leaving the laboratory. 
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Subjectively, participants also showed a steeper CAR increase on the Morning 3, 
again potentially reflecting anticipation. 
Participants had remained in the sleep laboratory between the second and 
third mornings under controlled conditions, with standardised activities and 
mealtimes. As there were no differences shown in state anxiety or in perceived stress 
between and second and third morning, this suggests that the anticipation of 
upcoming demand, irrespective of valence, may affect cortisol levels immediately 
prior to leaving the laboratory. Since anticipation appears to affect both sleep and the 
CAR, it will be necessary to separate the effects of anticipation and the effects of 
demand upon sleep. The potential effects of upcoming demand upon sleep and the 
HPA axis could therefore be appropriately tested through the manipulation of 
demand and anticipation within a consistent, controlled environment. This will be 
investigated within Study 2, where participants will believe that they will experience 
demand at the time of study enrolment. However, not all participants will experience 
demand. This will ensure that the effects of anticipation alone upon sleep and the 
CAR can be examined.  
Study 2 had two main aims. The first aim was to examine whether 
anticipation of forthcoming demand affected subjective sleep, objective sleep and 
indices of the CAR. The second aim was to examine the effects of anticipation, 
where this was met with subsequent demand, upon the same measures. Evidence 
from previous studies has suggested that the CAR may function as a marker of 
anticipation (Filaire et al., 2009; Filaire et al., 2007; Filaire et al., 2001; Rohleder et 
al., 2007) however this has included studies which have relied upon a single sample 
obtained during the CAR period (Filaire et al., 2009; Filaire et al., 2007; Filaire et 
al., 2001). A further limitation of these studies is that they do not measure the CAR 
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in a controlled environment, meaning that the CAR may be influenced by other 
factors, including light, differences in environment and adherence to the required 
time of sampling. Study 2 will employ the protocol previously used in Study 1 to 
measure sleep and the CAR, as this protocol addressed these limitations by 
examining the CAR in a comprehensive manner, through multiple saliva samples 
within a controlled laboratory environment. Study 1 observed elevated levels of 
cortisol immediately prior to leaving the controlled sleep environment on the final 
day of the study and it is speculated that these increased levels reflect anticipation of 
forthcoming demands.  
Study 2 will investigate this through experimentally manipulating 
anticipation of forthcoming demand and exploring the effects of this anticipation 
upon multiple indices of the CAR (CAR profile, awakening levels of cortisol, peak 
values, total secretion and the peak change). Study 2 will employ a manipulation 
where the anticipation and demand are seperated. The anticipated demand will either 
be met, where participants will be required to complete the cognitive tasks which 
they had been informed of at the time of enrolment, or will not be met, where 
participants will be informed that they are no longer required to complete the range 
of cognitive tasks, shortly before they are due to do so. This will allow the effects of 
anticipation, where the subsequent demand is met, to be compared with the effects of 
anticipation where the subsequent demand is not met. Study 2 therefore had two 
research questions: 
1. What are the effects of anticipation of forthcoming demand upon subjective 
sleep, objective sleep and the CAR? 
2. What are the effects of anticipation upon these measures when the 
anticipation is met with subsequent demand?  
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6.2. Method 
6.2.1. Participants and recruitment 
 A total of 22 normal healthy sleepers (11 male and 11 female; Mage = 23.42 
years
 , SDage = 3.61 years) participated in Study 2 and all participants were recruited 
and screened as described in Section 3.2. All participants provided written informed 
consent, and the study was approved by the Northumbria University Research Ethics 
Committee. Participants were paid a total of £150 and were provided with a full 
debrief upon completion of the study.  
Participants were allocated to one of two groups: anticipation and demand 
(AD, n = 11), where participants were informed in advance that they were required 
to complete the tasks described in Section 6.3.1 and completed these on Day 2, or the 
anticipation alone (AA, n = 11) group, where participants were informed in advance 
of the tasks but were told on Day 2 that they were not required to complete the tasks. 
Participants were placed in the AD group first in order to minimise the likelihood of 
participants in the AA group informing other participants of the manipulation. 
Objective sleep and CAR data from Study 1 participants (nine male and nine female; 
Mage = 23.46 years, SDage = 3.21 years) were used as a control group for comparisons 
in order to measure the effects of anticipation upon subjective sleep, objective sleep 
and the CAR, since these participants followed the same protocol where sleep and 
the CAR were measured in the absence of demand. Night 2 subjective sleep, 
objective sleep and the Morning 2 CAR were compared between the control group 
and all participants in Study 2 (i.e. participants who had been informed of 
forthcoming demand). This was done in order to examine how anticipation affected 
these variables in participants who were anticipating upcoming demand, compared to 
individuals (the control group) who were not expecting any upcoming demand.   
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6.2.2. Measures 
 The measures completed were described in Section 3.3 (PSQI:  Pittsburgh 
Sleep Quality Index, PSS: Perceived Stress Scale,  HADS: Hospital Anxiety and 
Depression Scale, HÖ-MEQ: Horne-Ostberg Morningness Eveningness 
Questionnaire, PSRS: Perceived Stress Reactivity Scale) and participants completed 
these measures upon arrival at the laboratory on the adaptation night. 
 
6.2.3. Polysomnography 
 PSG was applied on the adaptation night, Night 1 and Night 2 following the 
procedure described in Section 3.4.2. PSG obtained from the adaptation night was 
excluded from all further analyses in order to avoid any potential influence of a first-
night effect. 
 
6.2.4. Pre-sleep mood diaries 
 Participants also completed mood diaries on the adaptation night, Night 1 and 
Night 2, in bed, prior to lights out. The mood diaries were identical to those 
described in Section 3.4.1. 
 
6.2.5. Cortisol and cortisol awakening response (CAR) sampling 
Cortisol samples were obtained using Salivettes (Sarstedt, Leicester, UK) as 
described in Section 3.4.4. All samples were collected by a researcher and 
participants were instructed to chew on the Salivettes for 60 seconds. Saliva samples 
were obtained in order to measure the cortisol awakening response, daytime cortisol 
levels and pre-sleep cortisol levels. The CAR was measured in the same manner  as 
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described in Section 3.4.5, where samples were obtained at time intervals of 15 
minutes (awakening, +15, + 30, +45 and +60 minutes).  
 
6.2.6. Subjective sleep and mood 
 Participants were also required to complete sleep and mood diaries on 
Morning 1, Morning 2 and Morning 3 which assessed subjective sleep and quality. 
The diaries were identical to those described in Section 3.4.1.1. Sleep and mood 
diaries were completed 60 minutes following awakening, whilst participants were 
still in bed.  
 
6.3. Procedure 
6.3.1. Anticipation and demand group 
At the time of study enrolment, all participants were informed that they 
would be required to spend a full day (Day 2) in the sleep laboratory and would be 
required to perform a range of demanding tasks for the full day. Following 
enrolment, participants were monitored for two weeks prior to the laboratory stay 
using sleep and mood diaries (Section 3.4.1.1) and actigraphy (Section 3.4.1.2) in 
order to ensure relative sleep and circadian stability. Participants arrived at the sleep 
laboratory between 8.00pm and 9.00pm on the adapation night. Participants provided 
questionnaire and demographic information at the time of arrival on Night 1.  PSG 
(Section 3.4.3) was applied on the adapation night, Night 1 and Night 2 and lights 
out and lights on times were scheduled in accordance with habitual bed time and 
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Figure 6.1: Study 2 protocol  
 
Figure 6.2: Schedule of demand tasks (for AD group only) during the assessment period on Day 2
Day -14 to 0 Day 1 Day 2 Day 3
PSG: Adapation CAR: Morning 1 PSG: Night 1 PSG: Night 2 CAR: Morning 3
Baseline monitoring period Cortisol awakening response
Questionnaire & Demographics Sleep and mood measurement
Overnight polysomography Demand tasks / no tasks
Participants leave laboratory
CAR: Morning 2
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sleep durations from baseline sleep diaries. Participants were required to complete 
the mood section of the sleep and mood diaries (Section 3.4.1.1)  and a saliva sample 
was obtained prior to lights out each night. Participants were allowed to leave the 
laboratory two hours following awakening on Morning 1 after being instructed to 
adhere to their usual routine and returned to the laboratory on Night 1. Immediately 
before lights out on Night 1, all participants were instructed to read an instruction 
sheet, delivered by the same researcher (Appendix J) which provided details of  the 
daytime tasks to be completed the following day. Saliva samples were obtained for 
measuring of the CAR between awakening and 60 minutes post-awakening. 
Electrodes were removed at this point and participants were required to complete a 
sleep and mood diary. A saliva sample was obtained at +120 minutes. Participants 
remained in the sleep laboratory during Day 2 for the full day and were not permitted 
to leave or exercise at any point.  
The anticipation and demand (AD) group refers to the group of participants 
where the anticipation of forthcoming demand was met through the completion of a 
range of demanding tasks during Day 2. Participants in the AD condition completed 
a range of tasks in accordance with the schedule in Figure 6.1, where the tasks were 
chosen in order to ensure high levels of demand. Participants in the AD completed 
three different tasks during Day 2. Participants completed a modified version of the 
Emotional Stroop task (Barclay & Ellis, 2013),  the Multi-Tasking Framework 
(MTF, Purple Research Solutions;Wetherell & Sidgreaves, 2005) and the Iowa 
Gambling Task (IGT; Bechara, Damasio, Damasio, & Anderson, 1994). Further task 
information is provided in the following section (Section 6.3.2). A variety of tasks 
were included in order to ensure that participants were uncertain about the type of 
task that they would perform next.  In order to ensure high levels of motivation 
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throughout the testing day, participants were informed at the time of enrolment that 
the individual with the highest score on a randomly-selected task would win an 
Apple iPad.  Participants were allowed to perform activities including reading, 
watching television/films or use of the internet between tasks. 
 To allow comparison with control participants from Study 1, additional 
saliva samples were obtained at wake + 5 hours, wake + 8 hours, wake + 11 hours 
and wake + 14 hours. Participants were provided with standardised meals during 
Day 2 (as described in Section 5.3.4). Breakfast was provided 2 hours post-
awakening, lunch was provided at six hours post-awakening and dinner was 
provided 10 hours post-awakening. Participants were provided with additional 
snacks (e.g. fruit or chocolate) upon request, provided this did not occur 30 minutes 
before the next saliva sample. Participants received a full debrief at the end of the 
study on Morning 3. 
 
6.3.2. Day 2 demand tasks 
 
Participants within the AD condition completed three different tasks during 
Day 2, detailed in the following sections. All testing was completed on a PC with a 
17” monitor within the participant’s bedroom within the sleep laboratory. 
 
6.3.2.1. Modified Emotional Stroop task 
 Participants completed an modified version of the Emotional Stroop task 
(Barclay & Ellis, 2013) four hours post-awakening. The Emotional Stroop task is a 
measure of attention to sleep-related stimuli and 20 sleep-related, 20 neutral and 20 
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nonspecific threat lists were presented randomly in the centre of the computer screen 
in either red, blue, green or yellow coloured writing. Participants were required to 
respond by pressing a computer key with a corresponding coloured sticker as quickly 
as possible. An initial fixation cross was displayed for 500ms before the initial 
stimulus and for 500ms between each word. The word remained on the screen until a 
response was recorded. Written instructions were displayed on the screen prior to 
starting the task and participants initially completed a practice trial of 20 separate 
neutral words. The modified version of the Emotional Stroop task extended the task 
to a total of 120 trials and participants were told that the task would contain a rule 
change at an unspecified point. The first 60 trials of the task followed the protocol 
described above (i.e. pressing the corresponding computer key to the colour of the 
word displayed). After 60 trials the rules changed, where the colours of the words 
changed. Red words were then displayed in orange, yellow words were displayed in 
black, green words were displayed in brown and blue words were displayed in 
purple. Participants had a chart of the new rules beside them during the task and 
were required to respond in the same manner as before (e.g. by pressing the red key 
when an orange word appeared).  
 
6.3.2.2. Multi-tasking Framework 
 Participants were required to complete the Multi-Tasking Framework (MTF,  
Purple Research Solutions, UK) at seven time points throughout the day. The MTF 
consists of eight possible tasks which can be run individually or in combination and 
up to four tasks can be displayed simultaneously (Wetherell & Sidgreaves, 2005). 
Tasks can be run at a low, medium or high level of workload intensity. The MTF is 
representative of everyday demanding situations and has been shown to reliably 
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elicit workload stress, where increases in physiological and psychological variables 
(blood pressure, heart rate, perceived workload and mood) have been shown in 
relation to increases in the workload intensity of the MTF (Wetherell & Carter, in 
press). The MTF is also a suitable task for repeated use within the same sample of 
participants (Scholey et al., 2009).  
The four tasks used in the current study (Figure 6.3) were the auditory 
monitoring task, where individuals had to identify a target tone from two auditory 
tones played at regular intervals, the telephone number task, in which a 10 digit 
number had to be entered into a telephone keypad, a visual monitoring task, where 
six bars rose, at different speeds, towards a target line and participants had to click 
each bar in the order in which they rose. The final task was a number tap task, where 
a grid of 12 digits ranging from one to nine appeared on the screen and individuals 
were required to click on the highest digits in each set. Points are awarded for correct 
responses and points are deducted for incorrect responses or missed responses. A 
running score was displayed in the middle of the screen. Participants were required 
to complete all tasks simultaneously and tasks were set at a medium workload 
intensity, in order to ensure that participants found the tasks demanding but not 
impossible to complete. Participants were given a demonstration run lasting two 
minutes and each run of the MTF lasted for 10 minutes. Participants were instructed 
to perform the MTF to the best of their ability, where they were to be as fast and as 
accurate as possible. Participants were reminded of their score from the previous run 
of the MTF immediately prior to the next run. The score obtained during each run of 
the MTF was displayed on a scoresheet attached to a wall, in sight of the participant.  
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Figure 6.3: Example of the Multi-tasking Framework. 
 
6.3.2.3. Iowa Gambling Task 
 Participants were required to complete a modified version of the Iowa 
Gambling Task (IGT; Bechara et al., 1994) 12 hours after awakening, which is a 
measure of decision-making. Participants were initially presented with a screen 
providing instructions (Appendix L) which were a simplified version of those 
provided by Bechara, Tranel & Damasio (2000). Participants were informed that the 
game involves choosing one cards from any of four decks and that they would 
receive an amount of points which varies depending on the card chosen. Participants 
are informed before commencing the task that their main aim in the game is to attain 
as many points as possible. They are also informed that they are free to decide which 
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deck of cards they can select a card from and are also informed that they can switch 
from one deck of cards to another at any point. Participants were presented with a 
choice of four cards, equal in appearance and size. Following each card selection, a 
message was displayed indicating whether the participant won or lost points and the 
corresponding value of each gain/loss. Each deck of cards has a corresponding 
reward and punishment schedule which the participant is unaware of. Participants are 
not informed of how many card selections are available in the game and the task 
ends after 100 card selections. Participants gain 100 points when choosing a card 
from deck A or deck B and gain 50 points when choosing from deck C or deck D. 
Although the schedule and magnitude of punishments differ, deck A and deck B 
incur higher penalties than deck C or deck D. Deck A and deck B both incur net 
losses of 250 points after 10 trials and deck C and D result in a net gain of 250 points 
after 10 trials. Choosing from deck A and deck B results in a loss and are 
disadvantageous decks for the player, whereas deck C and deck D result in a net gain 
and are advantageous for the player.  Normal, healthy participants display a tendency 
to pick more cards from advantageous decks and fewer cards from disadvantageous 
decks over the duration of the task (Bechara et al., 1994).  
 
6.3.2.4. Perceived effort (NASA-TLX) 
Participants in the AD group were also required to report their levels of 
perceived workload immediately after each task by completing the NASA-Task 
Load Index (NASA-TLX; Hart & Staveland, 1988). The NASA-TLX (Appendix N) 
consists of six subscales (measuring mental, physical and temporal demand, effort, 
performance and frustration). Participants were required to mark on a 100mm VAS 
anchored with ‘low’ at one end and ‘high’ at the other.  
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6.3.3. Anticipation alone group 
The anticipation alone (AA) group refers to the group of participants where 
the anticipation of forthcoming demand prior to Day 2 was not met during Day 2. 
Participants within the AA group followed the same procedure as the AD group, 
until immediately following provision of the wake +120 minutes saliva sample on 
Day 2, participants in the AA group were provided with standardised instructions 
(Appendix M) which informed them that they were no longer required to complete 
any tasks. Participants in the AA group spent their day performing the same 
activities (e.g. reading, watching television/films or using the internet) as the AD 
group did between the completion of tasks. Additional saliva samples were obtained 
and standardised meals were provided at identical time points to the AD group, with 
snacks provided upon request. Participants received a full debrief at the end of the 
study on Morning 3. 
 
6.3.4. Mood: state anxiety and perceived stress 
 Participants in both the AA and AD groups were required to complete mood 
diaries measuring state anxiety and subjective stress (as described in Section 3.4.1.1) 
during Day 2 (Appendix N) Both groups completed these at the same time points 
during Day 2 (at wake +3hrs, +4hrs, +5hrs, +7hrs, +8hrs, +9hrs, +11hrs, +12hrs, 
+13hrs) and the AD group completed these following each task. 
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6.3.5. Treatment of results 
6.3.5.1. Baseline, age and demographic data 
No participants showed evidence of sleep or circadian problems from two-
week baseline sleep diary data or actigraphy data. Actigraphy data was not used in 
any further analyses.  Scores obtained from tasks completed during Day 2 were not 
included within any further analyses as the purpose of the tasks was to induce 
demand. In order to compare age and questionnaire data between the AA and AD 
groups, these measures were compared using a series of independent-samples t-tests.  
 
6.3.5.2. Night 1 subjective and objective sleep 
In order to compare measures of subjective sleep continuity and mood on 
Night 1, the AA and AD groups were combined to provide an anticipation group as 
both the AA and AD groups at this time point would have expected to complete the 
Day 2 demand tasks during the following day. This was compared to data obtained 
from the two-week baseline period, excluding non-work days, using a series of 
paired–samples t-tests. In order to compare objective sleep between the anticipation 
(AA & AD) and control group on Night 1, multivariate analysis of variance 
(MANOVA) tests were conducted on measures of sleep continuity (TST, SE%, 
WASO, SOL and NWAK), on measures of sleep architecture (percentages of time 
spent in REM, N1, N2 and N3 sleep) and on the latency to each stage of sleep (REM, 
N1, N2 and N3).  
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6.3.5.3. Night 1 pre-sleep cortisol levels 
In order to examine the effects of anticipation upon pre-sleep cortisol levels, 
Night 1 pre-sleep cortisol levels were compared between the combined anticipation 
(AA & AD) groups and control participants, using an independent-samples t-test. 
One participant was removed from the control group due to excessively high (> 
75nmol/l) cortisol levels.  
 
6.3.5.4. Morning 2 CAR 
CAR data from three participants in the control group were excluded due to 
saliva samples containing an insufficient volume of saliva for analysis (n = 2) and 
due to excessively high (>75 nmol/l,Kunz-Ebrecht et al., 2004)  cortisol levels (n = 
1). Due to samples containing an insufficient volume of saliva for analysis, CAR 
data was excluded from some participants from the AD group (n = 3) and AA group 
(n = 2). The Morning 2 CAR was compared between anticipation (AD & AA) and 
control groups using a 2 (condition) × 5 (time point) mixed ANOVA. Effect sizes 
were reported alongside ANOVA results, expressed as partial eta squared (η²p), 
Separate independent–samples t-tests were conducted to compare additional 
Morning 2 CAR indices (awakening levels, peak change, AUCG and peak value) 
between the AA and control groups.  
 
6.3.5.5. Night 2 subjective sleep, mood and objective sleep 
Measures of subjective sleep continuity and quality and mood obtained 
during Night 2 were compared between the AA and AD groups using a series of 
independent-samples t-tests. In order to compare the objective sleep of the AA and 
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AD group on Night 2, MANOVAs were conducted on measures of sleep continuity 
(TST, SE%, WASO, SOL and NWAK), on measures of sleep architecture 
(percentages of time spent in REM, N1, N2 and N3 sleep) and on the latency to each 
stage of sleep (REM, N1, N2 and N3).  
 
6.3.5.6. Morning 3 CAR 
The Morning 3 CAR was compared between AA and AD groups using a 2 
(condition) × 5 (time point) mixed ANOVA. Additional indices (awakening levels, 
peak change, AUCG and peak values) were compared between AA and AD groups 
using a series of independent–samples t-tests.  
 
6.3.5.7. Morning 2 and Day 2 perceived stress and state anxiety 
Levels of perceived stress following the CAR period (wake +1 hour) were 
compared between the AD and AA groups on Morning 2 using independent-samples 
t-tests. This was done in order to examine whether the two groups showed any 
differences in perceived stress prior to either completing or not completing the 
demand tasks on Day 2. Perceived levels of stress from the first and last Day 2 mood 
diaries (completed at wake + 3 hours and at wake + 13 hours) were compared 
between the AD and AA groups using a 2 (condition) × 2 (time point) mixed 
ANOVA in order to examine whether AD participants showed any difference in 
perceived stress levels following the first task and the final task. Day 2 daytime 
levels of state anxiety were compared between the AA and AD groups using a 2 
(condition) × 10 (time point: 60 minutes post-awakening (representing the end of the 
CAR period; wake +1hr) and at each time point during Day 2) mixed ANOVA. 
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Effect sizes were reported alongside ANOVA results, expressed as partial eta 
squared (η²p).  Scores from the NASA-TLX (AD participants only) were not 
analysed, however a subjective inspection the scores on each subscale indicated the 
effects of the demanding tasks were consistent throughout Day 2. 
 
6.3.5.8. Day 2 and Night 2 cortisol: diurnal and pre-sleep levels  
Day 2 diurnal cortisol levels were compared between the AA ,AD and control 
groups using a 3 (condition) × 5 (time point: wake + 5hrs, wake + 8hrs, wake + 
11hrs, wake + 14hrs, presleep) mixed ANOVA. Effect sizes were reported alongside 
ANOVA results, expressed as partial eta squared (η²p), Day 2 total cortisol secretion 
was calculated using the AUCG formula (as discussed in Section 3.4.5) using cortisol 
levels at wake + 5 hours, wake + 8 hours, wake + 11 hours, wake + 14 hours and 
presleep cortisol levels. Greenhouse-Geisser corrected degrees of freedom were 
reported where appropriate.The AUCG was compared between the AA and AD 
groups using an independent-samples t-test.    
 
6.4. Results 
6.4.1. Demographic and questionnaire comparisons 
The AA and AD group did not show any significant differences (all p-values 
>.05) in age, demographics or in any questionnaire measure, as summarised in Table 
6.1.  In addition, both groups did not show any significant differences in mood 
(subjective stress or in state anxiety) either during the baseline period (p >.05), on 
Morning 2 (p > .05) or on Morning 3 (p > .05). 
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6.4.2. Does anticipation affect sleep, the CAR and pre-sleep cortisol levels? 
6.4.2.1. Subjective sleep: Night 1 and baseline comparison 
 
Participants estimated their subjective total sleep time to be significantly 
reduced (t(21) = -2.91, p < .01) during the night before stress in the laboratory (Night 
1), compared to their two-week baseline period. Participants also reported 
significantly higher subjective levels of mental alertness in bed during the night prior 
to stress in the laboratory (t(21) = -2.44, p < .05), indicating that participants felt 
 
 
Table 6.1  
Age and demographic comparisons: AD and AA groups. 
Measure AD AA 
 Mean SD Mean SD 
Age 24.66 4.54 22.19 1.88 
PSQI 3.45 2.11 3.27 1.74 
PSS 
23.82 6.16 22.45 8.19 
FIRST 18.82 7.28 18.45 4.87 
HADS Anxiety 4.73 2.69 6.09 3.59 
HADS 
Depression 1.91 1.92 2.82 1.99 
HÖ –MEQ 48.27 9.68 50.27 10.27 
PSRS Total 21.27 9.01 16.45 5.87 
PSQI: Pittsburgh Sleep Quality Index, PSS: Perceived Stress Scale, FIRST: 
First Insomnia Response to Stress Test, HADS: Hospital Anxiety and 
Depression Scale, HÖ -MEQ: Horne-Östberg Morningness-Eveningness 
Questionnaire, PSRS: Perceived Stress Reactivity Scale 
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more mentally alert during the night before the anticipated stressor compared to an 
equivalent baseline period. Participants also displayed a trend towards displaying a 
higher NWAK (t(21) = 2.00, p = .058) during the night prior to an anticipated 
stressor, compared to their two-week baseline period. This is summarised in Table 
6.2. 
Table 6.2  
Subjective sleep continuity and quality comparisons:  Anticipation (AA 
& AD) baseline and  Night 1  
 Anticipation 
Baseline 
Anticipation 
Night 1 
Variable Mean SD Mean SD 
SOL 19.43 18.14 19.19 16.07 
NWAK 1.36 1.07 .87 .76 
WASO (mins) 7.73 9.31 5.32 6.25 
TST (mins) 457.64 55.99 484.91 62.76 
TIB (mins) 534.55 41.83 561.18 75.58 
SE (%) 85.56 8.33 86.21 8.46 
How well do you feel? (0 – 4) 2.73 .83 2.84 .64 
How enjoyable was your sleep?  
(0 – 4) 
2.91 .81 2.89 .53 
How mentally alert were you in 
bed last night? (0 – 4) 
.91 .61 1.21 .67 
How physically tense were you in 
bed last night? (0 – 4) 
.64 .85 .78 .55 
AA: anticipation alone, AD: anticipation and demand , SOL: Sleep 
onset latency, NWAK: number of awakenings, WASO: wake after sleep 
onset, TST: total sleep time, TIB: time in bed, SE (%): sleep efficiency 
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6.4.2.2. Objective sleep: Night 1 anticipation (AA & AD) and control 
comparison 
The anticipation of the upcoming demand did not affect objective sleep on 
Night 1, as indicated by no significant effect of condition upon sleep continuity, 
upon sleep architecture or upon the latency to each stage of sleep (all p-values > .05). 
This is summarised in Table 6.3.   
Table 6.3  
Objective sleep:  Anticipation and Control Night 1 Comparisons 
 Anticipation (AA&AD) Control 
Variable Mean SD Mean SD 
TST (mins) 452.80 41.21 434.78 23.44 
SE (%) 95.96 1.89 94.71 2.19 
WASO 8.68 4.31 12.08 7.27 
SOL 10.25 7.21 12.28 9.47 
NWAK 12.09 4.95 13.78 5.78 
Time in REM (%) 24.07 6.15 22.59 4.17 
Time in N1 (%) 3.30 1.85 3.38 1.41 
Time in N2 (%) 51.06 8.33 54.45 5.76 
Time in N3 (%) 21.58 5.86 19.58 5.12 
Latency to REM (mins) 95.80 36.67 109.75 39.92 
Latency to N1 (mins) 10.25 7.21 12.28 9.47 
Latency to N2 (mins) 16.41 12.42 17.19 11.08 
Latency to N3 (mins) 27.68 12.82 29.50 12.63 
AA: anticipation alone, AD: anticipation and demand , TST: total sleep time, SE 
(%): sleep efficiency, WASO: wake after sleep onset, SOL: Sleep onset latency, 
NWAK: number of awakenings, REM: rapid eye movement, N1: stage 1, N2: stage 
2, N3: stage 3. 
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6.4.2.3. Pre-sleep cortisol levels: Night 1 anticipation (AA & AD) and 
control comparison  
Night 1 pre-sleep cortisol levels were compared between anticipation (AA & 
AD) and control groups. The differences between  pre-sleep cortisol levels for the 
anticipation (M = 1.69 nmol/l; SD = 1.99 nmol/l) and the control (M = 1.45 nmol/l; 
SD = .62 nmol/l) groups was not significant (t(37) = -.46, p > .05), indicating that 
there were no differences in pre-sleep cortisol levels between individuals who were 
anticipating upcoming demand and control participants who were not. 
 
 
6.4.2.4. CAR: Morning 2  
The Morning 2 CAR was compared between anticipation (AA & AD) and 
control groups. There was a significant main effect of time point (F(2.92, 84.80) = 
6.64, p < .001, η²p = .19) reflecting the typical changes in cortisol levels during the 
CAR period. The main effect of condition was not significant (F(1,29) = .83, p > .05, 
η²p = .03). The time point × condition interaction was significant (F(2.92, 84.80)  = 
2.91, p < .05, η²p = .09) indicating that the anticipation group displayed a steeper 
CAR and displayed higher levels of cortisol throughout the CAR period, compared 
to the control group (Figure 6.4). Follow-up tests were conducted on each time point 
of the CAR using Bonferroni corrections for multiple comparisons (.05/5 = .01) 
however no comparisons reached significance at the corrected level. The CAR is 
shown in Table 6.4 and Figure 6.4. Analysis of additional CAR indices (awakening 
cortisol levels, peak change, AUCG and peak value) showed that there was a 
significant effect of the condition on peak change (t(24.60) = -2.09, p < .05), where 
the anticipation group showed a greater peak change on Morning 2 compared to the  
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Table 6.4  
Cortisol levels at each time point of the CAR: Morning 2 Anticipation (AA & AD) and Control comparisons 
 Awakening +15 minutes +30 minutes +45 minutes +60 minutes 
Variable Mean SD Mean SD Mean SD Mean SD Mean SD 
Anticipation (AA/AD) 8.23 4.45 10.76 5.76 12.44 5.13 11.64 4.67 12.12 5.47 
Control 8.85 4.47 9.10 4.26 10.58 3.62 9.40 3.97 8.66 3.56 
AA: anticipation alone, AD: anticipation and demand 
 
   
Table 6.5  
Additional indices of the CAR: Morning 2 Anticipation (AA & AD) and Control comparisons 
 Awakening Peak Change AUCG Peak Value 
Group Mean SD Mean SD Mean SD Mean SD 
Anticipation (AA/AD) 8.23 4.45 5.73 5.35 675.19 274.51 13.96 6.04 
Control 8.85 4.47 2.32 2.77 567.50 219.04 11.17 3.67 
AA: anticipation alone, AD: anticipation and demand , AUCG : area under the curve with respect to ground 
 
207 
 
 
Figure 6.4: Mean (±SEM) cortisol levels at each time point of the CAR: for Morning 2 Anticipation (AA&AD) and Control groups. 
Significant effect of condition observed upon peak change, where anticipation group showed a greater peak change than the Control 
group. There were no significant effects shown upon awakening levels, AUCG or peak value. 
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control group. There was no significant effect of condition on awakening levels, total 
secretion (AUCG) or on the peak value of the CAR (p > .05). Additional indices are 
summarised in Table 6.5.  
 
6.4.3. Does anticipation met with demand affect daytime mood and cortisol 
levels? 
Day 2 levels of state anxiety, perceived levels of stress, daytime cortisol 
levels were compared between AA and AD groups. 
 
6.4.3.1. Morning 2 perceived stress and state anxiety 
Following the CAR period on Morning 2, mood diaries indicated that 
participants in the AD and AA conditions did not show any differences in perceived 
stress (t(19) = 1.11, p > .05) or in state anxiety (t(19) = 1.42, p > .05) prior to the AA 
group being informed that they were not required to complete any demand tasks on 
Day 2. 
 
6.4.3.2. Day 2 perceived stress 
The condition × time point interaction was not significant (F(1,20) = .22, p > 
.05, η²p = .01 and neither the main effects of time point (F(1,20) = 3.73, p > .05, η²p = 
.16) or condition (F(1,20) = .59, p > .05, η²p = .03) were significant. This indicated 
that participants in the AD condition did not consider Day 2 to be more stressful than 
the AA group. 
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6.4.3.3. Day 2 state anxiety  
There was a significant main effect of time point (F(4.43, 88.59) = 3.04, p < 
.05, η²p = .13) and a significant main effect of condition (F(1,20) = 4.66, p < .05, η²p 
= .19. The time point × condition interaction was significant (F(4.43, 88.59) = 2.71, 
p < .05, η²p = .12) with a medium effect size, which indicated that the AA and AD 
groups showed different levels of state anxiety during Day 2. Follow-up tests were 
conducted and were adjusted for multiple comparisons (.05/10 = .005). The AD 
group showed significantly higher levels of state anxiety at wake + 3 hours (p = 
.003), which occurred after the AD group completed the first task. Daytime levels of 
state anxiety are summarised in Figure 6.5. 
 
Figure 6.5: Mean (±SEM) Day 2 AA and AD state anxiety levels (*p < .05) 
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6.4.3.4. Day 2 diurnal cortisol levels 
Day 2 diurnal (daytime and presleep) levels were compared between the AA, 
AD and control groups. The main effect of time point was significant (F(2.02, 70.74) 
= 3.15, p < .05, η²p = .08) reflecting the decline in diurnal cortisol levels thoughout 
the day. The main effect of condition was significant (F(2,35) = 3.28, p = .05, η²p = 
.16, however Bonferroni-adjusted follow-up tests were not significant, indicating that 
overall diurnal cortisol levels were not significantly different between all groups 
irrespective of time point. The time point × condition interaction was not significant 
(F(4.04,70.74) = .98, p > .05, η²p = .05, indicating that the diurnal decline in cortisol 
levels at specific time points did not differ between those who anticipated demand, 
whether or not this was met, and the control participants who did not anticipate or 
experience demand. This is shown in Figure 6.6. There were no significant 
differences in total cortisol secretion, in terms of the AUCG, between AA (M = 
4010.76, SD = 2119.09 arbitrary units), AD (M = 3623.25, SD = 1075.68 arbitrary 
units) and control (M = 3000.09, SD = 897.03 arbitrary units) groups, (F(2,36) = 
1.88, p > .05. η²p = .09). 
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Table 6.6  
Cortisol levels at each time point of Day 2: AA and AD comparisons 
 
 Wake + 
5hrs 
Wake +8hrs Wake +11hrs Wake +14hrs Pre-sleep 
Variable Mean SD Mean SD Mean SD Mean SD Mean SD 
AA  5.48 7.46 3.66 2.55 6.13 4.77 4.29 5.94 6.01 11.28 
AD 4.21 1.89 3.93 1.42 4.58 2.57 1.34 0.53 1.37 0.98 
AA: anticipation alone, AD: anticipation and demand 
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Figure 6.6: Mean (±SEM) Day 2 AA and AD cortisol levels. 
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6.4.4. Does anticipation alone, or anticipation and demand, affect sleep and 
the CAR? 
The effects of anticipation and anticipation, where this was met with demand, 
and the subsequent effects of the manipulation upon subjective sleep and objective 
sleep the night following the manipulation were also measured. The subsequent 
effects of the manipulation upon the CAR of the following morning were also 
measured.  This was examined by comparing Night 2 subjective and objective sleep, 
and the Morning 3 CAR, between the AA and AD groups. 
 
6.4.4.1. Subjective sleep: Night 2  
The AA and AD groups showed no significant differences on any measure of 
subjective sleep continuity or quality on Night 2, following the manipulation (all p-
values > .05).  The difference between the AA and AD groups in terms of SOL 
showed a trend towards significance (t(12.02) = 2.05, p = .063). Participants who 
had experienced anticipation where this was not met with subsequent demand (AA 
group) took approximately twice as long to get to sleep as participants who had 
experienced anticipation where this was met with demand (AD group) This is 
summarised in Table 6.7. 
 
6.4.4.2. Objective sleep: Night 2  
The results showed that there was no effect of condition on objective sleep 
continuity, sleep architecture or upon the latencies to each stage of sleep on Night 2 
(all p-values > .05). This indicated that participants who had experienced 
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anticipation alone, did not show any differences in objective sleep when 
compared to participants who had experienced anticipation where this was met with 
subsequent demand. Night 2 measures of objective sleep continuity, sleep 
architecture and the latency to each stage of sleep are summarised in Table 6.8. 
 
Table 6.7 
Subjective sleep continuity and quality: Night 2 AA and AD 
comparisons 
 AA Night 2 AD Night 2 
Variable Mean SD Mean SD 
SOL 21.36 16.45 10.68 5.25 
NWAK 1.00 .89 1.18 1.15 
WASO (mins) 5.82 6.66 3.36 5.84 
TST (mins) 455.82 60.45 470.27 40.04 
TIB (mins) 532.27 42.80 539.55 44.52 
SE (%) 85.44 7.70 87.20 3.27 
How well do you feel? (0 – 4) 2.82 .75 2.82 .75 
How enjoyable was your sleep?  
(0 – 4) 
3.00 .63 3.09 1.04 
How mentally alert were you in 
bed last night? (0 – 4) 
.73 .47 .91 .94 
How physically tense were you in 
bed last night? (0 – 4) 
.64 .67 .64 .67 
AA: anticipation alone, AD: anticipation and demand , SOL: Sleep 
onset latency, NWAK: number of awakenings, WASO: wake after sleep 
onset, TST: total sleep time, TIB: time in bed, SE (%): sleep efficiency 
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Table 6.8 
Objective sleep:  AA & AD Night 2 Comparisons 
  AA AD 
Variable Mean SD Mean SD 
TST (mins) 456.86 40.48 443.00 39.48 
SE (%) 96.21 2.13 94.55 2.74 
WASO 9.55 9.17 12.45 10.22 
SOL 8.27 5.40 13.23 10.25 
NWAK 10.91 4.44 12.73 4.34 
Time in REM (%) 24.08 7.33 23.86 6.32 
Time in N1 (%) 2.62 1.46 3.74 1.76 
Time in N2 (%) 51.19 7.03 51.48 9.13 
Time in N3 (%) 22.10 5.67 20.90 6.66 
Latency to REM (mins) 95.00 46.38 102.27 57.93 
Latency to N1 (mins) 8.27 5.40 13.23 10.25 
Latency to N2 (mins) 13.68 7.24 21.14 9.88 
Latency to N3 (mins) 26.23 9.96 33.95 14.00 
AA: anticipation alone, AD: anticipation and demand, TST: total sleep time, SE (%): 
sleep efficiency, WASO: wake after sleep onset, SOL: Sleep onset latency, NWAK: 
number of awakenings, REM: rapid eye movement, N1: stage 1, N2: stage 2, N3: 
stage 3. 
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6.4.4.3. CAR: Morning 3  
Results of the comparison between the AA and the AD groups on the 
Morning 3 CAR showed that there was a main effect of time point (F(2.52, 37.74) = 
9.43, p < .001, η²p = .39) reflecting the typical changes in cortisol during the CAR 
period. The main effect of condition was not significant (F(1,15) = .39, p > .05, η²p = 
.03). The time point × condition was not significant (F(1,15) = .39, p > .05, η²p = .03) 
indicating that participants who had experienced anticipation alone did not show a 
different CAR profile to those who had experienced anticipation where this was met 
with subsequent demand. Visually, both the AA and AD groups showed a similar 
profile until 30 minutes post-awakening, with the AA group showing sustained 
levels of cortisol and a steeper decline compared to the AD group. The cortisol 
profile between both groups was similar until 30 minutes post-awakening, where the 
AA group showed sustained levels of cortisol and a steeper rate of decline than the 
AD group. The Morning 3 CAR is shown in Table 6.9 and Figure 6.7. There were no 
significant differences between the AA and AD groups on any additional CAR 
indices during Morning 3 (awakening cortisol levels, peak change, AUCG and peak 
value). Additional indices are summarised in Table 6.10. 
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Table 6.9:  
Cortisol levels at each time point of the CAR: Morning 3 AA & AD comparisons 
 Awakening +15 minutes +30 minutes +45 minutes +60 minutes 
Variable Mean SD Mean SD Mean SD Mean SD Mean SD 
AA 6.41 3.04 9.16 3.83 13.33 7.03 11.39 5.65 10.57 6.50 
AD 7.00 3.79 8.60 4.49 14.37 10.24 14.17 8.49 14.90 7.62 
AA: anticipation alone, AD: anticipation and demand 
 
Table 6.10:   
Additional CAR indices: Morning 3 Anticipation & Control comparisons 
 Awakening Peak Change AUCG Peak Value 
Group Mean SD Mean SD Mean SD Mean SD 
AA 6.41 3.04 8.54 6.70 635.44 258.62 14.94 7.59 
AD 7.00 3.79 10.13 8.47 721.30 396.51 17.12 10.32 
AA: anticipation alone, AD: anticipation and demand , AUCG : area under the curve with 
respect to ground 
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Figure 6.7: Mean (±SEM) cortisol levels at each time point of the CAR: Morning 3 AA & AD groups. 
There was no significant effect of condition upon awakening cortisol levels, peak change, AUCG or the 
peak value. 
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6.5. Discussion  
The aim of Study 2 had two aims, where the first aim was to investigate whether 
the anticipation of forthcoming demand  affected subjective sleep, objective sleep 
and multiple indices of the CAR (the CAR profile, awakening levels of cortisol, peak 
values, total secretion and the peak change). The second aim was to examine the 
effects of anticipation where this was subsequently met with demand, upon these 
measures. This was done through an experimental manipulation where anticipation 
and demand were seperated. Participants were informed that they were required to 
complete a full day of cognitive tasks at the time of enrolment and were informed on 
the day of testing that they were no longer required to do so (the AA group of 
participants) or completed these tasks as expected (the AD group of participants). 
This allowed the effects of anticipation, where this was met with demand, to be 
compared with the effects of anticipation, where this was not met with subsequent 
demand, upon subjective sleep, objective sleep and the CAR.  
 
6.5.1. Does anticipation affect sleep and the CAR? 
The anticipation of demand affected subjective sleep, where there was a 
reduction in total sleep time on Night 1 compared to their two-week baseline period 
immediately before participation (Table 6.2).  This was not due to a reduction in TIB 
due to being in the laboratory, since TIB was not significantly different between the 
baseline period and the laboratory stay. Importantly, the anticipation of demand led 
to higher levels of mental alertness during the night prior to the anticipated stressor, 
indicating that the manipulation was effective. The anticipation of demand did not 
affect objective sleep (Table 6.3) in terms of sleep continuity, sleep architecture or in 
the latency to each stage of sleep. The findings of the current study correspond with 
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earlier studies which have displayed that the anticipation of forthcoming demands 
can disrupt subjective sleep, as Torsvall and colleagues (1987)  showed that 
engineers on watch duty but where no alarms occurred showed greater subjective 
difficulties in falling asleep, obtained less sleep and rated their sleep quality as being 
poorer in comparison to a free night. Similarly, Wuyts and colleagues (Wuyts et al., 
2012b) showed that participants in a simulated on-call situation showed a lower 
subjective sleep duration compared to a reference night. The results of Study 2 with 
regards to objective sleep differ in comparison to earlier studies which have shown 
that anticipation also affects objective sleep. Torsvall and Akerstedt (1988) showed 
that on-call nights on board a ship led to a shorter duration of objective sleep and 
reduced amounts of REM and slow wave sleep as compared to a free night. 
However, these studies required participants to believe that they would experience 
sleep disruption during the night and differs from the current study as participants 
were not expecting to be awoken during the night.   
The results of Study 2 also showed that anticipation can affect the CAR, 
potentially indicating that the CAR is a marker of anticipation. This was shown in 
the CAR measured on Morning 2, as participants who believed that they would 
experience a full day of demanding cognitive tasks showed a steeper CAR, with 
higher levels of cortisol throughout the CAR period, compared to a control group 
who were not expecting any demand, with a medium effect size (η²p = .09; Table 6.4, 
Figure 6.4). Those who were expecting demand also showed a steeper peak change 
in the CAR compared to the control group who were not expecting demand (Table 
6.5). This builds on preliminary evidence from competition studies that the CAR is a 
marker of anticipation, in terms of awakening levels (Filaire et al., 2001; Rohleder et 
al., 2007) and cortisol levels 30 minutes post-awakening (Filaire et al., 2009; Filaire 
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et al., 2007) where the CAR was measured in a less comprehensive manner and 
where the CAR was not measured in a controlled environment. The findings of 
Study 2 also build upon the findings of Study 1. Within Study 1, the standard 
protocol was used in the absence of stress, showing that cortisol levels were highest 
immediately before leaving the sleep laboratory on the final morning, potentially 
reflecting the effects of anticipation of forthcoming demands outside of the 
laboratory. Interestingly, CAR profiles within both groups appeared to show a large 
amount of individual variability, reflected in the large associated standard deviations. 
This was despite the CAR being measured in a laboratory environment with 
extremely high levels of control over factors known to affect the CAR, including 
light, which potentially indicates that individuals may vary in their response to 
anticipation (i.e. some individuals show a greater CAR than others do when 
anticipating upcoming demands). Overall, this provides strong evidence that the 
CAR, measured in a comprehensive and controlled manner, is a marker of 
anticipation.  
 
6.5.2. Does anticipation alone, or anticipation and demand, affect sleep and 
the CAR? 
The experience of anticipation and demand, in terms of completing the full day 
of demanding tasks within the laboratory, did not affect subjective sleep during the 
subsequent night (Night 2; Table 6.7). Whilst any differences were not statistically 
significant, individuals in the AD group, who expected and completed the range of 
demanding tasks, showed double the subjective sleep-onset latency than the AA 
group (21.4 minutes compared to 10.7 minutes), who would have been expecting 
tasks but did not complete them. However, this difference was not statistically 
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significant. The AD group also showed a large amount of variability with regards to 
SOL. This was also the case for WASO, TST and SE. Although there were no 
statistically significant differences in terms of objective sleep between the AA and 
the AD group during Night 2 (Table 6.8), interestingly, the AA group displayed a 
greater sleep efficiency, less WASO, a lower SOL and fewer NWAK than the AD 
group. In addition, the latencies to each stage of sleep appeared to be reduced within 
the AA group compared to the AD group. This may reflect individual differences in 
the response to stress during Day 2 within the AD group. Whilst not statistically 
significant, this pattern of high individual variability was not displayed within the 
cortisol levels of the AD group during Day 2 (Figure 6.6), as the AA group appeared 
to show a higher level of variability in cortisol levels. Overall, this suggests that 
there were individual differences in the response to the unexpected manipulation and 
there may have been individual differences in the subsequent effects upon subjective 
and objective sleep.  
The results of Study 2 differ from other studies which have used demand as a 
stressor.  Wuyts and colleagues (Wuyts et al., 2012a) showed that 30 minutes of 
cognitive tasks before bed showed there to be no differences in subjective sleep 
continuity or quality compared to a reference night, however objectively there was a 
longer SOL following the demand. However, participants spent a night in their own 
homes between the reference and task night meaning that any potential effects of 
anticipation and/or demand during the time spent outside of the laboratory may have 
influenced the results. Koulack and colleagues (1985) showed that demand prior to 
sleep, in the form of either easy or hard intelligence tasks, led to an increase in 
objective SOL and a decrease in REM density compared to a control night. 
However, there were no between-group differences in this study and it may have 
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been the case that participants completing hard tasks did not consider these to be 
harder than the group completing easy tasks. 
The CAR on Morning 3 did not show any statistically significant differences 
between the AA and AD groups, either in terms of cortisol levels or in any of the 
additional indices (awakening levels, peak value, total cortisol secretion over the 
CAR period, or peak change; Table 6.9 & Table 6.10). The cortisol profile between 
both groups was similar until 30 minutes post-awakening, where the AA group 
showed sustained levels of cortisol and a steeper rate of decline than the AD group 
(Figure 6.7). Whilst this was not statistically significant and the effect size was 
small-to-medium (η²p = .03), the AD group displayed mean cortisol levels which 
were approximately 1 nmol/l greater than the AA group at 30 minutes post-
awakening, approximately 2.5 nmol/l greater at 45 minutes post-awakening and 
approximately 4.5 nmol/l greater at 60 minutes post-awakening. Thorn and 
colleagues (2006), investigating weekend and weekday differences in the CAR, 
observed a highly significant (p = .001) interaction between the time point of 
sampling and condition with similar differences in cortisol levels during the CAR in 
a larger sample of participants (n = 48). Cortisol levels were similar at awakening, 
and levels at each sampling point were higher at subsequent intervals (15, 30 and 45 
minutes post-awakening) with similar differences in cortisol levels at each time point 
(approximately 1 nmol/l at wake +15 minutes, 2 nmol/l at wake + 30 minute and 
approximately 3 nmol/l higher at wake +45 minutes) to the present study. Whilst this 
must be interpreted with caution, it provides preliminary evidence that the CAR may 
also serve as a marker of recovery from previous demand, as well as a marker of 
forthcoming demand. Adam and colleagues (E. K. Adam et al., 2006) showed that 
subjective loneliness, sadness, threat and a lack of control immediately before bed 
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was associated with a greater CAR during the following day in a sample of older 
adults.  
 
6.5.3. Study strengths and limitations 
The major strength of the current study is that the effects of stress upon sleep 
were measured through the use of a standard protocol. This enabled the effects of 
anticipation upon to be teased apart from the effects of anticipation where this was 
met with subsequent demand. Furthermore, this study also included a physiological 
marker of stress by examining the CAR as a marker of HPA function. A particular 
strength is with regards to the collection of the CAR, since this was performed with 
an extremely high level of control over factors including light, where the CAR was 
collected in ultraviolet light. A further strength is with regards to the nature of the 
demanding tasks used within the thesis, as the IGT and modified Stroop task were 
included to induce uncertainty and the MTF was included at multiple time points. 
The MTF is representative of everyday situations, has been shown to reliably elicit 
physiological and psychological stress and is suitable for the repeated testing of 
participants (Wetherell & Carter, in press).   
Potential limitations of the study include the relatively small sample size, the 
homogenous age range of the participants, the short length of the protocol and the 
fact that participants followed their habitual sleep/wake schedule. However, these 
limitations are not likely to have affected the results of the thesis and offer 
opportunities for future research. These limitations are discussed in more detail in 
the following chapter. 
 
224 
 
6.5.4. Summary 
Study 2 indicated that the anticipation of forthcoming demand, affected 
subjective sleep but not objective sleep.  This was shown as participants who 
expected to complete a full day of demanding cognitive tasks showed a reduced 
subjective total sleep time during the night before the demand (Night 1), compared to 
a baseline period prior to the laboratory stay. Anticipation did not affect objective 
sleep during the night before demand. In addition, the CAR, a marker of HPA axis 
activity, was affected by anticipation of forthcoming demands. This was shown as 
participants who expected to complete demanding tasks showed a steeper CAR, with 
higher levels of cortisol during the CAR period, compared to a control group. In 
addition, the peak change was steeper within participants who were expecting 
demand. No differences were shown in objective sleep. Participants who experienced 
anticipation, where the demand was met, displayed higher levels of anxiety 
immediately after the first cognitive task compared to participants who experienced 
anticipation where this was not met with subsequent demand. This indicated that the 
experimental manipulation was effective and provoked anxiety.  
Sleep and the CAR were examined on the night of sleep following the 
manipulation and there were no effects shown upon subjective sleep or objective 
sleep. There was a trend towards an increased SOL in those who had experienced 
anticipation and demand; taking approximately twice as long to fall asleep than those 
who experienced demand. The CAR measured on the morning following the 
manipulation, showed that whilst the differences were not statistically significant, 
individuals who had experienced anticipation met by demand appeared to show a 
steeper, sustained CAR compared to those who had experienced anticipation only. 
This potentially indicates that the CAR may have a secondary adaptive role.  
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Overall, the results indicate that the anticipation of a stressor, whether this is met, or 
not met by subsequent demand, disrupts subjective sleep but not objective sleep. 
Additionally, this is reflected in the CAR, with Study 2 providing evidence that the 
CAR is a marker of anticipation with a possible secondary role in the adaptation to 
demand.  
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CHAPTER 7.  
General discussion 
 
7.1. Overview 
This chapter will provide an overall summary of the thesis and will explain the 
findings in relation to the Spielman 3P and Cano-Saper models of insomnia, which 
focus on the role of stress in the development of insomnia. This chapter will outline 
that the precipitant factor within the 3P model can be separated into anticipation and 
demand, before summarising the associated implications for practice and policy. 
This chapter will also explain the additional contributions of the thesis to the CAR 
literature before summarising general strengths and limitations. Potential future 
directions are suggested, in particular focusing on the influence of predisposing 
factors within the context of the 3P model. These would determine how these factors 
mediate the effects of anticipation upon sleep and may include personality variables 
and the influence of genetics.   
   
7.2. Thesis summary 
The overall aim of the thesis was to examine the effects of stress upon sleep, 
where subjective and objective sleep was measured, teasing apart the effects of 
anticipation, where this was either met, or not met, with subsequent demand. 
Previous studies which have examined the effects of stress upon sleep have done so 
using naturalistic stressors such as earthquakes or war, or using experimental 
stressors. However, the results of the effects of naturalistic stressors upon sleep have 
been shown to be inconsistent, due to effects such as the wide variation in the nature 
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of the stress, the diverse nature of participants and the time lag between the stressor 
and the measurement of sleep. The effects of experimental stressors upon sleep have 
also been shown to be inconsistent. A further limitation of the experimental stressors 
is that typically they have not included a physiological marker of stress within the 
protocol, meaning that the effectiveness of the stressor cannot be objectively 
verified.  
Overall, these inconsistent findings may be due to the differences in the 
measurement of sleep and stress. These inconsistent findings necessitated the 
development of a standardised measurement protocol for the measurement of sleep 
and stress in the same context where a physiological marker of stress was included. 
Cortisol was included as a marker of HPA axis function, focusing on the CAR, 
where cortisol levels increase sharply upon awakening. Cortisol was included a 
marker due to the relevance of HPA axis activity to insomnia and due to its use 
within stress studies and the CAR was included due to a) the close link between the 
CAR and sleep/wake; and b) as the function of the CAR was speculated to be related 
to anticipation, or demand, with both potential functions being relevant to the main 
objective of the thesis. A standardised protocol for measuring stress and sleep in the 
same context was developed in the thesis and an initial feasibility study measured 
sleep and the CAR in a home or a laboratory environment using the protocol.  
The aim of the feasibility study was to determine whether or not the protocol 
could feasibly be used within a home environment, where sleep was measured over 
three consecutive weekday nights and the CAR over three subsequent weekday 
mornings. Whilst there were minimal differences in sleep and the CAR between the 
two measurement locations, the laboratory protocol offered a higher level of control 
over participant activities between the second and third nights of sleep and 
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measurement of the CAR on the second and third mornings. In addition, the choice 
of a laboratory environment afforded greater control over other factors known to 
affect the CAR, including light, since the CAR was measured in extremely low 
levels of light within the laboratory environment. This minimised the SCN input to 
the HPA axis and subsequent effects upon the CAR.  
Study 1 examined the relationship between subjective sleep, objective sleep and 
the CAR using the protocol in the absence of stress, showing a positive relationship 
between subjective NWAK and the peak change of the CAR. Importantly, subjective 
sleep, objective sleep and the CAR were shown to be temporally stable and a further 
important finding of Study 1 was that cortisol levels were highest on the final 
morning of the study, immediately before leaving the laboratory at wake + 120 
minutes. As all participants remained in a highly-controlled laboratory environment 
between the second and third mornings, it is possible that this either reflected the 
anticipation of obligations and activities upon leaving the laboratory, or that this 
indicated a reaction to previous activities.  
Study 2 used the standard protocol to assess the impact of stress upon subjective 
sleep, objective sleep and the CAR. Within Study 2, all participants expected that 
they would experience a full day of demanding tasks during Day 2 within the 
laboratory, thus allowing the effects of the anticipation of stress upon sleep and the 
CAR to be measured. Study 2 also assessed the effects of anticipation and demand 
upon these measures, as whilst all participants expected stress, only half of the 
participants completed the tasks.  
The results of Study 2 showed that anticipation alone affected subjective sleep 
but not objective sleep, where participants displayed a lower subjective total sleep 
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time compared to a two-week normative baseline period but not objective sleep. The 
CAR was also affected by anticipation, where anticipation led to greater cortisol 
levels throughout the CAR and a steeper peak change compared to control 
participants who had followed an identical protocol in the absence of stress. 
Anticipation and demand did not affect either subjective sleep or objective sleep and 
whilst anticipation and demand did not lead to any statistically significant changes 
within the CAR, the alterations shown to the CAR were meaningful. Overall, the 
most important contribution of the thesis to the sleep and stress literature is that the 
thesis showed that the anticipation alone of stress can disrupt sleep, when teased 
apart from anticipation and demand.  
As outlined in Chapter 1, two theoretical models of insomnia, the Spielman 3P 
model (Spielman et al., 1987; Spielman & Glovinsky, 1991; Spielman et al., 1996) 
and the Cano-Saper animal model of insomnia (Cano et al., 2008) outline how stress 
can lead to poor sleep and the development of insomnia.  The Spielman 3P model of 
insomnia has a role for stress as precipitating factors, which can include acute 
stressors such as medical or psychiatric illnesses, or in the example provided by 
Spielman and colleagues, where a young man receives a job promotion (Spielman et 
al., 1987; Spielman & Glovinsky, 1991; Spielman et al., 1996), interacting with 
predisposing vulnerability factors and resulting in a period of sleep disruption.  
The Cano-Saper rodent model of insomnia also has a role for stress (Cano et al., 
2008). Within the Cano-Saper model of insomnia, stress was induced by placing a 
male rat at the peak level of sleep and placing it into a dirty cage which had 
previously been occupied by a male rate for a period of one week, with the rat 
showing sleep disturbances and HPA axis activation.  
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Previous research has assessed the impact of natural stressors, such as natural 
disasters and wars, showing that sleep disturbances are common following such 
events (Askenasy & Lewin, 1996; L. M. Davidson et al., 1987; Dooley & Gunn, 
1995; Kato et al., 1996; North et al., 1999; Schuster et al., 2001). The disruptive 
effects have been shown across multiple measures of subjective and objective sleep 
continuity. For example, a study which examined participants during and 30 days 
after the Gulf War indicated that 51% of participants reported disturbed sleep and 
that 19% of participants who reported normal sleep before the war developed 
insomnia (Askenasy & Lewin, 1996).  
However, these studies have typically examined the effects upon subjective 
sleep and have used cross-sectional study designs.  Major limitations of this 
approach include the fact that the stressful event is associated with a range of 
associated and upcoming demands and also that there is a time lag between the 
stressful event and the assessment of sleep. Whilst the studies have examined a 
relationship between stress and insomnia, they do not account for the initiation of the 
period of poor sleep and examine how this influences the development of insomnia. 
For example, an earthquake is likely to affect various aspects of an individual’s life 
(e.g. their home and their job) with a range of associated demands (e.g. finding or 
repairing a home) and upcoming demands (e.g. having to find new employment).  
Other studies examined the effects of more common naturalistic stressors upon 
sleep (both objective and subjective), including financial strain, health events 
including illness or the anticipation of surgery, bereavement, and examinations (Hall 
et al., 2008; Hall et al., 2009; Hardison et al., 2005; Palesh et al., 2007; Reynolds 
3rd et al., 1992; Reynolds 3rd et al., 1993; Wright et al., 2010). The findings from 
these studies have also been inconsistent but have indicated that the stressors cause 
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disruptions to subjective and objective sleep. For example, one study indicated that 
older adults who reported that they found on-going financial strain to be either 
“somewhat upsetting” or “very upsetting” showed objective sleep differences 
compared to older adults who did not report on-going financial strain or rated it as 
being “not upsetting”, showing a longer SOL, greater WASO and lower sleep 
efficiency (Hall et al., 2008). However, limitations of these studies include; the lack 
of adequate control groups, the cross-sectional design and the diverse nature of 
participants included in the studies (typically with co-morbid conditions). Due to the 
nature of the stress, these would have had both anticipation and demand associated 
with the stress and in order to accurately assess the impact of stress upon sleep, it 
was necessary to separate the anticipation from the demand.  For example, in the 
case of an illness, the illness has both direct and indirect disruptive effects upon 
sleep. Potential direct effects may occur from the illness itself and from associated 
medication, and indirect effects may come from the overall stress arising from the 
situation and from the anticipation of financial loss. Whilst the effects of naturalistic 
stressors upon sleep typically lead to sleep disturbances, the effects upon subjective 
and objective sleep problems are inconsistent and in the outcome measures used.  
Other limitations of naturalistic studies have included the wide variation in the 
nature of the stress and in the diverse nature of participants. The effects of 
experimental stressors upon subjective sleep and objective sleep have been examined 
and have been shown to be disruptive, leading to effects including an increase in 
objective SOL and decrease in REM density following intelligence tasks (Koulack et 
al., 1985) and increases in objective SOL following cognitive tasks (Wuyts et al., 
2012a). As with naturalistic stressors, there have been a wide variation in the nature 
of stress employed, including tasks such as intelligence tests or watching 
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psychologically stressful films (Baekeland et al., 1968; Koulack et al., 1985; 
Vandekerckhove et al., 2011; Wuyts et al., 2012a).  
Experimental studies also have other limitations, including potential confounds 
from the stress being experienced during the first night of a laboratory protocol 
(Baekeland et al., 1968). These studies are also limited by the fact that they do not 
tend to include a physiological marker of stress, meaning that it cannot objectively 
be shown whether the stress paradigm is physiologically stressful or not. In addition, 
anticipation has also been shown to affect subjective and objective sleep, in both 
naturalistic and experimental studies, with inconsistent findings (Torsvall & 
Akerstedt, 1988; Torsvall et al., 1987).  
Overall, naturalistic and experimental studies of stress showed that whilst stress 
disrupted subjective and objective sleep, the overall findings were inconsistent. The 
inconsistent findings are potentially due to factors such as the wide variation in 
stressors and in the diverse nature of study participants. Additionally, other studies 
showed that anticipation was also shown to affect subjective and objective sleep. The 
thesis therefore developed a standard protocol for examining the effects of stress 
upon sleep, where the protocol teased apart the effects of anticipation from 
anticipation where this was met with subsequent demand. Within the protocol, all 
participants experienced anticipation; however, not all participants experienced 
demand. Previous research which has examined the relationship between stress and 
sleep has not included a physiological marker of stress, meaning that it is not 
possible to determine whether or not individuals found the stressor to be objectively 
stressful. For this reason, the stress hormone cortisol, which is the end product of the 
HPA axis (Hucklebridge et al., 2005) was included within the thesis as a 
physiological marker of stress. Increases of cortisol are typically observed following 
233 
 
an acute psychosocial stressor (Dickerson & Kemeny, 2004; Kirschbaum et al., 
1993) 
The HPA axis is of importance within insomnia since cortisol is a method by 
which physiological hyperarousal can be measured, with cortisol being involved 
within hyperarousal models of insomnia (Riemann et al., 2010). The Cano-Saper 
model of insomnia showed that hyperarousal as measured through HPA axis 
activation occurred following a stressor. Within the model, a stressor was employed 
in the form of a cage exchange where male rats were placed into another cage which 
had been occupied by another male rat, resulting in a stress response due to the 
territorial nature of the rat and where the stress resulted in sleep disturbances and 
HPA axis activation (Cano et al., 2008).  
It had previously been shown that 24-hour cortisol levels within a group of 
individuals with insomnia were positively related to the level of WASO, suggesting 
a relationship with sleep disturbance (Vgontzas et al., 1998). It had also been shown 
that those with insomnia displayed higher levels of cortisol in the evening and early 
part of the night (Vgontzas et al., 2001) and higher nocturnal levels of cortisol 
compared to a control group of normal sleepers (Rodenbeck et al., 2002). However a 
separate study showed that there were no differences in nocturnal cortisol levels 
between those with insomnia and healthy controls (Riemann et al., 2002).  Other 
studies had focused on cortisol levels at awakening, potentially accounting for these 
differences, where Backhaus and colleagues measured salivary cortisol levels, at 
awakening, 15 minutes post-awakening and at bedtime over a period of seven 
consecutive days (Backhaus et al., 2004).  Those with insomnia showed lower 
cortisol levels at awakening than controls and awakening cortisol levels showed a 
negative relationship with nightly awakenings. 
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The thesis measured the CAR as a marker of HPA axis activity, referring to the 
increase in cortisol levels observed upon awakening. The CAR was chosen as an 
ideal physiological marker given the close relationship of cortisol secretion with the 
circadian system (Morris et al., 2012). The CAR was also included as a 
physiological marker of HPA axis function as the potential functions of the CAR 
were very closely related to the main objective of the thesis. These potential 
functions may include acting as a marker of anticipation (Filaire et al., 2009; Filaire 
et al., 2007; Filaire et al., 2001; Rohleder et al., 2007) or as a marker of recovery (E. 
K. Adam et al., 2006). However, as summarised in Chapter 2, the CAR is affected 
by a range of methodological factors including; light (Figueiro & Rea, 2012; Scheer 
& Buijs, 1999; Thorn et al., 2004), unexpected awakenings (Born et al., 1999), the 
time of awakening (Stalder et al., 2009; Thorn et al., 2006) and the deviation from 
required sampling times (Clow et al., 2004).  
The protocol developed within the thesis standardised the measurement of sleep 
and the CAR. This was important as despite the close links between sleep and the 
CAR, the relationship between sleep and the CAR was shown to be inconsistent, 
potentially due to methodological factors. A meta-analysis of 23 CAR studies had 
previously shown that sleep duration was positively related to awakening cortisol 
levels during the CAR (Garde et al., 2012). However, very few studies had examined 
the relationship between objective sleep and the CAR in a sample of good sleepers or 
within a controlled environment. In addition, different measures of the CAR had 
been included where the relationship was examined. 
 For example, it was shown that there was no relationship between measures of 
sleep architecture and total cortisol secretion during the CAR period in healthy 
controls or army veterans with PTSD (van Liempt et al., 2013). REM sleep was 
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shown to negatively relate to awakening cortisol levels within alcohol-dependent 
inpatients (Junghanns et al., 2007) and awakening cortisol levels and increased 
percentages of Stage 1, Stage 3 and REM sleep in caregivers compared to non-
caregivers. However in the study of caregivers both groups showed differences in 
their objective sleep, with an increased total percentage of Stage 1 and decreased 
REM sleep compared to non-caregivers (Fonareva et al., 2011).  
In order to provide a standardised way by which the relationship between stress 
and sleep could be examined within the thesis, Chapter 3 outlined a common method 
for measuring subjective sleep, objective sleep and the CAR, where the CAR was 
measured using multiple indices. Following the development of the standard 
protocol, a feasibility study conducted within Chapter 4 investigated whether the 
standard protocol could feasibly be used within a home environment, or whether a 
laboratory environment was potentially more suitable. The feasibility study 
measured objective sleep and the CAR in healthy good sleepers, where they were 
assessed within either a home environment or in a laboratory environment, with 
increased levels of control over bed and awakening times, monitoring of sleep, 
collection of the CAR and consistency in environment and daily activities.  One 
cortisol sample was missing during the CAR period within a home environment 
compared to the laboratory environment, potentially as a result of adherence to 
sample collection instructions.  
The measurement of objective sleep, through ambulatory PSG, was well-
tolerated and did not result in any missing data. Measures of objective sleep 
continuity and sleep architecture were similar between the two groups, with some 
subtle differences shown in WASO, SOL and in the latency to each stage. The CAR 
profile was similar when measured within a home and laboratory environment, 
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however cortisol levels at each time point appeared to be lower when measured 
within a laboratory environment, with lower standard deviations in cortisol levels at 
each time point. This was potentially due to the influence of extraneous factors 
during the CAR period, including variations in light levels and the inability to 
control awakening times and movement within a home environment. Whilst the 
results of the feasibility study indicated that the protocol was suitable either for use 
within a home or laboratory environment, in order to maximise the level of control 
over the protocol, Study 1 was conducted within a laboratory environment. This was 
of particular relevance to light, since light can potentially affect the CAR and saliva 
samples were collected in very low ultraviolet light in the laboratory environment. 
  Study 1 tested the protocol in order to measure sleep and the CAR, and to 
observe the relationship between these two these measures in normal sleepers. A 
total of 18 healthy good sleepers participated for three consecutive nights, where the 
CAR was measured on three consecutive weekday mornings following each night of 
sleep. Between the second and third morning of the protocol, participants remained 
in the laboratory environment and were allowed to perform activities including 
reading, computer work and watching films but were not allowed to leave the 
laboratory or exercise at any point. Chapter 5a and 5b assessed the relationship 
between subjective sleep, objective sleep and the CAR, where the CAR was 
measured comprehensively through multiple indices (cortisol levels at each sampling 
point, total cortisol secretion during the CAR period, peak change and peak cortisol 
levels). Subjective sleep remained constant between the second and third night of 
measurement. The CAR did not show any differences between three mornings of 
measurement, either in terms of the cortisol levels at each time point of the CAR or 
in any of the indices measured, indicating that the CAR is temporally stable within 
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normal sleepers in a laboratory environment. A positive relationship was observed 
between the number of subjective awakenings and the peak change of the CAR.  
Chapter 5 also investigated the relationship between mood and the CAR.  Average 
levels of perceived stress at awakening were related to two indices of the CAR, 
where perceived stress showed a positive relationship with cortisol levels at 
awakening and with the peak value of the CAR.  Since Study 1 used the protocol to 
measure sleep and the CAR in the absence of stress, this provided a first indication 
that the anticipation of upcoming demands may be associated with the CAR.  
The relationship between objective sleep and the CAR was also examined in 
Study 1, which showed that that certain measures of objective sleep architecture 
were associated with the CAR. Lower awakening cortisol levels were associated a 
greater percentage of Stage 2 sleep and a greater decrease in the peak change of the 
CAR was associated with a greater latency to REM sleep. Study 1 showed that 
outside the CAR period, cortisol levels were greatest immediately prior to leaving 
the laboratory on the final morning, in addition to a subjectively steeper and more 
sustained CAR on Morning 3.  
Participants had remained in the sleep laboratory between the second and third 
mornings under controlled conditions, with standardised activities and mealtimes, 
and displayed shown no differences in state anxiety or perceived stress between the 
second and third mornings. Due to the temporal stability of sleep and mood, this 
suggested that the anticipation of upcoming activities may have influenced cortisol 
levels.  
The controlled nature of Study 1 suggested that this may have been, as one 
possibility of many, due to the anticipation of forthcoming demands upon leaving the 
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laboratory.  As such, this suggested that the CAR may be influenced by forthcoming 
demands. Previous studies had demonstrated an association between forthcoming 
demands and indices of the CAR, in terms of elevated awakening levels (Filaire et 
al., 2001; Rohleder et al., 2007) and elevated cortisol levels at 30 minutes post-
awakening (Filaire et al., 2009; Filaire et al., 2007) . Whilst these studies have 
suggested that the CAR may function as a marker of anticipation, it is also a 
possibility that the CAR may function as a marker of demand and Study 2 explored 
this possibility further.   
Study 2 used the same protocol to examine the relationship between stress 
and sleep, where anticipation, and the combination of anticipation and demand, were 
teased apart. Specifically, the effects of teasing anticipation and anticipation where 
this was met with subsequent demand, and their impact upon subjective sleep, 
objective sleep and the CAR were measured. Healthy participants followed the same 
protocol as employed in Study 1; however, participants were informed at the time of 
enrolment that they would experience one full day of demanding tasks within the 
sleep laboratory.  Whilst all participants were informed of the upcoming tasks, only 
half of the participants completed the tasks, as the participants who were not required 
to do so were informed of this change on the morning of testing. This ensured that 
whilst all participants anticipated the stressor, only half of the participants within 
Study 2 experienced anticipation and demand.  
The anticipation and demand condition included three cognitive tasks, 
completed at specific time points throughout the day. The MTF (Wetherell & 
Sidgreaves, 2005) was completed at multiple time points during the day.  The other 
two demand tasks within Study 2, which employed a modified version of the 
Emotional Stroop (Barclay & Ellis, 2013) and of the Iowa Gambling Task (Bechara 
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et al., 1994; Bechara et al., 2000) were chosen because they induce uncertainty since 
the rules of the tasks change. Overall, the anticipation of stress affected subjective 
sleep, as indicated by the reduction in total sleep time on Night 1 compared to the 
baseline period. This was not due to a reduction in TIB since TIB was not 
significantly different between the baseline period and the laboratory stay. That said, 
there were no between-group differences in either subjective or objective measures 
of sleep on Night 2, following the full day of tasks (i.e. those who had experienced 
anticipation and demand) compared to those who had experienced just the 
anticipation.  
This suggests that the addition of demand to anticipation had limited impact. 
Whilst there were no statistically significant differences in any subjective or 
objective sleep measure on Night 2, participants in the anticipation met with demand 
group showed a subjective SOL that was double the length of participants who did 
not complete the tasks. This SOL had a high associated standard deviation which 
suggested a wide variation in the individual SOL. The AA group also showed a 
greater sleep efficiency, less WASO, a lower SOL and fewer NWAK than the AD, 
alongside reduced latencies to each stage of sleep. This may reflect individual 
differences in the response to stress.  
The anticipation of upcoming stress affected one dimension of the CAR, as 
participants in Study 2 showed a steeper peak change in cortisol levels during the 
CAR period compared to individuals who were not expecting any stress (using the 
equivalent data from those in Study 1). No between-group differences were observed 
in total cortisol secretion, awakening cortisol levels or peak values. The anticipation 
group showed a subjectively larger CAR profile than a control group and although 
this was not statistically significant this also suggested that the CAR may have a role 
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within anticipation. Taken together these findings suggest that the CAR may 
function as a marker of anticipation (Filaire et al., 2009; Filaire et al., 2007; Filaire 
et al., 2001; Rohleder et al., 2007).  
The CAR, as measured on Morning 3 of the study, suggested that there were 
no differences between those who had experienced demanding tasks and those who 
did not in any dimension of the CAR. However, whilst there were no statistically 
significant differences in cortisol levels during the CAR period, the CAR profile was 
elevated within those who completed the tasks, which suggested that the CAR may 
also function as a marker of recovery.  
Overall, Study 2 suggested that the anticipation of stress disrupts subjective 
sleep and that the CAR appears to function as a marker of anticipation, potentially 
with a secondary ‘recovery’ role. Overall, the results of the thesis indicate that the 
anticipation alone of an upcoming stressor is sufficient to affect subjective sleep. In 
addition, the anticipation of stress also resulted in the activation of the HPA axis, as 
reflected in the increased peak change of the CAR. The following section discusses 
the overall findings of the thesis in relation to models of insomnia that explicitly 
outline the role of a stressor in the development of insomnia. 
 
7.3. Thesis findings in relation to models of insomnia with a focus on stress-
diathesis   
The overall findings of the thesis show greater levels of support for the 
Spielman 3P model of insomnia (Spielman et al., 1987; Spielman & Glovinsky, 
1991; Spielman et al., 1996). This is explained further in the following section. 
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7.3.1. Cano-Saper rodent model of insomnia 
The Cano-Saper animal model of insomnia (Cano et al., 2008) is a model where 
stress is induced by placing a male rat, at the peak phase of their sleep, into a dirty 
cage which had been occupied by another male rat for a period of one week. Due to 
the territorial nature of rats, this cage exchange acted as a stressor. Rats who 
experienced the cage exchange displayed a higher percentage of wake and a 
decreased percentage of NREM sleep, both in the initial two-hour period following 
the stressor and in a second two-hour period measured five and six hours following 
the stressor, analogous to a period of acute insomnia. Cage exchange rats also took 
twice as long to get to sleep than control rats and showed a reduced percentage of 
REM sleep. This was the case in the first and second hours after the cage exchange, 
indicating a stress response and five and six hours afterwards, analogous to a period 
of acute insomnia. The cage exchange rats also displayed almost double the sleep 
latency than control rats, showing a mean sleep latency of 58.7 minutes compared to 
a control group duration of 31.8 minutes. There were no differences in NREM bouts, 
but cage exchange rats also showed a reduced percentage of REM sleep. Cage 
exchange rats also showed higher levels of sleep fragmentation, observed through 
fewer transitions from NREM to REM sleep and a greater amount of transitions to 
wakefulness. The study also examined neuronal activity by measuring the expression 
of Fos proteins, showing an increase in Fos levels in the caudal mp-PVH, an area 
which contains CRH. Importantly, this indicated that the cage exchange procedure 
affected objective sleep and increased HPA axis activity. 
  In Study 2 of the thesis, the anticipation of stress did have an effect upon the 
HPA axis, as reflected in the CAR peak change measured on the second morning. 
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This indicated that the anticipation of the stressor led to an increased CAR and also a 
steeper peak change in cortisol levels during the CAR period. Conversely, the 
anticipation of stress did not affect objective sleep. However, the assumed 
mechanisms within the Cano-Saper model of insomnia are where the stressor 
impacts upon high-frequency EEG activity (Perlis et al., 2011) relating to gross 
changes in sleep EEG. Although the effects of stress upon high-frequency EEG were 
not assessed in Study 2 we expected at least some gross EEG changes to be apparent. 
One explanation for the disparity in findings rests on the fact of extrapolating from 
animal to human models. Furthermore, the thesis showed that anticipation of stress 
disrupted subjective sleep, whereas the Cano-Saper model cannot take subjective 
sleep disturbances or the element of anticipation reported into account.  Based on the 
findings of the cage-exchange study, Cano and colleagues believe that the effects of 
the stressor reflect an inability to inhibit wakefulness instead of an inability to sleep 
(Cano et al., 2008).  
However, within Study 2 the effects of anticipation did not affect objective 
sleep and only affected subjective total sleep time, where anticipation led to a 
reduced total sleep time compared to a two-week habitual baseline period. This 
instead indicates that the anticipation of stress does not lead to an inability to inhibit 
wakefulness but instead potentially indicates that stress causes a perceived inability 
to sleep. That said, this discrepancy may arise from the extrapolation of the animal 
model to humans. The ability to translate this animal model to humans may be 
improved by employing neuroimaging methods in order to examine regionally-
specific brain activity in relation to the anticipation of an upcoming stressor. 
Additionally, quantitative EEG could be employed in order to examine whether 
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high-frequency activity is affected by the anticipation of stress in humans, employing 
the protocol used within Study 2. 
 
7.3.2. Spielman 3P model of insomnia  
The Spielman 3P model of insomnia (Spielman et al., 1987; Spielman & 
Glovinsky, 1991; Spielman et al., 1996) frames insomnia in terms of 3Ps: 
predisposing factors, precipitating factors and perpetuating factors.  Within the 
context of the 3P model, Study 2 acted as a precipitating event by introducing stress, 
where the effects of anticipation alone affected subjective sleep and also affected the 
CAR. As there appeared to be a high variability in the individual response to the 
anticipation, as shown in the CAR and in cortisol levels throughout the full day (Day 
2) spent within the laboratory, further work will be needed in order to understand 
how predisposing factors, such as the underlying genetic differences or 
psychological factors, such as the tendency to excessively worry to ruminate (Perlis 
et al., 2011; Spielman & Glovinsky, 1991; Spielman et al., 1996), can influence the 
extent to which anticipation can affect sleep. Additionally, the findings of the thesis 
offer a greater level of support for the Spielman 3P model than the Cano-Saper 
model. The results of the thesis are compatible with the sleep/stress switch point 
aspect of the model, where the anticipation of the upcoming stressor can result in an 
individual going beyond their threshold, or ‘sleep/stress switch point’, in terms of the 
insomnia. The most important finding from the thesis, in relation to the Spielman 3P 
model, is that the results of Study 2 suggest that the precipitating factor of the model 
can also include the anticipation of stress rather than the stressful experience itself. 
As the Spielman 3P model currently frames the precipitating factor as being a 
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stressor, in terms of a stressful event, rather than the anticipation of stress, the 
following section adapts the 3P model to reflect the findings of the thesis. 
 
7.4. Proposed adaptation of Spielman 3P model 
The proposed adaptation of the Spielman 3P model, based on the findings of 
the thesis, suggests that the precipitating factor can be either the anticipation of stress 
or the experience of stress. This was shown in Study 2 as the anticipation of stress, 
where participants believed that they would experience a series of demanding tasks 
at multiple time points during the following day, disrupted subjective sleep. This 
stress also resulted in HPA axis activation where the CAR peak change was steeper 
compared to a control group who followed the same protocol in the absence of 
stress. Within the adapted 3P model, the anticipation of stress, whether this is 
positive or negative in nature and whether this is accompanied by the resulting 
demand or not, can be considered to be a precipitating factor, where this is 
accompanied by HPA axis activation.. The anticipation of stress then interacts with 
the predisposing factors and pushes the individual above the insomnia threshold (i.e. 
the sleep/stress switch point) at the acute insomnia stage of the model. The 
perpetuating factors are identical to the original model, where the individual employs 
the behaviours described in an attempt to lessen the impact of the precipitant factor.  
The hypothetical example provided by Spielman & Glovinsky (1991), where 
a young man receives a job promotion, can also be framed in terms of the thesis 
findings. In the example provided by Spielman & Glovinsky (1991) state that the 
stress of the young man receiving a job promotion (the precipitating event) results in 
a higher level of scrutiny, provoking the development of an anxiety state and pushing 
245 
 
the individual over the threshold for insomnia. The individual tries to cope by 
recouping the lost sleep at the weekend (perpetuating factors). As the thesis has 
shown that it is the anticipation of the precipitant factor which can disrupt sleep, the 
anticipation of the job promotion and the anticipation of the increased scrutiny result 
in the precipitating factor, which is the response to the anticipated stress. This 
interacts with the predisposing factors and pushes the young man over the insomnia 
threshold. The demand of the new job further adds to the poor sleep. At the next 
stage of the model, the anticipation of the stress has subsided and the young man 
attempts to compensate with the perpetuating factors as in the original model.  
 
7.4.1. Associated implications for practice 
The findings of the thesis have implications in terms of practice. Within the 
context of the adapted 3P model, it is the anticipation of stress which interacts with 
the predisposing factors which pushes the individual above the insomnia threshold 
potentially resulting in the secondary physiological response in terms of the CAR. 
The results from the current thesis also indicate that it is the anticipation of a 
forthcoming stressful event rather than the frequency or the valence of a stressful 
event, which is important in evoking the physiological response shown in the CAR. 
Previous research has examined life events within insomnia. Healey and colleagues 
(Healey et al., 1981) reported that during the year in which they developed a sleep 
problem, individuals reported that they had experienced a greater number of stressful 
life events in comparison to good sleepers and also reported a greater number of 
negative events. In a separate study, Bastien and colleagues (Bastien et al., 2004) 
reported that where individuals with insomnia reported a precipitating event 
associated with the onset of the sleep disturbance, 65% of these were negative. The 
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findings of the thesis indicate that the anticipation of stress, and not just the stressful 
event itself or the frequency or greater accumulation of stressful events, which 
results in a sleep disturbance.  It is possible that by attempting to reduce the 
disruptive effect of anticipation, this will prevent the individual from reaching the 
threshold for insomnia.  
It is possible that therapeutic methods might be employed to reduce the 
impact of the response in those ‘at risk’ of sleep disturbances in order to reduce the 
impact of anticipation and reduce the risk of the individual reaching the insomnia 
threshold. This potentially shifts the focus away from the treatment of the insomnia 
to the prevention of insomnia, focusing on primary prevention rather than secondary 
treatment. Such an approach may complement existing non-pharmacological 
treatments for insomnia which incorporate stress management techniques, 
specifically cognitive-behavioural therapy for insomnia (CBT-I). CBT-I consists of 
behavioural components, cognitive components and recommendations which 
integrate both components, focussing on sleep education (Manber et al., 2011). 
Methods for lessening the impact of anticipation may include stress reduction 
strategies or coping strategies. As participants within Study 2 felt significantly more 
mentally alert in bed during the night before they believed they would complete a 
range of demanding tasks (i.e. when anticipating the stressor within Study 2), it is 
possible that such strategies may be effective at this point. Harvey & Payne (Harvey 
& Payne, 2002) tested the effects of a pre-sleep imagery distraction task within a 
group of individuals with insomnia, in which they were instructed to imagine an 
interesting, engaging, pleasant and relaxing situation. The individuals who were 
given the imagery distraction task showed a shorter subjective SOL than the group 
without instructions. It is possible that such a strategy may reduce the impact of 
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anticipation within normal sleepers and it should be examined whether this results in 
subsequent effects upon the CAR during the following morning,  Additionally, such 
an approach could aim to reduce catastrophising, as individuals with insomnia show 
the tendency to catastrophise (Harvey & Greenall, 2003). As the anticipation of 
stress also affected the CAR, where the anticipation of stress led to greater cortisol 
levels over the CAR period and a steeper peak change in the CAR compared to a 
two-week baseline period, future research should examine whether the CAR reflects 
the degree of sleep disturbance associated with the anticipation of stress. Combined 
with the potential treatment options described above, future work should determine 
whether these indices of the CAR can be used as a marker of therapeutic efficacy. 
 
7.4.2. Associated implications for policy 
The thesis findings also have implications with regards to policy. As the results 
show that the anticipation of stress can disrupt sleep, the focus of insomnia should 
turn to prevention, using methods such as coping strategies or distraction techniques, 
in addition to the secondary treatment of the insomnia disorder. Aiming to prevent 
the insomnia occurring in the first place through treatments designed to lessen 
anticipation may be cost-effective, given that the cost of prescribing z-hypnotics 
(zaleplon, zolpidem and zopiclone) and benzodiazepine hypnotic drugs cost 
approximately £12 million and £18 million over the 12-month period from March 
2007 to March 2008 (National Institute for Clinical Excellence, 2008).  
The prevention of insomnia may also be cost-effective if this was able to reduce 
the associated economic impact, since individuals with insomnia show double the 
rate of absenteeism from work compared to good sleepers (Leger et al., 2006), that 
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insomnia is a predictor of long-term sick leave (Sivertsen et al., 2009b) and that the 
costs of insomnia are typically burdened by the employer (Godet-Cayre et al., 2006).   
The results of the thesis may also have implications with regards to policy 
regarding populations such as caregivers. As anticipation can affect subjective sleep, 
it is possible that where a caregiver anticipates a stressful event as a result of a policy 
change, they may exhibit disrupted sleep. It may be the case that caregivers have a 
greater susceptibility to anticipation, compared to a non-caregiver, due to chronic 
stress exhibited with caregiving, meaning that they would be more likely to cross the 
insomnia threshold. Caregivers for children with autism or attention deficit 
hyperactivity disorder have been shown to exhibit greater levels of psychological 
distress compared to non-caregiver parent controls (Lovell, Moss, & Wetherell, 
2012)  and elderly spousal caregivers of individuals with dementia have shown 
increased levels of psychological distress, in turn related to HPA axis activity, 
compared to controls (Vedhara et al., 1999). Therefore, in order to reduce the 
disruptive effects of anticipation of a policy change upon sleep, if shown to be 
effective, the primary prevention strategies outlined in the previous section should be 
disseminated to these populations. 
 
 
7.5. Additional contributions to the CAR literature 
The current thesis also contributes to the CAR literature. The protocol outlined 
for measurement of the CAR in the thesis has the potential be used within other 
populations within a sleep medicine framework in order to examine HPA axis 
function, including within individuals with insomnia (Elder et al., 2014). A further 
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contribution of the thesis to the CAR literature is regarding the relationship between 
the CAR and sleep. The secretion of cortisol follows the circadian rhythm  (Morris et 
al., 2012), pointing towards a potential role of sleep, however where the relationship 
between subjective sleep and the CAR had been assessed, the findings have been 
inconsistent. The results of the thesis add to the CAR literature in two ways, a) by 
informing the relationship between the CAR and sleep, measured subjectively and 
objectively, in a highly-controlled manner and b) by confirming that the CAR is a 
primarily a marker of anticipation, with a potential secondary role as a marker of 
demand. Study 1 showed that the subjective number of awakenings and that certain 
measures of objective sleep architecture were associated with the CAR, with lower 
awakening cortisol levels showing an association with a greater percentage of Stage 
2 sleep and where the peak change showed an association with a greater latency to 
REM sleep. These results potentially indicated that the CAR may have an 
involvement within memory consolidation, since Stage 2 sleep may enhance 
memory consolidation either individually or in conjunction with REM and SWS 
(Marshall & Born, 2007) or that it may specifically support emotional memory 
consolidation (Diekelmann et al., 2009). A further possibility is that relationship 
may have represented the effects of emotional regulation upon the CAR 
(Vandekerckhove & Cluydts, 2010).  
Study 2 provided strong evidence that the CAR is a marker of anticipation, 
reflecting the anticipation of forthcoming demands. This was shown within Study 2 
as participants who expected to complete a full day of demanding tasks, 
experiencing anticipation, displayed a steeper CAR with higher levels of cortisol 
during the CAR period, compared to a control group, within the context of a 
standardised protocol with extremely high levels over the CAR. This adds to 
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previous preliminary evidence showing that the CAR is a marker of anticipation , in 
terms of awakening levels (Filaire et al., 2001; Rohleder et al., 2007) and cortisol 
levels 30 minutes post-awakening (Filaire et al., 2009; Filaire et al., 2007). The 
results of the thesis also indicate that the CAR may have a secondary adaptive role 
regarding demand, as the CAR measured on the morning after the experimental 
manipulation within Study 2 indicated that individuals who had experienced 
anticipation where this was met by demand showed a subjectively steeper and more 
sustained CAR compared to participants who had experienced anticipation only. 
This indicated that the CAR may have a secondary role as a marker of adaptation 
and builds on other work showing that the CAR may have a role in recovery, where 
subjective feelings of loneliness, sadness, threat and a lack of control prior to 
bedtime, in older adults, were associated with a greater CAR displayed on the 
following morning (E. K. Adam et al., 2006). As discussed in the previous section, if 
the CAR can objectively indicate the extent to which sleep is disrupted by the 
anticipation of stress, then this has implications for practice, since the CAR could 
potentially be used as a marker of therapeutic efficacy. 
 
7.6. General strengths and limitations of the thesis 
The major strength of the thesis is that the effects of stress upon sleep were 
measured using a standard protocol, specifically developed for this purpose. 
Specifically, the protocol enabled the effects of anticipation upon sleep to be teased 
apart from the effects of anticipation where this was met by subsequent demand. In 
addition, the thesis included a physiological marker of stress, through the inclusion 
of cortisol as a marker of HPA axis function. The development and use of the 
protocol is a particular strength of the thesis, since this has specifically allowed the 
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effects of anticipation where this has not been met with demand to be teased apart 
from the effects of anticipation where this has been met with demand.  
The inclusion of the CAR as a marker of HPA axis activity is a specific 
strength of the thesis as previous stress studies have tended not to include a 
physiological marker of stress, meaning that it cannot be confirmed that the stressor 
reliably elicits stress. A further strength is in the nature of the demanding tasks used 
within Study 2, which were shown to reliably elicit stress.  
In addition to the IGT and modified Stroop tasks, which were designed to 
induce uncertainty, participants completed the MTF at seven points throughout the 
day. The MTF is a task which is representative of everyday demanding situations 
and has been shown to elicit stress with corresponding physiological and 
psychological responses (Wetherell & Carter, in press).  Due to the development of 
the standard protocol, the use of this protocol in the measurement of stress upon 
sleep resulted in two important findings. The first important finding was that it is the 
anticipation of a stressor alone which can disrupt subjective sleep and the second 
important finding is with regards to the CAR, providing strong evidence that this 
functions as a marker of anticipation.   
There are potential general limitations within the thesis, however these are 
not likely to have impacted the overall findings and in some cases are major 
strengths of the design. One potential limitation is within the homogenous nature of 
participants included within Study 1 and Study 2, since participants were generally 
young adults drawn from a university staff and/or student population. However, this 
potential limitation is actually a particular strength of the thesis. Ellis and colleagues 
(Ellis, Perlis, Bastien, Gardani, & Espie, 2014) have previously demonstrated that 
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the mean age of onset of acute insomnia occurs at  approximately 33 years of age. As 
the population included within Study 1 and Study 2 were relatively young, with a 
mean participant age of approximately 23 years within Study 1 and Study 2, it is 
therefore an advantage that participants were assessed in each study prior to the 
onset of any sleep disturbances.  
Whilst future research could examine potential differential effects of age 
upon the anticipation of stress, potentially within children or older adults, this was 
beyond the scope of the thesis. A further potential limitation is with regards to 
power. Whilst the sample size employed within Study 2 was relatively small, 
significant findings were observed regarding the effects of anticipation upon 
subjective sleep and it is possible that an increased sample size may have increased 
the observed effects.   
A further potential limitation is that any night-to-night variability in sleep and 
the CAR was unable to be taken into consideration within Study 1, which assessed 
the relationship between sleep and the CAR in the absence of stress, or within Study 
2, which assessed the effects of anticipation, where this was either met or not met 
with subsequent demand, upon sleep and the CAR. However, there is currently no 
standard protocol for measuring sleep and the CAR other than the protocol outlined 
within the thesis and Study 1 showed that subjective sleep, objective sleep and the 
CAR were temporally stable between nights. Therefore, this is unlikely to have 
adversely impacted upon the results of the thesis.  One potential solution would be to 
extend the protocol in order to examine the night-to-night variability within sleep 
and the CAR over multiple consecutive nights and mornings and indeed 
Wohlegemuth and colleagues (Wohlgemuth, Edinger, Fins, & Sullivan, 1999) 
suggest that up to fourteen consecutive nights of PSG might be necessary in order to 
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obtain stable objective sleep data. In the case of the CAR, Hellhammer and 
colleagues suggest that the CAR should be collected over six consecutive days are 
needed to reduce the impact of trait measures (Hellhammer et al., 2007). However 
this was in the case of home CAR measurements and the laboratory environment 
employed within Study 2 afforded an extremely high level of control over factors 
known to affect the CAR, including light. Additionally, for practical reasons it was 
not feasible to extend the protocol employed within the thesis beyond the current 
period. Whilst this limitation does offer an opportunity for future research, it is not 
likely to have impacted upon the results of the thesis.   
A final potential limitation is that within Study 1 and Study 2, participants 
were allowed to sleep in the laboratory in accordance with their routine sleep/wake 
schedule and were not instructed to adhere to a pre-determined awakening time. This 
could be considered a limitation as this more accurately models a non-work day 
scenario where individuals are relatively free to follow their own sleep/wake 
schedule, rather than a work day where sleep/wake schedules are socially determined 
(i.e. by work). However, in the absence of a standard protocol for measuring sleep, 
stress and the CAR within the same context, and in the absence of a prior 
understanding of how sleep and the CAR relate to each other within the context of a 
relatively free sleep/wake schedule, it was beyond the scope of the thesis to examine 
this. This was also not possible due to practical reasons. Future studies could use the 
protocol employed within the thesis in order to examine if a pre-determined 
sleep/wake schedule increases the impact of anticipation upon sleep and the CAR.   
 
7.7. Future directions 
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7.7.1. Timing of stress 
One way in which the thesis could be extended could be to vary the timing of 
the stressor. Whilst the thesis showed that the anticipation of stress affected 
subjective sleep and HPA axis activity in terms of the CAR, participants anticipated 
stress at a specific time point in advance (i.e. on Day 2 of the study). As the results 
of the thesis have shown that the anticipation of a stressor at a specific time can 
disrupt sleep and the CAR, one potential future direction would be to employ the 
standard protocol and extend this over a period of multiple days. This would allow 
the protocol to examine whether the effects of anticipation of a stressor at an 
unspecified time point are greater than the effects of anticipation at a pre-determined 
time point and to examine the subsequent effects upon the CAR.  
 
7.7.2. Predisposing factors 
The main future direction for research is to examine individual predictors of 
the extent to which the anticipation of stress disrupts sleep. Research examining 
individual predictors has, to date, the response to sleep disturbances, but has not 
specifically examined how these affect the anticipation of stress.  Drake and 
colleagues examined the response to stress, where participants completed the FIRST 
questionnaire, assessing the likelihood of experiencing sleep disturbances in 
response to stressful situations. Participants were split into a low and high 
vulnerability group on the basis of the FIRST scores and the high vulnerability group 
showed objective sleep disruptions to the first night spent within a sleep laboratory, 
even after controlling for a history of insomnia symptoms. Those with high FIRST 
scores reported insomnia to be more common (Drake et al., 2004). Where Drake and 
colleagues examined how these factors can influence the response to stress and 
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suggest that there are individual factors influencing the response, it will be necessary 
to examine how these factors affect the impact of anticipation.   
In the context of the original 3P model of insomnia (Spielman et al., 1987; 
Spielman & Glovinsky, 1991; Spielman et al., 1996), Study 2 examined the impact 
of the precipitating event in by examining the effects of stress upon sleep. In the 
context of the 3P model, this suggests instead that the anticipation of stress affects 
sleep, interacts with predisposing factors and subsequently pushes the individual 
over the insomnia threshold. It is possible that there are individual variations in the 
degree to which anticipation disturbs sleep, potentially driven by predisposing 
factors.  
One future direction would be to investigate the extent to which personality 
variables moderate the effects of the anticipation upon subjective sleep and the CAR. 
It has previously been shown that within a study of normal sleepers, perfectionism 
showed a relationship with the perceived severity of sleeping problems and also with 
higher levels of concern regarding the negative consequences of the sleeping 
problem (Lundh et al., 1994). A group of insomnia patients displayed higher levels 
of perfectionism than normal sleepers (Lundh et al., 1994) and associations, albeit 
weak, have been shown in another study (Jansson-Fröjmark & Linton, 2007). One 
approach would be to examine how individuals with high or low levels of 
perfectionism and assess the approach of the anticipation of a stressor upon 
subjective sleep, objective sleep and HPA axis activity. Similarly, other relevant 
personality traits which may be investigated could include neuroticism (van de Laar 
et al., 2010). 
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Another approach would be to examine potential genetic influences and 
examine how these interact with the anticipation of stress. Within adults, twin 
genetic studies have shown that insomnia does appear to be heritable (Barclay & 
Gregory, 2013). Similarly, there is also scope for genetic factors being a 
predisposition towards insomnia within the Spielman 3P model (Spielman et al., 
1987; Spielman & Glovinsky, 1991; Spielman et al., 1996).  Genetic influences are 
also relevant to cortisol, used in the thesis as a marker of HPA axis activation, since 
a meta-analysis of 1,686 study participants showed that individuals who were 
homozygous carriers for the serotonin transporter linked promoter region (5-
HTTLPR) gene short allele displayed increased levels of salivary cortisol secretion 
in response to psychosocial stress paradigms than individuals with either short/long 
or long/long genotypes  (R. Miller, Wankerl, Stalder, Kirschbaum, & Alexander, 
2013). Within the context of the hyperarousal model of insomnia, Riemann and 
colleagues (Riemann et al., 2010) speculate that the vulnerability towards insomnia 
may be inherited genetically.  One stress study has examined the relationship 
between 5-HTTLPR, sleep and stress in a sample of dementia caregivers and non-
caregiver control participants (Brummett et al., 2007).  Dementia caregivers rated 
their sleep quality as being poorer than controls, Whilst there was no direct effect of 
the 5-HTTLPR genotype on sleep quality, there was an interaction between genetics, 
sleep and stress, where dementia caregivers who had the short allele of the 5-
HTTLPR showed the poorest sleep quality compared to controls.  Taken together, 
the influence of genetics should be explored in relation to the effects of stress upon 
sleep and the CAR and this represents one promising approach for future research. 
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7.8. Conclusions 
This thesis has examined the effects of stress upon subjective sleep, objective 
sleep and the CAR. This was done through the development of a standard protocol 
where the effects of anticipation upon sleep and the CAR, where this was either met 
by subsequent demand or not met by subsequent demand, were measured. Overall, 
the anticipation of stress can disrupt very specific aspects of sleep and the HPA axis 
functioning. As a consequence it is proposed that the Spielman 3P model frames the 
anticipation of stress as an additional precipitating factor. The thesis has also shown 
that the CAR primarily appears to function as a marker of anticipation with a 
potential secondary role as a marker of demand. The findings of the thesis have 
implications for practice, since interventions should primarily target potential 
disruptive effects of anticipation, with secondary treatment upon the resulting sleep 
disturbance, using methods such as coping strategies. The findings of the thesis also 
have implications for policy and are relevant to groups such as caregivers, since the 
anticipation of forthcoming event may result in a sleep disturbance. The findings of 
the thesis suggest that one future direction is to examine the influence of 
predisposing factors upon the anticipation of stress. These predisposing factors 
include variables such as neuroticism, perfectionism and genetic variables, including 
the effects of the 5HTTLPR gene. By understanding how the predisposing factors 
relate to the disruptive effects of anticipation, this will further the understanding of 
the sleep/stress switch point. 
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Appendix A  
Example screening questionnaire used in the feasibility study, Study 1 and Study 2 
 
                
Screening Questionnaire 
 
 
Date:_______                 
Name of potential participant:________________________________________ 
 
 
 
 
 
Please answer the following questions so that it can be determined whether or 
not you meet the criteria to take part in this study. 
1. SLEEP DIFFICULTIES 
Have you ever had a sleep problem:     __Yes   __No (If no go to section 2) 
 
If yes, Is this an ongoing problem at the moment?    __Yes   __No 
How long have you had the sleep problem or how long did it last?  _____Years  
_____Months 
What is the nature of your sleep problem? 
 
Getting off to sleep / Staying Asleep / Waking too early / Feeling unrefreshed on 
waking / Sleeping at odd times / Excessive daytime sleepiness 
 
 
2. OTHER SLEEP/WAKE DISORDERS  
Have you travelled over three time zones in the last six months?   __Yes  __No 
Have you or your spouse/bed partner ever noticed one of the following in the last 
month:  
A. RESTLESS LEGS: Crawling or aching feelings in the legs (calf) and  
         inability to keep legs still;                                                                                                    
__Yes  __No 
B. PERIODIC LEG MOVEMENTS:  Leg twitches or jerks during the night;               
__Yes  __No  
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C.  APNOEA: Snoring, pauses in breathing at night, short of breath, chocking  
 at night; morning headaches, chest pain, dry mouth;                                                      
__Yes  __No 
D. NARCOLEPSY: Sleep attacks, sleep paralysis, hyp. hall., cataplexy;                       
__Yes  __No 
E. GASTRO-ESOPHAGEAL REFLUX:  Sour taste in mouth, heart burn; reflux;       
__Yes  __No 
F. PARASOMNIAS: Nightmares, night terrors, sleep walking, sleep talking;              
__Yes  __No 
G. SHIFT WORK DISORDER: Rotating work patterns 
 __Yes  __No 
 
3. NATURE OF SLEEP/WAKE DIFFICULTY 
How much sleep do you think you need to function during the day ____Hours 
____Minutes 
How much sleep do you get on a typical weekday _____Hours ____Minutes 
How much sleep do you get on a typical weekend _____Hours ____Minutes 
 4. GENERAL HEALTH
Do you consider yourself to be in good health?  __Yes   __No 
Do you suffer from an ongoing illness (e.g. Asthma or Diabetes?)   __Yes   __No 
If yes, could you specify? 
_________________________________________________________________________________ 
Are you currently on any medication?    __Yes   __No  
 
-If yes, what, and at what 
dose__________________________________________________________________________                   
 
Have you suffered a head injury?    __Yes __No 
Do you have a history or current complaint of depression or anxiety ___Yes ___No 
 
5. DEMOGRAPHICS 
Address:___________________________________________________________________________
____________________________________________________________________________________
________________________________ 
 
Post code:________________________ E-mail-
address:________________________________________________ 
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Telephone: _______________________ Mobile 
phone:_______________________________________ 
 
Preferable time for future contact (check one):   Morning __         Afternoon __         
Evening __ 
 
Date of birth:_______________            Age:________     Gender:   Male__                  
Female__ 
 
I agree to be contacted in the future from the Northumbria Centre for Sleep Research?           
__Yes __No 
 
 
-What would be your preferred medium to receive the questionnaires, sleep diaries 
and more information regarding this study?               __Online (internet access)           
__Hard copies 
 
 
 
 
 
 
Now please e-mail this questionnaire back to greg.elder@northumbria.ac.uk so that 
your eligibility to take part in the study can be assessed. Once you have done this the 
researcher will be in touch with you shortly.  Please send any questions to the same e-
mail address.  
 
 
 
Thank you for your time!  
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Appendix B 
Pittsburgh Sleep Quality Index 
 
 
 
 
 
 
 
 
1. During the past month, when have you usually gone to bed at night? 
USUAL BED TIME: _____________________ 
(i. e. 10pm or 22.00) 
 
2. During the past month, how long (in minutes) has it usually taken you to fall asleep 
each night? 
 
NUMBER OF MINUTES: ________________ 
 
2b. How long have you usually been awake during the night? 
 
    NUMBER OF MINUTES: ________________ 
 
3. During the past month, when have you usually got up in the morning? 
 
    USUAL GETTING UP TIME: _____________ 
 
4.  During the past month, how many hours of actual sleep did you get at night?  This 
may be different to the number of hours you spend in bed. 
 
    HOURS OF SLEEP PER NIGHT: __________ 
 
4b. How many nights per week do you usually have difficulties sleeping? 
 
    NUMBER OF NIGHTS PER WEEK: _______ 
 
5. During the past month, how often have you had trouble sleeping because you: 
 
  Not during 
the past 
month 
Less than 
once a week 
Once or 
twice a 
week 
Three or 
more times 
a week 
(a) Cannot get to sleep within 30 
minutes 
    
(b) Wake up in the middle of the 
night or early morning 
    
(c) Have to get up and use the      
(A) The following questions relate to your usual sleep habits during the past month 
only.  Your answers should indicate the most accurate reply for the majority of days and 
nights in the past month. 
 
Please answer all the questions. 
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bathroom 
 
 reason(s), please describe: ______________________________________________ 
 
How often during the past month have you had trouble sleeping because of this? 
[  ] Not during the past month 
[  ] Less than once a week 
[  ] Once or twice a week 
[  ] Three or more times a week 
 
6. During the past month, how would you rate your sleep quality overall? 
 
[  ] Very good 
[  ] Fairly good 
[  ] Fairly bad 
[  ] Very Bad 
 
7. During the past month, how often have you taken mediĐiŶe ;presĐriďed or ͚oǀer the 
ĐouŶter͛Ϳ to help you sleep? 
 
[  ] Not during the past month 
[  ] Less than once a week 
[  ] Once or twice a week 
[  ] Three or more times a week 
 
8. During the past month, how often have you had trouble staying awake while driving, 
eating meals or engaging in social activity? 
 
[  ] Not during the past month 
[  ] Less than once a week 
[  ] Once or twice a week 
[  ] Three or more times a week 
 
9. During the past month, how much of a problem has it been for you to keep up enough  
enthusiasm to get things done? 
 
[  ] No problem at all 
[  ] Only a very slight problem 
[  ] Somewhat of a problem 
[  ] A very big problem 
 
10. Do you have a bed partner or room-mate? 
  Not during 
the past 
month 
Less than 
once a week 
Once or 
twice a 
week 
Three or 
more times 
a week 
(e) Cough or snore loudly     
(f) Feel too cold     
(g) Feel too hot     
(h) Had bad dreams     
(i) Have pain     
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[  ] No bedroom partner or room-mate 
[  ] Partner/ room-mate in other room 
[  ] Partner in same room, but not same bed 
[  ] Partner in same bed 
 
If you have a room-mate or bed partner, ask him/ her how often in the past month you 
have had: 
 
(a) Loud snoring 
 
[  ] Not during the past month 
[  ] Less than once a week 
[  ] Once or twice a week 
[  ] Three or more times a week 
 
(b) Long pauses between breaths while asleep 
 
[  ] Not during the past month 
[  ] Less than once a week 
[  ] Once or twice a week 
[  ] Three or more times a week 
 
(c) Legs twitching or jerking while you sleep 
 
[  ] Not during the past month 
[  ] Less than once a week 
[  ] Once or twice a week 
[  ] Three or more times a week 
 
(d) Episodes of disorientation or confusion during sleep 
 
[  ] Not during the past month 
[  ] Less than once a week 
[  ] Once or twice a week 
[  ] Three or more times a week 
 
(e) Other restlessness while you sleep; please describe  
__________________________________________________________________________________
________________________________________________________ 
 
[  ] Not during the past month 
[  ] Less than once a week 
[  ] Once or twice a week 
[  ] Three or more times a week 
  
310 
 
Appendix C 
Perceived Stress Scale 
 
 
 
 
 
 
 
 
 
In the last month, how often have you been upset 
because of something that happened 
unexpectedly?   1   2   3   4   5     
In the last month, how often have you felt that 
you were unable to control the important things 
in your life?   1   2   3   4   5     
In the last month, how often have you felt 
nervous and stressed?   1   2   3   4   5     
In the last month, how often have you dealt with 
irritating life hassles?   1   2   3   4   5     
In the last month, how often have you felt that 
you were effectively coping with important 
changes that were occurring in your life?   1   2   3   4   5     
In the last month, how often have you felt 
confident about your ability to handle your 
personal problems?   1   2   3   4   5     
In the last month, how often have you felt that 
things were going your way?   1   2   3   4   5     
In the last month, how often have you found that 
you could not cope with all the things you had to 
do? 
  
1   2   3   4   5     
In the last month, how often have you been able 
to control irritations in your life?   1   2   3   4   5     
In the last month, how often have you felt that 
you were on top of things?   1   2   3   4   5     
In the last month, how often have you been 
angered because of things that happened that 
were outside of your control? 
  
1   2   3   4   5     
In the last month, how often have you found 
yourself thinking about things that you have to 
accomplish? 
  
1   2   3   4   5     
In the last month, how often have you been able 
to control the way you spend your time? 
  
1   2   3   4   5     
In the last month, how often have you felt 
difficulties were piling up so high that you could 
not overcome them? 
  
1   2   3   4   5     
             
 
 
2.Almost 3.Some 4.Fairly 5.Very 
 1.Never Never 
 
Times Often Often 
(K) The questions in this scale ask you about your feelings and thoughts during the last 
month. In each case, you will be asked to indicate how often you felt or thought in a 
certain way. Although some of the questions are similar, there are differences between 
them and you should treat each one as a separate question. The best approach is to 
answer each one as a separate question. That is, don't try to count up the number of 
times you felt a particular way, but rather indicate the number that seems like a 
reasonable estimate. Please circle the most appropriate response.                                                
311 
 
Appendix D 
Hospital Anxiety and Depression Scale 
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Appendix E 
Horne-Östberg Morningness-Eveningness Questionnaire  
 
 
 
 
 
 
 
 
 
 
 
1. Considering your own feelings, at what time would you get up if you were entirely free 
to plan your day? 
 
Tiŵe: ……………………………… 
 
2. Considering only your own feelings, at what time would you go to bed if you were 
entirely free to plan your day? 
 
Tiŵe: …………………………….. 
 
3. If there is a specific time you have to get up in the morning, to what extent are you 
dependent on being woken up by an alarm clock? 
 
a. Not at all dependent [ ] 
b. Slightly dependent [ ] 
c. Fairly dependent [ ] 
d. Very dependent [ ] 
 
4. Assuming adequate environmental conditions, how easy do you find getting up in the 
morning? 
 
a. Not at all easy [ ] 
b. Slightly easy [ ] 
c. Fairly easy [ ] 
d. Very easy [ ] 
 
5. How alert do you feel during the first half hour after having woken in the morning? 
 
a. Not at all alert [ ] 
b. Slightly alert [ ] 
c. Fairly alert [ ] 
d. Very alert [ ] 
 
(L) 
a) Please read each question very carefully before answering. 
b) Answer all questions. 
c) Each question should be answered independently of others. Do NOT go back and 
check your answers. 
d) Please select ONE answer only and respond by checking [x] the most appropriate 
answer. 
e) Please answer each question as honestly as possible. Both your answers and results 
will be kept in strict confidence. 
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6. How is your appetite during the first half hour after having woken in the morning? 
 
a. Not at all good [ ] 
b. Slightly good [ ] 
c. Fairly good [ ] 
d. Very good [ ] 
 
7. During the first half hour after having woken in the morning, how tired do you feel? 
 
a. Very tired [ ] 
b. Slightly tired [ ] 
c. Fairly refreshed [ ] 
d. Very refreshed [ ] 
 
8. When you have no commitments the next day, at what time do you go to bed 
compared to your usual bedtime? 
 
a. Seldom or never later [ ] 
b. Less than one hour later [ ] 
c. 1-2 hours later [ ] 
d. More than 2 hours later [ ] 
 
9. You have decided to engage in some physical exercise. A friend suggests that you do 
this one hour twice a week and the best time for him is between 0700 and 0800h. 
Bearing in mind nothing else but your own inclinations, how do you think you would 
perform? 
 
a. Would be on good form [ ] 
b. Would be on reasonable form [ ] 
c. Would find it difficult [ ] 
d. Would find it very difficult [ ] 
 
 
10. At what time in the evening do you feel tired and in need of sleep? 
 
Tiŵe: ……………………………. 
 
11. You wish to be at your peak for a test which you know is going to be mentally 
exhausting and lasting for two hours. You are entirely free to plan your day, when would 
you do this task? 
 
a. 0800 – 1000 [ ] 
b. 1100 – 1300 [ ] 
c. 1500 – 1700 [ ] 
d. 1900 – 2100 [ ] 
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12. If you went to bed at 2300h at what level of tiredness would you be? 
 
a. Not at all tired [ ] 
b. A little tired [ ] 
c. Fairly tired [ ] 
d. Very tired [ ] 
 
13. For some reason you have gone to bed several hours later than usual, but there is no 
need to get up at any particular time the next morning. Will you: 
 
a. Wake up at the usual time and not go back to sleep [ ] 
b. Wake up at the usual time and doze [ ] 
c. Wake up at the usual time and go back to sleep [ ] 
d. Wake up later than usual [ ] 
 
14. One night you have to remain awake between 0400 and 0600h. You have no 
commitments the next day. Which suits you best: 
 
a. Not to go to bed until 0600h [ ] 
 
b. Nap before 0400h and sleep after 0600h [ ] 
 
c. Sleep before 0400h and nap after 0600h [ ] 
 
d. Sleep before 0400h and remain awake after 0600h [ ] 
 
15. You have to do two hours physical work. Which hours would you prefer to do it 
between: 
 
a. 0800 – 1000 [ ] 
b. 1100 – 1300 [ ] 
c. 1500 – 1700 [ ] 
d. 1900 – 2100 [ ] 
 
16. You have decided to engage in some physical exercise. A friend suggests that you do 
this between 2200 and 2300h twice a week. How do you think you would perform: 
 
a. Would be on good form [ ] 
b. Would be on reasonable form [ ] 
c. Would find it difficult [ ] 
d. Would find it very difficult [ ] 
 
17. Suppose that you can choose your own work hours, but had to work five hours in the 
day. Which five consecutive hours would you choose: 
 
Hours: ……………………………………………. 
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18. At what time of day do you feel your best? 
 
Tiŵe: ………………………………………….. 
 
19. OŶe hears of ͞ŵorŶiŶg͟ aŶd ͞eǀeŶiŶg͟ types. WhiĐh do you ĐoŶsider yourself to ďe? 
 
a. Morning type [ ] 
b. More morning than evening [ ] 
c. More evening than morning [ ] 
d. Evening type [ ] 
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Appendix F 
Ford Insomnia Response to Stress Test 
 
 
 
 
 
 
Before an important meeting the next day 
 
 Not likely Somewhat likely Moderately likely Very likely 
 
After a stressful experience during the day 
 
 Not likely Somewhat likely Moderately likely Very likely 
 
After a stressful experience in the evening 
 
 Not likely Somewhat likely Moderately likely Very likely 
 
After getting bad news during the day 
 
 Not likely Somewhat likely Moderately likely Very likely 
 
After watching a frightening movie or TV show 
 
 Not likely Somewhat likely Moderately likely Very likely 
 
After having a bad day at work 
 
 Not likely Somewhat likely Moderately likely Very likely 
 
After an argument  
 
 Not likely Somewhat likely Moderately likely Very likely 
 
Before having to speak in public 
 
 Not likely Somewhat likely Moderately likely Very likely 
 
Before going on holiday the next day 
 
 Not likely Somewhat likely Moderately likely Very likely 
 
 
  
(M) When you experience the following situations, how likely is it for you to have 
difficulty sleeping? Please circle an answer even if you have not experienced these 
situations recently situations recently. 
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Appendix G 
Perceived Stress Reactivity Scale 
 
 
 
 
 
 
 
 
1. When tasks and duties build up to the extent that they are hard to 
manage...  
 
[ ] I am generally untroubled 
  [ ] I usually feel a little uneasy 
  [ ] I normally get quite nervous 
 
2. When I want to relax after a hard day at work... 
 
[ ] This is usually quite difficult for me 
[ ] I usually succeed 
[ ] I generally have no problem at all 
 
3. When I have conflicts with others that may not be immediately resolves... 
 
[ ] I generally shrug it off 
[ ] It usually affects me a little 
[ ] It usually affects me a lot 
 
4. When I make a mistake... 
 
[ ] In general, I remain confident 
[ ] I sometimes feel unsure about my abilities 
[ ] I often have doubts about my abilities 
 
5. WheŶ I͛ŵ ǁroŶgly ĐritiĐised ďy others... 
 
[ ] I am normally annoyed for a long time 
[ ] I am annoyed for just a short time 
[ ] In general, I am hardly annoyed at all 
 
6. When I argue with other people... 
 
[ ] I usually calm down quickly 
[ ] I usually stay upset for some time 
[ ] It usually takes me a long time until I calm down 
 
7. When I have little time for a job to be done... 
 
[ ] I usually stay calm 
[ ] I usually feel uneasy 
[ ] I usually get quite agitated 
(N) This questionnaire asks about your reactions to situations which you may have 
experienced in the past. Three answers are suggested. Please indicate the answer that 
ŵost Đlosely desĐriďes your oǁŶ reaĐtioŶ iŶ geŶeral. Please doŶ͛t skip aŶy iteŵ, eǀeŶ if 
it may be hard to find the best answer. 
318 
 
 
 
 
8. When I make a mistake... 
 
[ ] I am normally annoyed for a long time  
 [ ] I am normally annoyed for a while 
 [ ] I generally get over it easily 
 
9. When I am unsure what to do or say in a social situation... 
 
[ ] I generally stay cool 
[ ] I often feel warm 
[ ] I often begin to sweat 
 
10. When I have spare time after working hard... 
 
[ ] It often is difficult for me to unwind and relax 
[ ] I usually need some time to unwind properly 
[ ] I am usually able to unwind effectively and forget  
     about the problems of the day 
 
11. When I am criticised by others... 
 
[ ] Important arguments usually come to my mind  
    when it is too late to still make my point  
[ ] I often have difficulty finding a good reply 
[ ] I usually think of a reply to defend myself 
 
12. When something does not go the way I expected... 
 
[ ] I usually stay calm 
[ ] I often get uneasy 
[ ] I usually get very agitated 
 
13. When I do not attain a goal... 
 
[ ] I usually remain annoyed for a long time 
[ ] I am usually disappointed, but recover soon 
[ ] In general, I am hardly concerned at all 
 
14. When others criticise me... 
 
[ ] I geŶerally doŶ͛t lose ĐoŶfideŶĐe at all 
[ ] I generally lose a little confidence 
[ ] I generally feel very unconfident 
 
15. When I fail at something... 
 
[ ] I usually find it hard to accept 
[ ] I usually accept it to some degree 
[ ] In general, I hardly think about it 
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16. When there are too many demands on me at the same time... 
 
[ ] I generally stay calm and do one thing after the other 
  [ ] I usually get uneasy 
  [ ] Usually, even minor interruptions irritate me 
 
17. When others say something incorrect about me... 
 
[ ] I usually get quite upset 
[ ] I normally get a little bit upset 
[ ] In general, I shrug it off 
 
18. When I fail at a task... 
 
[ ] I usually feel very uncomfortable 
[ ] I usually feel somewhat uncomfortable 
[ ] IŶ geŶeral, I doŶ͛t ŵiŶd 
 
19. When I argue with others... 
 
[ ] I usually get very upset 
  [ ] I usually get a little bit upset 
  [ ] I usually doŶ͛t get upset 
 
20. When I am under stress... 
 
[ ] I usually ĐaŶ͛t eŶjoy ŵy leisure tiŵe at all 
[ ] I usually have difficulty enjoying my leisure time 
[ ] I usually enjoy my leisure time 
 
21.  When tasks and duties accumulate to the extent that they are hard to cope 
with... 
 
[ ] My sleep is unaffected 
[ ] My sleep is slightly disturbed 
[ ] My sleep is very disturbed 
 
22. When I have to speak in front of other people... 
 
[ ] I often get very nervous 
[ ] I often get somewhat nervous 
[ ] In general, I stay calm 
 
23. When I have many tasks and duties to fulfil... 
 
[ ] In general, I stay calm 
[ ] I usually get impatient 
[ ] I often get irritable 
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Appendix H 
Example subjective sleep diary  
 
 
 
 
 
SLEEP & MOOD DIARY 
 
 
Instructions: 
This diary is designed to provide a record of how you feel and your experience of sleep. 
Each page relates to your mood and sleep experiences for a particular day. Please complete 
one page each morning, soon after you wake up. Take a few minutes to do this, trying to be 
as accurate as you can. We are interested in how you feel at the time you complete the 
diary It is your best estimate that we are looking for, but try not to get into the habit of 
clockwatching at night. 
 
 
 
Participant Number: 
 
Study title: 
 
Date: 
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Day 1: Please complete today’s date ___ / ___ / _____ 
 MEASURING THE PATTERN OF YOUR SLEEP 
1 What time did you wake this morning? 
  
2 At what time did you rise from bed? 
  
3 At what time did you go to bed last night? 
  
4 Lights Out: At what time did you put the lights out to go to sleep? 
  
5 How long did it take you to fall asleep (minutes)? (After Lights Out) 
  
6 How many times did you wake up during the night? 
  
7 How long were you awake during the night (in total)? 
  
8 About how long did you sleep altogether (hours/mins)? 
  
9 How many sleeping pills did you take to help you sleep? 
  
 MEASURING THE QUALITY OF YOUR SLEEP 
 not at all  moderately  very 
10 How well do you feel this morning? 
 0 1 2 3 4 
11 How enjoyable was your sleep last night? 
 0 1 2 3 4 
12 How mentally alert were you in bed last night? 
 0 1 2 3 4 
13 How physically tense were you in bed last night? 
 0 1 2 3 4 
 
Read each statement then mark on the line at the most appropriate point to indicate  
how you feel right now, at this moment 
 
I feel calm* 
not at all       very much 
 
I feel tense* 
not at all       very much 
 
I am upset* 
not at all       very much 
 
I feel relaxed* 
not at all       very much 
 
I feel content* 
not at all       very much 
 
I feel worried* 
not at all       very much 
 
I feel stressed 
not at all       very much 
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Appendix I 
Diagram of the Northumbria Centre for Sleep Research 
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Appendix J 
Feasibility study – home group saliva sample collection instructions 
 
 
You will go to bed at your usual bedtime, and you will wake at the time you would 
usually wake up on a morning. You will be asked to provide saliva samples 
immediately upon awakening and 15, 30, 45 and 60 minutes after this, including one 
sample early afternoon (before eating lunch) and one before sleeping. This will be 
done by chewing on a dental cotton swab for approximately a minute. For the first 
hour after you wake, you will not be allowed to eat or brush your teeth as this can 
interfere with the measurements we are taking. You will be allowed to drink water. 
You will be required to keep all saliva samples in a household fridge until the 
researcher collects them. 
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Appendix K 
Study 2 written instructions given to all participants prior to sleep on Night 1. 
“On your second day in the sleep lab, you will be required to complete a 
range of mentally demanding computerised tests at regular intervals throughout the 
day and provide four saliva samples. Your performance on each task will be 
carefully monitored and it is very important that you perform as well as you possibly 
can on these tasks. Each task will take between 10 and 20 minutes to complete. 
These tasks will be completed from the moment you wake until you go to bed. We 
will measure your mood before each task, and we will also monitor the amount of 
effort that you are putting into each task. 
Your tests will include a measure of attention, where you have to press the 
coloured key on the computer keyboard corresponding with the letter of the word 
you are shown. It is important that you do this as quickly as you possibly can. 
You will also have to complete a combination of four tasks where you have 
to perform several tasks at once. You will have to complete this as quickly and 
accurately as possible, and you will also need to try to achieve the highest score you 
possibly can. In this task you will be able to see your score, and you should do your 
very best to beat your score each time as you will complete this particular task at 
various points during the day. It is very important that you make sure that you are 
performing all of the tasks to the best of your ability. 
The final task which you will complete is a decision-making card task, and 
again your job is to work out what the rules are, and to achieve as high a score as you 
possibly can. You will have the chance to win an iPad if you achieve the highest 
score on a randomly-selected task.” 
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Appendix L 
Iowa Gambling Task instructions 
 
“.You will be presented with 4 decks of cards and will be asked to choose 
from one at a time. You can choose from any deck and change between decks as you 
see fit. Each time you select a card, the computer will inform you of a change in your 
score. The object of the task is to gain as much money as possible. Some decks will 
help you to achieve this goal better than others. Try and make your decisions as if 
you were using your own money. After you select a card, you must wait 6 seconds to 
select another. Press the SPACE key to begin.” 
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Appendix M 
Study 2 written instructions given to participants in the anticipation alone (AA) 
condition  
 
“You will no longer have to complete the demanding tasks today, and you are 
free to perform other activities in the laboratory. You will still be eligible to win the 
iPad, as everyone who participates in this study will be placed into a random draw 
irrespective of whether or not they have performed the tasks. The details of the study 
you are taking part in are extremely important and crucial to the research questions 
being addressed. For this reason, we kindly ask that you do not discuss the details of 
the study with others beyond the fact that you are taking part in a sleep study where 
your sleep is monitored in the laboratory.  If it apparent that details of the study have 
been discussed we reserve the right to remove your entry into iPad prize.”   
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Appendix N 
Study 2 Day 2 mood diary 
 
Day 2 Mood Diary 1  
(GE_S2_P__T1) 
 
 
Read each statement then mark on the line at the most appropriate point to indicate  
how you feel right now, at this moment 
 
I feel calm* 
not at all       very much 
 
I feel tense* 
not at all       very much 
 
I am upset* 
not at all       very much 
 
I feel relaxed* 
not at all       very much 
 
I feel content* 
not at all       very much 
 
I feel worried* 
not at all       very much 
 
I feel stressed 
not at all       very much 
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Appendix O 
NASA-TLX 
Please mark each line at the point which matches your experience of the test you 
have just completed. 
 
A) MENTAL DEMAND – How much mental demand and perceptual activity was 
required (thinking, deciding, calculating, remembering, looking etc)?  Was your task 
easy or demanding, simple or complex? 
 
Low         High 
 
B) PHYSICAL DEMAND – How much physical activity was required (pulling, turning, 
controlling activating etc)?  Was your task easy or demanding, slow or brisk, slack or 
strenuous, restful or laborious? 
 
Low         High 
 
C) TEMPORAL DEMAND – How much time pressure did you feel due to the rate of 
the task? Was the pace slow and leisurely or rapid and frantic? 
 
Low         High 
 
D) EFFORT – How hard did you have to work, mentally and physically, to achieve 
your level of performance? 
 
Low         High 
 
E) PERFORMANCE – How successful do you think you were in performing the tests?  
How satisfied were you with your performance ? 
 
Poor         Good 
 
F) FRUSTRATION – How insecure, discouraged, irritated, stressed and annoyed 
versus secure, gratified, content, relaxed and complacent did you feel? 
 
Low         High 
  
329 
 
Appendix P 
Feasibility study (laboratory participants) and Study 1 participant information sheet 
 PARTICIPANT INFORMATION. 
 
 
TITLE OF PROJECT: Measuring the cortisol awakening response in good sleepers 
within a controlled sleep environment  
 
Participant ID Number:   
 
Principal Investigator: Greg Elder 
 
Investigator contact details: 
Northumbria Centre for Sleep Research, NB408 Northumberland Building,  
Northumbria University NE1 8ST 
Email: greg.elder@northumbria.ac.uk 
 
This project is funded by: Northumbria University 
 
Number of participant points / payment:0 / £150 
 
 
         INFORMATION TO POTENTIAL PARTICIPANTS 
1. What is the purpose of the project? 
The purpose of the project is to investigate levels of a specific hormone (cortisol) in healthy, 
good sleepers both upon awakening and throughout the course of the day, within a sleep 
laboratory. 
 
2. Why have I been selected to take part? 
You are a healthy, non-smoking individual, aged between 18-40 who has indicated that you 
would like to take part. 
 
3. What will I have to do? 
In the two weeks before visiting the sleep laboratory, you will complete a sleep diary 
providing details including the time you went to bed, how long it took you to get to sleep, and 
what time you woke up. In this period you will also wear an actiwatch  (a small wrist-watch 
like device worn like a watch) which will measure your movements. If you are female you will 
be asked basic questions regarding your menstrual cycle and oral contraceptive use as 
these can both affect the hormone we are measuring. Please try as best as you can to keep 
the time you go to bed and get up relatively stable during this two-week period. 
 
Your participation in the study will last three days in total, and you will stay overnight in the 
sleep laboratory during the first night, having electrodes applied to your scalp and body to 
measure various aspects of your sleep. The electrodes are for measurement purposes only 
and cannot themselves generate any electrical signals. The equipment that will be attached 
to you is specially designed to be worn whilst you sleep, and is hard-wearing. Two research 
staff will remain in the sleep research unit at all times and will monitor you sleeping via 
bedroom CCTV which will record audio and video for your safety. You will go to bed at your 
usual bedtime, and you will then be woken up at the usual time you awake based on the 
information you provided, and will be asked to provide saliva samples immediately upon 
awakening and 15, 30, 45 and 60 minutes after this. This will be done by chewing on a 
dental cotton swab for approximately a minute. For the first hour after you awake, you will 
not be allowed to eat or brush your teeth as this can interfere with the measurements we are 
taking. You will be allowed to drink water.  
 
You will then be free to leave the sleep laboratory whilst still wearing the actiwatch, and you 
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will be asked to return to the sleep laboratory with the actiwatch the following evening at 
8pm. You will stay a second night in the sleep laboratory, will again be woken at your usual 
awakening time, and will be asked to provide saliva samples immediately upon awakening 
and 15, 30, 45 and 60 minutes later in the same manner as before. You will then provide 
saliva samples every hour in the same way until it is your usual bedtime, and you will not be 
able to take anything by mouth for 30 minutes before each sample. During the day you will 
be free to perform activities such as reading books and watching films within the sleep 
laboratory, but you will not be permitted to leave the laboratory. 
 
You will then spend a final night in the sleep laboratory in the same way as before. and will 
again be woken at your usual awakening time in order provide a saliva sample immediately. 
You will then again provide samples 15, 30, 45 and 60 minutes after you awake, and you will 
then be free to leave the sleep laboratory. 
 
4. What are the exclusion criteria (i.e. are there any reasons why I should not take 
part)?  
You will be unable to take part in the study if you are currently a shift worker, as this may 
mean you have an unstable sleep/wake cycle. You also cannot take part if you are suffering 
from any sleep disorders (e.g. jet lag or insomnia), if you have any uncontrolled illnesses, or 
if you suffer from any disorders including depression or hormonal disorders. You cannot take 
part in this study if you currently smoke, as this can affect the measurements we are taking. 
You cannot take part if you are under 18 or are over 40 years of age. We request that you 
do not participate in any other research studies whilst taking part in the current study, 
including within the two-week period where you wear the actiwatch and fill out the sleep 
diary, as this may result in your exclusion from the study. We would request that you provide 
us with full details of any other study if you believe this may be the case. 
 
5. Will my participation involve any physical discomfort? 
The sleep laboratory is designed to be a comfortable environment similiar to a home 
environment. Whilst you are unlikely to suffer any physical discomfort, the application of 
electrode conducting gel may cause minor irritation. You will be able to withdraw from the 
study at any time by informing the researcher. 
 
6. Will my participation involve any psychological discomfort or embarrassment? 
Your participation is unlikely to involve any psychological discomfort or embarrassment. It is 
possible that you may find your first night in the sleep laboratory to be unusual.  
 
7. Will I have to provide any bodily samples (i.e. blood, saliva)? 
You will have to provide saliva samples throughout the study as described earlier, and this 
will be carried out by appropriately-trained staff in accordance with risk-assessed 
procedures.  
 
8. How will confidentiality be assured? 
All data provided will be completely anonymous, and will not be linked to you in any manner. 
You will be allocated a participant code that will always be used to identify any data that you 
provide. Your name or other personal details will not be associated with your data, for 
example the consent form that you sign will be kept separate from your data. 
 
Only the research team will have access to any identifiable information; paper records will be 
stored in a locked filing cabinet and electronic information will be stored on a password-
protected computer. This will be kept separate from any data and will be treated in 
accordance with the Data Protection Act. 
 
9. Who will have access to the information that I provide? 
Any information and data gathered during this research study will only be available to the 
research team identified in the information sheet. Should the research be presented or 
published in any form, then that information will be generalized (i.e. your personal 
information or data will not be identifiable).  Only the research team will have access to any 
identifiable information; paper records will be stored in a locked filing cabinet and electronic 
information will be stored on a password-protected computer. This will be kept separate from 
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any data and will be treated in accordance with the Data Protection Act. 
 
10. How will my information be stored / used in the future? 
All information and data gathered during this research will be stored in line with the Data 
Protection Act. During that time the data may be used by members of the research team 
only for purposes appropriate to the research question, but at no point will your personal 
information or data be revealed. Insurance companies and employers will not be given any 
individual’s information, samples, or test results, and nor will we allow access to the police, 
security services, social services, relatives or lawyers, unless forced to do so by the courts. 
 
11. Has this investigation received appropriate ethical clearance? 
Yes, the study and its protocol has received full ethical approval from the Northumbria 
University School of Life Sciences Ethics Committee. 
 
12. Will I receive any financial rewards / travel expenses for taking part? 
Yes. You will recieve £150 payable upon full completion of the study for your time. If you 
withdraw before the end of the study you will receive £25 payment upon completion of the 
first night, or £75 after the second night. 
 
13. How can I withdraw from the project? 
During the study itself, if you do decide that you do not wish to take any further part then 
please inform one of the research team as soon as possible, and they will facilitate your 
withdrawal and discuss with you how you would like your data to be treated in the future. 
After you have completed the research you can still withdraw your data by contacting one of 
the research team (their contact details are provided in section 14).  
 
If, for any reason, you wish to withdraw your data please contact the investigator within a 
month of your participation. After this date, it may not be possible to withdraw your individual 
data as the results may already have been published. As all data are anonymised, your 
individual data will not be identifiable in any way. 
 
14. If I require further information who should I contact and how? 
If you require further information regarding the study, would like to withdraw your data, or to 
make a complaint you can either contact the principal investigator (Greg Elder - 
greg.elder@northumbria.ac.uk) or Dr. Jason Ellis (jason.ellis@northumbria.ac.uk) 
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Appendix Q 
Example participant consent forms for feasibility study (laboratory participants) and 
Study 1  
 
 
 
 
Signature of participant.......................................................    Date.....……………….. 
 
 
(NAME IN BLOCK LETTERS)....................................................………………………. 
 
 Signature of Parent / Guardian in the case of a minor  
 
......................................................................................... 
 
 
 
Signature of researcher.......................................................    Date.....……………….. 
 
 
(NAME IN BLOCK LETTERS)....................................................………………………. 
 
  
INFORMED CONSENT FORM 
 
 
Project Title: Measuring the cortisol awakening response in good sleepers within a controlled  
sleep environment  
 
Principal Investigator: Greg Elder 
Participant Number: ______ 
 
               please tick  
  where applicable 
I have read and understood the Participant Information Sheet (Version 1.2, Feb 2011)  
 
I have had an opportunity to ask questions and discuss this study and I have received 
satisfactory answers.   
I understand I am free to withdraw from the study at any time, without having to give a 
reason for withdrawing, and without prejudice.   
I agree to take part in this study.  
 
I would like to receive feedback on the overall results of the study at the email address 
given below.  I understand that I will not receive individual feedback on my own 
performance. 
 
Email address…………………………………………………………………… 
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                 FOR USE WHEN VIDEO/TAPE RECORDINGS WILL BE TAKEN 
 
Project title: Measuring the cortisol awakening response in good sleepers within a  
controlled sleep environment 
 
Principal Investigator: Greg Elder 
 
Participant Number: ______ 
 
I hereby confirm that I give consent for the following recordings to be made: 
 
Recording Purpose Consent 
Video of bodily movements during 
sleep 
 
To assess any undiagnosed sleep 
problems and to monitor your 
safety overnight  
 
Sound recordings 
 
To assess any snoring events that 
occur overnight and to monitor your 
safety  
 
 
Clause A: I understand that other members of the Northumbria Centre for Sleep 
Research  may be exposed to the recording(s) and be asked to provide judgements. 
The outcome of such judgements will not be conveyed to me unless it is discovered I 
have a sleep problem that is detrimental to my health. My name or other personal 
information will never be associated with the recording(s).  
 
Tick the box to indicate your consent to Clause A              
 
 
 
Signature of participant.......................................................    Date.....……………….. 
 
Signature of Parent / Guardian in the case of a minor  
 
.........................................................................................      Date.....……………….. 
 
Signature of researcher.......................................................    Date.....……………….. 
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FOR USE WHEN TISSUE IS BEING REMOVED AND STORED 
 
Project Title: Measuring the cortisol awakening response in good sleepers within a  
controlled sleep environment 
 
Principal Investigator: Greg Elder 
 
Participant Number: __________ 
 
I agree that the following tissue or other bodily material may be taken and used for 
the study:  
 
Tissue/Bodily material Purpose Removal Method 
e.g. saliva 
 
e.g. for cortisol analysis e.g. via Salicaps 
Saliva 
 
For cortisol analysis Saliva collection tubes 
 
I understand that if the material is required for use in any other way than that 
explained to me, then my consent to this will be specifically sought. I understand that 
I will not receive specific feedback from any assessment conducted on my samples, 
but should any kind of abnormality be discovered then the investigator will contact 
me.  
 
I understand that the University may store this tissue in a Licensed Tissue 
Bank only for the duration of the study, it will then be destroyed. 
 
Method of disposal:    
Clinical Waste              
 
Other                            
 
If other please specify........................................................... 
 
I consent to the University distributing this tissue to partners in this research 
study, outside of the University, for further testing (please tick the box if you 
agree).                                                                     
 
                                                        
Signature of participant.......................................................    Date.....……………….. 
         
Signature of researcher.......................................................    Date.....……………….. 
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Appendix R 
Example participant debrief sheet for feasibility study (laboratory participants) and 
Study 1  
 
 
PARTICIPANT DEBRIEF 
 
TITLE OF PROJECT: Measuring the cortisol awakening response in good sleepers  
within a controlled sleep environment 
 
Principal Investigator: Greg Elder 
 
Investigator contact details:  
Northumbria Centre for Sleep Research, NB408 Northumberland Building,  
Northumbria University NE1 8ST 
Email: greg.elder@northumbria.ac.uk 
 
Participant Identification Number: __________ 
 
1. What was the purpose of the project? 
The purpose of the project was to investigate the pattern of the levels of a specific stress 
hormone (cortisol) both when you woke up, and over the course of a day. This particular 
hormone can be detected in saliva. The patterns of this hormone have not been examined in 
healthy people who have been staying in a sleep laboratory, and the purpose of the project 
was to develop a way of investigating this hormone so we can test and help develop 
treatments for individuals with sleep problems. 
 
2. How will I find out about the results? 
You can be notified of the results of the study after completion, via email or post, if you 
provide the researcher with these details. The researcher will email or post a general 
summary of results will be emailed or posted to you approximately 12 weeks following the 
completion of the study. 
 
3. Will I receive any individual feedback? 
You can receive a general summary of the research findings. This is standard research 
practice and is to protect your anonymity. You can request to see the information we have 
however we cannot provide feedback regarding this. 
 
4. What will happen to the information I have provided? 
You be allocated a participant number that will always be used to identify any data that you 
provide, and your name or other personal details will not be associated with your data. The 
information you have provided will then be combined with the information of other volunteers 
in order to provide meaningful results. You will not be identified at any point and all data will 
be completely anonymous. 
 
5. How will the results be disseminated? 
It is expected that the results of the study will be disseminated through presentations and 
publications. 
 
6. Have I been deceived in any way during the project? 
No, you have not been deceived in any way during this project. 
 
7. If I change my mind and wish to withdraw the information I have provided, how do I 
do this? 
If you wish to withdraw the information you have provided, please contact the principal 
investigator at the above postal or email address. All information will then be destroyed. 
336 
 
 
If you have any concerns or worries concerning the way in which this research has been 
conducted, or if you have requested, but did not receive feedback from the principal 
investigator concerning the general outcomes of the study within a few weeks after the study has 
concluded, then please contact Chair of the School Ethics Committee, Dr Nick Neave via email 
at nick.neave@northumbria.ac.uk. 
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Appendix S 
Example participant information sheet: Study 2 
 
 
 
    PARTICIPANT INFORMATION. 
 
TITLE OF PROJECT: Measuring the effects of cognitive demand upon sleep 
and cortisol. 
 
Participant ID Number:   
 
Principal Investigator: Greg Elder 
 
Investigator contact details:    
Northumbria Centre for Sleep Research,  
NB408 Northumberland Building,  
Northumbria University NE1 8ST 
Email: greg.elder@northumbria.ac.uk 
 
This project is funded by: Northumbria University 
Number of participant points / payment: 0 / £150 
 
 
         INFORMATION TO POTENTIAL PARTICIPANTS 
1. What is the purpose of the project? 
The purpose of the project is to investigate the effects of mentally demanding tasks 
upon sleep, and levels of a specific hormone called cortisol, which plays a role in 
regulating sleep and wake periods.  The study will be conducted in healthy, good 
sleepers within a sleep laboratory. 
 
2. Why have I been selected to take part? 
You are a healthy, non-smoking, individual, aged between 18-40 with a stable 
sleep-wake cycle, who has indicated that you would like to take part. 
 
3. What will I have to do? 
In the two weeks before visiting the sleep laboratory, you will complete a sleep diary 
providing details including the time you went to bed, how long it took you to get to 
sleep, and the time at which you woke up. In this period you will also wear an 
actiwatch (a small device which measures movement, worn like a watch) which will 
measure your movements. Please try as best as you can to keep the time which 
you go to bed and the time at which you get up relatively stable during this two-
week period. 
 
Your participation in the study will last three days in total, and you will sleep for 
three nights (Nights 1 – 3) and stay for one full day (from Morning 2 until Night 3) in 
the sleep laboratory. Each night you will have electrodes applied to your scalp and 
body to measure various aspects of your sleep. The electrodes are for 
measurement purposes only and cannot themselves generate any electrical signals, 
and the equipment that will be attached to you is specially designed to be worn 
whilst you sleep. Two research staff will remain in the sleep research laboratory at 
all times and will monitor you sleeping via bedroom CCTV which will record audio 
Version 1.0 
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and video for your safety. You will also be asked to complete a booklet of 
questionnaires on Night 1. If you are female, you will be asked basic questions 
regarding your menstrual cycle and oral contraceptive use as these can both affect 
the hormone we are measuring. You will be asked to again wear an actiwatch from 
your arrival at the sleep laboratory on Night 1, until you complete the study on 
Morning 3. 
 
You will go to bed at your usual bedtime each night after providing us with a saliva 
sample, which will be done by chewing on a dental cotton swab for approximately a 
minute. You will not be allowed to eat or brush your teeth for a period of one hour 
before each sample when you are in the laboratory as this can interfere with the 
measurements we are taking. Each morning, you will be woken up at a specified 
time based on your usual sleeping patterns, and will be asked to provide saliva 
samples immediately, and 15, 30, 45, 60 and 120 minutes after this. For the first 
hour after you wake, you will remain in bed in low light and will be allowed to nap 
between each sample if you wish. During this time, You will be allowed to drink a 
small amount of water following the first sample if required. You will also be asked 
to complete a sleep and mood diary before you get out of bed. Once you have 
completed the sleep and mood diary we will remove any equipment you are wearing 
and will allow you time to get ready, before we take the final saliva sample (120 
minutes after your wake time) 
 
On Morning 1 (the first morning you wake up in the lab) you will be free to leave the 
sleep laboratory whilst wearing an actiwatch, and you will be asked to return to the 
sleep laboratory with the actiwatch later that day for your second night.  
 
On Morning 2, you will provide saliva samples in the same manner as on Morning 1. 
Following this, you will remain in the sleep laboratory for a full day and will be 
required to complete a range of mentally demanding computerised tests throughout 
this day. These tests will include measures of attention, decision-making and multi-
tasking, and will be explained in full on the second morning. Your performance will 
be monitored and it is very important that you perform as well as you possibly 
can on these tasks. These tasks will last between 5 and 20 minutes depending on 
the task which you complete, and you will complete these at hourly intervals until 
late evening/night-time. We will also measure your mood before and after each task, 
and we will also ask you the amount of effort you put into each task. You will also be 
required to provide additional saliva samples at several time points on this day. 
 
On Morning 3, you will provide saliva samples in the same way as on the previous 
two mornings. You will then receive a full debrief and you will then be free to leave 
the sleep laboratory.  
 
Please note that you will not be allowed to have any electrical equipment in your 
bedroom with you at any time during your stay, as this may interfere with our 
equipment. 
 
4. What are the exclusion criteria (i.e. are there any reasons why I should not 
take part)?  
You will be unable to take part in the study if you are currently a shift worker, as this 
may mean you have an unstable sleep/wake cycle. You also cannot take part if you 
are suffering from any sleep disorders (e.g. jet lag or insomnia), if you have taken a 
trans-meridian flight within the previous three months, if you have any uncontrolled 
illnesses, or if you suffer from any disorders including depression or hormonal 
disorders. You cannot take part in this study if you currently smoke, as this can 
affect the measurements we are taking. You cannot take part if you are under 18 or 
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are over 40 years of age, and you may be unable to take part in this study if you 
have previously taken part in a study within the Northumbria Centre for Sleep 
Research.  
 
5. Will my participation involve any physical discomfort? 
The sleep laboratory is designed to be a comfortable environment very similar to 
your home environment. Whilst you are unlikely to suffer any physical discomfort, 
the application of electrode conducting gel may cause minor irritation. You will be 
able to withdraw from the study at any time by informing the researcher. 
 
6. Will my participation involve any psychological discomfort or 
embarrassment? 
Your participation is unlikely to involve any psychological discomfort or 
embarrassment. It is possible that you may find your first night in the sleep 
laboratory to be unusual. 
 
7. Will I have to provide any bodily samples (i.e. blood, saliva)? 
You will have to provide saliva samples throughout the study as described earlier, 
and this will be carried out by appropriately-trained staff in accordance with risk-
assessed procedures. 
 
8. How will confidentiality be assured? 
All data provided will be completely anonymous, and will not be linked to you in any 
manner. You will be allocated a participant code that will always be used to identify 
any data that you provide. Your name or other personal details will not be 
associated with your data, for example the consent form that you sign will be kept 
separate from your data. 
 
Only the research team will have access to any identifiable information; paper 
records will be stored in a locked filing cabinet and electronic information will be 
stored on a password-protected computer. This will be kept separate from any data 
and will be treated in accordance with the Data Protection Act. 
 
9. Who will have access to the information that I provide? 
Any information and data gathered during this research study will only be available 
to the research team identified in the information sheet. Should the research be 
presented or published in any form, then that information will be generalized (i.e. 
your personal information or data will not be identifiable).  Only the research team 
will have access to any identifiable information; paper records will be stored in a 
locked filing cabinet and electronic information will be stored on a password-
protected computer. This will be kept separate from any data and will be treated in 
accordance with the Data Protection Act. 
 
10. How will my information be stored / used in the future? 
All information and data gathered during this research will be stored in line with the 
Data Protection Act. During that time the data may be used by members of the 
research team only for purposes appropriate to the research question, but at no 
point will your personal information or data be revealed. Insurance companies and 
employers will not be given any individual’s information, samples, or test results, 
and nor will we allow access to the police, security services, social services, 
relatives or lawyers, unless forced to do so by the courts. 
 
11. Has this investigation received appropriate ethical clearance? 
Yes, the study and its protocol have received full ethical approval from the 
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Northumbria University School of Life Sciences Ethics Committee. 
 
12. Will I receive any financial rewards / travel expenses for taking part? 
Yes. You will receive £150 payable upon full completion of the study for your time. If 
you withdraw before the end of the study you will receive £25 payment upon 
completion of the first night, or £75 after the second night. Additionally, you will have 
the chance to win an iPad if you achieve the highest score on a randomly-selected 
task, taken from the set of cognitive tasks you will be required to complete following 
your second morning in the sleep laboratory. 
 
13. How can I withdraw from the project? 
During the study itself, if you do decide that you do not wish to take any further part 
then please inform one of the research team as soon as possible, and they will 
facilitate your withdrawal and discuss with you how you would like your data to be 
treated in the future. After you have completed the research you can still withdraw 
your data by contacting one of the research team (their contact details are provided 
in section 14).  
 
If, for any reason, you wish to withdraw your data please contact the investigator 
within a month of your participation. After this date, it may not be possible to 
withdraw your individual data as the results may already have been published. As 
all data is anonymous, your individual data will not be identifiable in any way. 
 
14. If I require further information who should I contact and how? 
If you require further information regarding the study, would like to withdraw your 
data, or to make a complaint you can either contact the principal investigator (Greg 
Elder - greg.elder@northumbria.ac.uk) or Dr. Jason Ellis 
(jason.ellis@northumbria.ac.uk) 
 
 
  
341 
 
Appendix T 
Participant consent forms: Study 2 
 
 
 
 
 
Signature of participant.......................................................    Date.....……………….. 
 
 
(NAME IN BLOCK LETTERS)....................................................………………………. 
 
 Signature of Parent / Guardian in the case of a minor  
 
......................................................................................... 
 
 
 
Signature of researcher.......................................................    Date.....……………….. 
 
 
(NAME IN BLOCK LETTERS)....................................................………………………. 
 
  
INFORMED CONSENT FORM 
 
 
Project Title:   Measuring the effects of cognitive demand upon sleep and cortisol. 
 
Principal Investigator: Greg Elder 
Participant Number: ______ 
 
               please tick  
  where applicable 
I have read and understood the Participant Information Sheet (Version 1.0, May 2012)  
 
I have had an opportunity to ask questions and discuss this study and I have received 
satisfactory answers.   
I understand I am free to withdraw from the study at any time, without having to give a 
reason for withdrawing, and without prejudice.   
I agree to take part in this study.  
 
I would like to receive feedback on the overall results of the study at the email address 
given below.  I understand that I will not receive individual feedback on my own 
performance. 
 
Email address…………………………………………………………………… 
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                 FOR USE WHEN VIDEO/TAPE RECORDINGS WILL BE TAKEN 
 
Project title: Measuring the effects of cognitive demand upon sleep and 
cortisol. 
 
Principal Investigator: Greg Elder 
 
Participant Number: ______ 
 
I hereby confirm that I give consent for the following recordings to be made: 
 
Recording Purpose Consent 
Video of bodily movements during 
sleep 
 
To assess any undiagnosed sleep 
problems and to monitor your 
safety overnight  
 
Sound recordings 
 
To assess any snoring events that 
occur overnight and to monitor your 
safety  
 
 
Clause A: I understand that other members of the Northumbria Centre for Sleep 
Research  may be exposed to the recording(s) and be asked to provide judgements. 
The outcome of such judgements will not be conveyed to me unless it is discovered I 
have a sleep problem that is detrimental to my health. My name or other personal 
information will never be associated with the recording(s).  
 
Tick the box to indicate your consent to Clause A              
 
 
 
Signature of participant.......................................................    Date.....……………….. 
 
Signature of Parent / Guardian in the case of a minor  
 
.........................................................................................      Date.....……………….. 
 
Signature of researcher.......................................................    Date.....……………….. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FOR USE WHEN TISSUE IS BEING REMOVED AND STORED 
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Project Title: Measuring the effects of cognitive demand upon sleep and 
cortisol. 
 
Principal Investigator: Greg Elder 
 
Participant Number: __________ 
 
I agree that the following tissue or other bodily material may be taken and used for 
the study:  
 
Tissue/Bodily material Purpose Removal Method 
e.g. saliva 
 
e.g. for cortisol analysis e.g. via Salicaps 
Saliva 
 
For cortisol analysis Salivettes 
 
I understand that if the material is required for use in any other way than that 
explained to me, then my consent to this will be specifically sought. I understand that 
I will not receive specific feedback from any assessment conducted on my samples, 
but should any kind of abnormality be discovered then the investigator will contact 
me.  
 
I understand that the University may store this tissue in a Licensed Tissue 
Bank only for the duration of the study, it will then be destroyed. 
 
Method of disposal:    
Clinical Waste              
 
Other                            
 
If other please specify........................................................... 
 
I consent to the University distributing this tissue to partners in this research 
study, outside of the University, for further testing (please tick the box if you 
agree).                                                                     
 
                                                        
Signature of participant.......................................................    Date.....……………….. 
         
Signature of researcher.......................................................    Date.....……………….. 
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Actiwatch returned: 
 
Signature of participant: .......................................................    
Date.....……………….. 
 
Signature of researcher:.......................................................    Date.....……………….. 
 
 
 
ACTIWATCH SIGN OUT / ACTIWATCH RETURN SHEET 
 
 
Project title:  Measuring the effects of cognitive demand upon sleep and cortisol. 
 
Principal Investigator:  Greg Elder 
 
Participant Number: .......................................................    
 
Actiwatch serial number: .......................................................    
 
Participant contact number: .......................................................    
 
 
 
I understand that I am responsible for the actiwatch at all times and  
may have to replace it if it is lost or damaged whilst in my posession. 
 
 
 
Actiwatch signed out: 
 
Signature of participant: .......................................................    Date.....……………….. 
 
Signature of researcher:.......................................................    Date.....……………….. 
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Driving Disclaimer. 
 
 
Dear Participant, 
 
 
Due to the nature of the research we request that for your safety you do not drive or operate heavy 
machinery after leaving the Northumbria Centre for Sleep Research. As you have slept in an 
environment that is not your usual, please be aware that although you may feel fine, there is a risk you 
could become drowsy.  
 
 
Due to this we advise you to either get public transport to your next destination, and if this is not 
suitable we will be able to arrange a Taxi for you. Therefore the Northumbria Centre for Sleep 
Research associates will accept no responsibility should you choose to drive or do an activity that may 
pose a safety risk if your performance is impaired by drowsiness. 
 
 
Thank You 
 
Northumbria Centre for Sleep Research. 
 
 
Participant name:___________________________________ 
 
 
I have read and understood the above information: Signed: 
______________________Date_____/_____/_____ 
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Appendix U 
Participant debrief form – Study 2 
PARTICIPANT DEBRIEF 
 
 
TITLE OF PROJECT: Measuring the effects of cognitive demand upon sleep 
and cortisol. 
 
Principal Investigator: Greg Elder  
  
Investigator contact details:  
Northumbria Centre for Sleep Research,  
NB408 Northumberland Building,  
Northumbria University NE1 8ST 
Email: greg.elder@northumbria.ac.uk 
 
Participant Identification Number: __________ 
 
 
1. What was the purpose of the project? 
The purpose of the project was to investigate how both the experience of cognitive 
demand and the anticipation of forthcoming demand can affect both sleep and the 
levels of cortisol, a stress hormone which can be detected in the saliva samples you 
provided.  
 
Half of the participants in this study will have completed the cognitive tasks 
described to you in the start of the study, allowing us to examine how the effects of 
realistic cognitive demands can affect your sleep and cortisol. The other half of 
participants who took part in this study will have been told on the day of the 
cognitive testing that they were no longer required to complete any of the tests. This 
will allow us to examine sleep and cortisol in those who anticipated completing the 
tasks, but did not actually do any of them.  
 
All the sleep and cortisol measurements from this study will be compared to those 
from an earlier study in which people slept normally, allowing us to investigate how 
the expectation of demands may affect sleep quality. 
 
2. How will I find out about the results? 
Following completion of the study, the researcher will provide participants with a 
detailed explanation of the study and an explanation of the results. This will be sent 
to you by email approximately 12 weeks following the completion of the study. 
 
3. Will I receive any individual feedback? 
Individual feedback can be provided upon request, but this may not include any 
interpretation of scores. 
 
4. What will happen to the information I have provided? 
You be allocated a participant number that will always be used to identify any data 
that you provide, and your name or other personal details will not be associated with 
your data. The information you have provided will then be combined with the 
information of other volunteers in order to provide meaningful results. You will not 
be identified at any point and all data will be completely anonymous. 
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5. How will the results be disseminated? 
It is expected that the results of the study will be disseminated through 
presentations and publications. 
 
6. Have I been deceived in any way during the project? 
Yes. As explained in section 1, only half of the participants in this study will have 
completed the cognitive tasks which you were told you would have to complete in 
the study, and the remaining half will have been told on the day that they were not 
required to complete any of the tasks. This allows us to examine the effects of 
cognitive demand caused by completing the computerised tasks, and the 
anticipation of the demand by believing that you were going to complete the tasks, 
have upon your sleep and on your cortisol levels. 
 
If you completed the cognitive testing, you will have been informed that your 
performance would be closely monitored and you would have the chance to win an 
iPad if you achieved the highest score on a randomly-selected cognitive task. This 
is not the case as your performance will not be examined, but it was necessary for 
us to make sure that you were highly motivated throughout the day. If you did not 
complete the cognitive testing, you will have had these reasons explained to you at 
the start of your full day.  
 
To ensure fairness, all participants who took part in this study will be placed 
into a prize draw for an iPad, which will be drawn randomly by an independent 
party when the study is complete. 
 
7. If I change my mind and wish to withdraw the information I have provided, 
how do I do this? 
If you wish to withdraw the information you have provided, please contact the 
principal investigator at the above postal or email address. All information will then 
be destroyed. 
 
If you have any concerns or worries concerning the way in which this research has 
been conducted, or if you have requested, but did not receive feedback from the 
principal investigator concerning the general outcomes of the study within a few weeks 
after the study has concluded, then please contact Chair of the School Ethics 
Committee, Dr Nick Neave via email at nick.neave@northumbria.ac.uk. 
 
 
 
 
 
 
 
 
 
 
